





The protein network of the Rnf-proline reductase  




Von der Fakultät für Lebenswissenschaften 
der Technischen Universität Carolo-Wilhelmina zu Braunschweig 
zur Erlangung des Grades  
einer Doktorin der Naturwissenschaften 
(Dr. rer. nat.) 
genehmigte 
D i s s e r t a t i o n 
 
 




































1. Referent: Professor Dr. Dieter Jahn 
2. Referent: Professor Dr. Lothar Jänsch 
Eingereicht am: 16.12.2020 




Vorveröffentlichungen der Dissertation 
Teilergebnisse aus dieser Arbeit wurden mit Genehmigung der Fakultät für  




K. E. Rennhack, J. Wissing, M. Müsken, S. E. Will, I. Pusch, L. Jänsch, M. Rohde, M. 
Neumann-Schaal, D. Jahn and J. M. Borrero de Acuña: High-ordered electron transfer 
complex assembly during Stickland fermentation in Clostridioides difficile. (Talk). Annual 
conference of the VAAM, Leipzig (Germany) (2020) 
 
K. E. Rennhack, J. Wissing, M. Müsken, S. E. Will, I. Pusch, L. Jänsch, M. Rohde, M. Neu-
mann-Schaal, D. Jahn and J. M. Borrero de Acuña: High-ordered electron transfer com-
plex assembly during Stickland fermentation in Clostridioides difficile. (Progress report). 
PROCOMPAS Retreat, Königslutter (Germany) (2019) 
 
K. E. Rennhack, J. Wissing, I. Pusch, D. Jahn and J. M. Borrero de Acuña: High-ordered 
electron transfer complex assembly during Stickland fermentation in Clostridioides  
difficile. (Lightning talk #20). Gordon Research Conference (Molecular Form and  
Function of Proteins, in Nature and by Design), Holderness (US) (2019) 
 
K. E. Rennhack, J. Wissing, I. Pusch, L. Jänsch, D. Jahn and J. M. Borrero de Acuña:  
Protein-protein interactions involved in the Stickland fermentation in Clostridioides  




K. E. Rennhack, J. Wissing, I. Pusch, D. Jahn and J. M. Borrero de Acuña: High-ordered 
electron transfer complex assembly during Stickland fermentation in Clostridioides  
difficile. (Poster). Gordon Research Conference (Molecular Form and Function of  
Proteins, in Nature and by Design), Holderness (US) (2019) 
 
K. E. Rennhack, J. Wissing, I. Pusch, D. Jahn and J. M. Borrero de Acuña: Interactomic 
studies of proteins involved in the Stickland fermentation of Clostridioides difficile. 
(Poster). Annual conference of the VAAM, Mainz (Germany) (2019) 
 
K. E. Rennhack, D. Jahn and J. M. Borrero de Acuña: Interactomic studies of proteins 
involved in the Stickland fermentation of Clostridioides difficile. (Poster). 6th ICDS  





K. E. Rennhack, D. Jahn and J. M. Borrero de Acuña: Interactomic studies of proteins 
involved in the Stickland fermentation of Clostridioides difficile. (e-Poster). Annual  
































Table of contents 
Abbreviations ............................................................................................................ I 
1 Introduction ......................................................................................................... 1 
1.1 The gut microbiota of the human gastrointestinal tract ................................................... 1 
1.2 The human pathogen Clostridioides difficile and the CDI ................................................. 2 
1.2.1 The key players of the C. difficile pathogenesis ......................................................... 4 
1.2.2 Regulation of toxin gene expression in C. difficile ..................................................... 6 
1.3 Energy metabolism of the anaerobic bacterium C. difficile .............................................. 7 
1.3.1 Stickland fermentation reaction ................................................................................ 7 
1.3.2 CO2 -assimilation and energy generation via the Wood-Ljungdahl pathway ............ 9 
1.3.3 Ion-gradient formation during butyrate fermentation in C. difficile ....................... 10 
1.3.4 Ferredoxin:NAD+-oxidoreductase - Rnf complex ..................................................... 12 
1.4 Protein-protein interactions (PPIs) .................................................................................. 14 
1.4.1 Interactomics for the determination of cellular protein-protein networks ............ 14 
2 Aim of this study ................................................................................................ 17 
3 Materials and methods ...................................................................................... 18 
3.1 Materials .......................................................................................................................... 18 
3.1.1 Equipment ................................................................................................................ 18 
3.1.2 Resources ................................................................................................................. 21 
3.1.3 Chemicals, enzymes and kits ................................................................................... 23 
3.1.4 Strains of bacteria, plasmids and primers................................................................ 26 
3.2 Microbiological methods ................................................................................................. 31 
3.2.1 Sterilisation .............................................................................................................. 31 
3.2.2 Media and media supplements ............................................................................... 31 
3.2.3 Anaerobisation of solutions ..................................................................................... 33 
3.2.4 Determining the cell density .................................................................................... 33 
3.2.5 Cultivation of E. coli DH10B and E. coli ST18 strains ................................................ 34 
3.2.6 Cultivation of C. difficile 630∆erm ........................................................................... 34 
3.2.7 Characterization of the growth behavior of C. difficile 630Δerm ............................ 34 
3.2.8 Bacteria storage ....................................................................................................... 34 
3.3 Molecular biological methods ......................................................................................... 35 
3.3.1 Preparation of chemocompetent E. coli strains using CaCl2 .................................... 35 
3.3.2 Transformation of E. coli cells .................................................................................. 35 
3.3.3 Transfer of plasmid DNA in C. difficile 630Δerm (conjugation) ............................... 35 
3.3.4 Isolation of DNA from C. difficile 630Δerm .............................................................. 36 
3.3.5 Isolation of RNA from C. difficile 630∆erm .............................................................. 36 
3.3.6 Isolation of plasmid DNA from E. coli cells .............................................................. 37 
3.3.7 Determination of the DNA or RNA concentration by using Qubit® 3 fluorometer .. 37 
3.3.8 Agarose gel electrophoresis ..................................................................................... 37 
3.3.9 Polymerase chain reaction (PCR) ............................................................................. 38 
3.3.10 Construction of Prd and Rnf bait protein production vectors ................................ 39 
3.3.11 Mutagenesis in C. difficile 630∆erm using ClosTron® technology ........................... 44 
 
 
3.4 Affinity purification coupled with mass spectrometry – Protein production and bait-prey 
purification ...................................................................................................................... 47 
3.4.1 Recombinant bait protein production and cross-linking in C. difficile 630∆erm ..... 48 
3.4.2 Cell disruption and separation of the insoluble and soluble fraction ...................... 49 
3.4.3 Affinity chromatography of the bait-prey complexes ............................................. 49 
3.4.4 Storage and regeneration of the Strep-Tactin® column .......................................... 51 
3.4.5 Determination of protein concentration with Qubit® 3 fluorometer ..................... 51 
3.5 Biochemical methodes for the characterization of protein-protein  interactions .......... 52 
3.5.1 Discontinuous SDS-PAGE ......................................................................................... 52 
3.5.2 Detection of bait proteins by Western blot analysis ............................................... 53 
3.5.3 Preparation of gel-based LC-MS/MS samples ......................................................... 55 
3.5.4 Preparation of gel-free LC-MS/MS samples............................................................. 55 
3.5.5 LC-MS/MS measurements of gel-based and gel-free samples ................................ 56 
3.5.6 Analysis of the LC-MS/MS data ................................................................................ 56 
3.5.7 Double immunogold labeling detecting by transmission electron microscopy ...... 57 
3.6 Characterization of the rnfC mutant strain and multi-omic experiments....................... 60 
3.6.1 Growth behavior and phenotypic characterization by scanning electron  
microscopy ............................................................................................................... 60 
3.6.2 Bacteria cell preparation for the D-proline reductase activity assays, NAD+/NADH 
ratio determination, toxin ELISA and Omic experiments ........................................ 61 
3.6.3 Fluorometric assay of the D-proline reductase activity ........................................... 62 
3.6.4 NAD+/NADH ratio determination ............................................................................. 63 
3.6.5 Determination of the concentration of the toxins TcdA and TcdB via sandwich  
ELISA ......................................................................................................................... 64 
3.6.6 Multi-omic experiments........................................................................................... 65 
3.7 In vivo characterization of the rnfC mutant strain .......................................................... 68 
3.7.1 Mice infection experiments with C. difficile 630Δerm ............................................. 68 
4 Results ............................................................................................................... 70 
4.1 Identification of protein-protein interactions during Stickland  fermentation in  .............. 
 C. difficile 630∆erm – rationale of the approach ..................................................... 70 
4.1.1 Background control for the used interactomics approach ...................................... 71 
4.1.2 Interaction partners of the D-proline reductase subunits PrdA and PrdB in the 
absence of the cross-linker formaldehyde .............................................................. 72 
4.1.3 Interaction partners of the Rnf complex subunits RnfB and RnfC in absence of the 
cross-linker formaldehyde ....................................................................................... 75 
4.1.4 Interaction partners of the D-proline reductase subunits PrdA and PrdB in presence 
of the cross-linker formaldehyde ............................................................................. 77 
4.1.5 Interaction partners of the Rnf complex subunits RnfB and RnfC in presence of the 
cross-linker formaldehyde ....................................................................................... 80 
4.1.6 Summary of the strong-binary and cross-linked protein-protein interactions of the 
baits PrdA, PrdB, RnfB and RnfC .............................................................................. 83 
4.2 Identification and quantification of the bait-prey interactions between the Rnf complex 
and D-proline reductase with a gel-free LC-MS/MS approach ....................................... 86 
4.2.1 Quantification of protein-protein interactions of the formaldehyde cross-linked 
baits PrdA, PrdB, RnfB and RnfC .............................................................................. 87 
4.3 Verification of bait-prey interactions using transmission electron  microscopy (TEM) .. 95 
 
 
4.4 In vitro biochemically characterization of the rnfC mutant strain ................................ 100 
4.4.1 Growth behavior and morphological characterization of a rnfC mutant .............. 100 
4.4.2 D-proline reductase activity in dependence of a functional Rnf complex ............. 103 
4.4.3 Cellular NAD+/NADH ratio of the wildtype and the rnfC mutant strain ................ 106 
4.4.4 Influence of the rnfC mutant on the formation of the toxins TcdA and TcdB ....... 107 
4.4.5 Changes in the metabolism of the rnfC mutant holistically measured by  
metabolomics, transcriptomics and proteomics ................................................... 109 
4.5 In vivo behavior of the rnfC mutant strain in a mouse model ...................................... 125 
4.5.1 Single infection experiments of the rnfC-mutant strain, the rnfC-complemeted 
mutant strain and the wildtype in a mouse model ............................................... 125 
4.5.2 Competition infection experiments of the rnfC-mutant strain in comparison to the 
rnfC-complemeted mutant strain in a mouse model ............................................ 129 
5 Discussion ........................................................................................................ 132 
5.1 The high-ordered ion translocating Rnf-proline reductase complex in the Stickland 
fermentation of C. difficile 630∆erm ............................................................................. 133 
5.1.1 Protein-protein interactions between the Prd and the Rnf complex in the gel-based 
affinity chromatography coupled with LC-MS/MS ................................................ 133 
5.1.2 Quantitative interactomic analyses of Prd and Rnf using a gel-free affinity 
chromatography coupled with LC-MS/MS and their validation by electron 
microscopy co-localization studies ........................................................................ 136 
5.2 Metabolic rearrangements caused by a non-functional Rnf-Prd complex in  .................... 
 C. difficile ................................................................................................................ 140 
5.2.1 The restricted cell growth of the rnfC-lacking C. difficile strain ............................. 140 
5.2.2 Influence of a non-functional ion translocating Rnf-Prd complex on the reductive 
Stickland fermentation .......................................................................................... 140 
5.2.3 The alternative routes of energy production with an inactive Rnf-Prd complex 
containing in the rnfC mutant strain ...................................................................... 142 
5.3 The negative influence on infection process by a non-functional Rnf-Prd complex tested 
in a mouse model .......................................................................................................... 146 
6 Summary ......................................................................................................... 148 
7 References ....................................................................................................... 149 
8 Appendix ......................................................................................................... 158 
8.1 Vector map of the plasmid pMTL82151 ........................................................................ 158 
8.2 SDS-PAGEs of the baits PrdA, PrdB, RnfB, RnfC and the wildtype in absence of the cross-
linker formaldehyde ...................................................................................................... 159 
8.3 SDS-PAGEs of the baits PrdA, PrdB, RnfB and RnfC in presence of the cross-linker 
formaldehyde ................................................................................................................ 162 
8.4 Gel-based LC-MS/MS identified interaction partners of the C. difficile baits PrdA, PrdB, 
RnfB and RnfC in absence/ presence of the cross-linker formaldehyde ....................... 164 
8.5 In vitro biochemically characterization of the rnfC mutant strain ................................ 175 
8.5.1 Data of growth curves of the rnfC mutant strain CD630∆erm_rnfC636/637s::ermB 
compared to the wildtype CD630∆erm in BHI(S)................................................... 175 
8.5.2 Data of the fluorometric assay of the D-proline reductase activity ...................... 176 
 
 
8.5.3 Data of the NAD+/NADH ratio in the rnfC mutant and wildtype strain ................. 178 
8.5.4 Data of the TcdA and TcdB concentration in the rnfC mutant and willdtype strain 
supernatant performed via the toxin ELISA test .................................................... 179 
8.5.5 Fold change data of the metabolomics experiments ............................................ 181 
8.6 In vivo characterization of the rnfC mutant strain ........................................................ 185 











ALA 5-aminolevulinic acid 
AP Alkaline phosphatase 
Apr Ampicillin resistance 
APS Ammonium peroxodisulphate 
ATP Adenosine triphosphate 
BCIP 5-bromo-4-chloro-3-indolyl phosphate 
BHI(S) Brain Heart Infusion Broth with supple-
ments 
bp Base pair(s) 
BSA Bovine serum albumin 
catP Thiamphenicol resistance casette  
C. difficile Clostridioides difficile 
CDI C. difficile infections 
CDT C. difficile transferase  
CFU colony forming units 
Cm Chloramphenicol 
DNA Deoxyribonucleic acid 
dNTP Deoxynucleotide triphosphate 
DTT Dithiothreitol 
EDTA Ethylenediaminetetraacetic acid 
EM Electron microscopy 
Etf Electron-transferring-flavoprotein 
EtOH Ethanol 
ermB Erythromycin resistance casette 
ermr Erythromycin resistance 
FA Formic acid 
FC Fold change  
f.c. Final concentration 
Fd Ferredoxin  
Fe Iron  
g Gravitation 
h Hour 
HRP Horseradish peroxidase 




dH2O Distilled water 
kb Kilo base(s) 
kDa Kilo-Dalton 
LB Lysogeny broth 




MMTS Methyl methanethiosulfonate 
MQ Milli-Q® water 
NaCl Sodium chloride 
NAD+(H) Nicotinamide adenine dinucleotide (oxi-
dized and reduced) 
NTB  Nitrotetrazolium blue  
ODxxx Optical density at a wavelength of xxx nm  
PaLoc Pathogenicity locus  
PBS Phosphate buffered saline 
PCR Polymerase chain reaction  
PPIs Protein-protein interactions 
Prd D-proline reductase  
RNase Ribonuclease 
Rnf Ferredoxin-NAD+: oxidoreductase  
(origin: rhodobacter nitrogen fixation)  
rpm Revolutions per minute 
s Second 
SDS-PAGE Sodium dodecyl sulfate polyacrylamid gel 
electrophoresis 
SLP Substrate-level phosphorylation 
SPF Specific pathogen free conditions  
TBS Tris buffered saline 
TEM Transmission electron microscopy 
TEMED N,N,N',N'-Tetramethyl ethylenediamine 
Tmr Thiamphenicol resistance  
Tm  Thiamphenicol 
TFA Trifluoroacetic acid 
Tris Tris-(hydroxymethyl)-methyl-2-amino-
ethansulfonate 
TCEP Tris (2-carboxyethyl) phosphine 
U Unit 




v/v Volume per volume 
w/v Weight per volume 







1 Introduction  
1.1 The gut microbiota of the human gastrointestinal tract 
The Germ Theory of diseases proposed by Louis Pasteur ~130 years ago laid the basis 
for the understanding of the pathogenesis of microbes. It was postulated for the first 
time that the human health is strongly correlated with the occurrence of non-patho-
genic microorganisms that inhabit in our body (Hooper et al. 2002; Schottelius 1902). 
Today, it is established that a large number of microorganisms, mostly various species 
of bacteria, colonize different parts of the human body and form large, dynamic and 
complex communities, called the microbiota (Hattori and Taylor 2009; Hooper et al 
2002). In this line, ~1012 of these microorganisms are found on the epidermis and 1014 
in the intestinal tract of adults (Luckey 1972). The bacterial population of the gut micro-
biota consists of thousand of different bacteria, whereby the most abundant strains are 
from the phyla Bacteroidetes, Actinobacteria and Firmicutes (Kho and Lal 2018; Kachri-
manidou and Tsintarakis 2020). 
In the human intestine, the gut microbiota have the vital function of food processing. 
The degradation of nutrients leads to the synthesis of different compounds by the gut 
microbiota. Thus, the human body profits from these metabolic activities by the utiliza-
tion of formed additional nutrients and also signal molecules. In exchange, the gut mi-
crobiota receive a nutrient-rich as well as protected niche. Beyond that, the gut micro-
biota have further functions like vitamin synthesis or the protection against pathogen 
colonization (Kachrimanidou and Tsintarakis 2020; Hooper et al. 2002; Guarner and 
Malagelada 2003; Hattori and Taylor 2009). If this microbial balance in the gut is dis-
turbed, e.g. by the intake of antibiotics that destroy the microflora, a dybiosis effect 
occurs and can lead to severe disease progression like the case of Clostridioides difficile 







1.2 The human pathogen Clostridioides difficile and the CDI 
The human pathogen Clostridioides (Clostridium) difficile belongs to the Firmicutes phy-
lum. It is a Gram-positive, obligate anaerobic, rod-shaped and spore-forming bacterium 
(figure 1), which was first isolated in 1935 from the stool of a healthy newborn, but was 
only discovered in 1978 as a pathogen causing antibiotic-associated colitis as well as 
diarrhea. The broad spectrum of clinical symptoms associated with in infection by this 
pathogen range from mild diarrhea to toxic megacolon and colonic perforations (Kachri-
manidou and Tsintarakis 2020; Mylonakis et al. 2001; Bartlett et al. 1978; Bartlett et al. 







Figure 1: Electron microscopic image (stained) of Clostridioides difficile (image was taken by M. Rohde 
at the Helmholtz Centre for Infection Research, Braunschweig). The pathogenic bacterium C. difficile is 
an obligate anaerobic, Gram-positive and rod-shaped as well as spore-forming bacterium (blue stained) 
(Mylonakis et al. 2001; Bartlett et al. 1978; Bartlett et al. 1977; Larson et al. 1977).  
 
 
Besides antibiotic treatment, surgery, age and immunosuppression are other major fac-
tors sustaining symptomatic infections including CDI which has become a worldwide 
health problem (Kachrimanidou and Tsintarakis 2020; Rao and Safdar 2016). The sever-
ity of nosocomial CDIs in Canada, USA and Europe has increased significantly over the 




showed that deaths in the USA have risen to an estimated 14 000 per year (Kachri-
manidou and Tsintarakis 2020; Czepiel et al. 2019). The CDI infection cycle is illustrated 












Figure 2: The cycle of Clostridioides difficile infections (CDI) (after Rao and Safdar 2016). The figure illus-
trates the destruction of the normal gut microbiota by various indicated factors and the consequent loss 
of colonization resistance as well as the generation of a susceptible microbiota. The new circumstances 
favor the germination of spores of the human pathogen C. difficile into the vegetative form of the bacte-
rium, in which it is able to produce epithelial damaging toxins, leading to a CDI. Treatment of the infection 
with fecal transplantation often contributes to recovery. However, patients treated with antibiotics are 
sensitive to recurrent infections. 
 
 
It shows that destruction of the normal microbiota favours the germination of C. difficile 
spores in turn resulting the vegetative bacteria are able to produce toxins that contrib-
ute to the damage of the gut epithelium and mucosa. The infection can be treated by 
various methods (e.g. fecal transplantation, antibiotics) which may lead to either recov-
ery and the rebuilding of colonization resistance or to recurring infections (recurrence 




1.2.1 The key players of the C. difficile pathogenesis 
C. difficile is, as already mentioned, able to form spores as a survival strategy. With re-
gard to the disease process of the pathogen, these highly resistant spores can be trans-
mitted from patient to patients via smear infections and unhygienic conditions espe-
cially in a hospital environment. Clinical facilities, toilets, telephones and medical equip-
ment can be a temporally limited reservoir for these spores (Czepiel et al. 2019). If these 
spores enter the body of a healthy person, they usually do not germinate. Given the fact 
that the normal gut microflora is disrupted, spores can germinate by the induction of 
liver-produced primary bile acids. The natural function of primary bile acids is actually 
the transport and absorption of fats and water insoluble vitamins in the gut (Kochan et 
al. 2017; Baktash et al. 2018; Chiang 2009). Primary bile acids like chenodeoxycholic acid 
and cholic acid, routinely subjected to 7α-dehydroxylation by the healthy gut microbi-
ota, are converted into secondary bile acids, like deoxycholic acid and lithocholic acid. 
In vitro experiments strongly indicate that some primary bile acids have a promoting 
effect on the germination of C. difficile spores and secondary bile acids rather inhibit the 
process (Czepiel et al. 2019; Chiang 2009; Baktash et al. 2018).  
 
After germination of the spores of C. difficile, the virulence of the formed vegetative 
cells is determined by enzymes such as hyaluronidase, collagenase, chondroitin sulfa-
tase and toxins. The pathogen itself is non-invasive. The major toxins of C. difficile are 
enterotoxin A (TcdA) and cytotoxin B (TcdB). These were classified as members of the 
family of clostridial toxins, which further contain the hemorrhagic and lethal toxin of  
C. sordellii, the α-toxin of C. novyi and the TpeL of C. perfringens. These toxins are multi-
domain proteins which are able to transfer glycosyl groups to small Rho-GTPases for 
their inactivation. TcdA and TcdB of C. difficile damage the cytoskeleton of the epithelial 
cells. This leads to a disturbance of the tight junctions, a neutrophil adhesion, fluid se-
cretion and local inflammation. Finally, the integrity of the intestinal barrier collapses 
and functionality is lost. This leads to cell rounding and inhibition of cell division, which 
finally contributes to the death of the cells (Czepiel et al. 2019; Smits et al. 2016; Shen 




Some C. difficile strains can produce a third toxin, the so-called C. difficile transferase 
(CDT) or binary toxin. For example, the epidemic ribotype 027 has the ability to produce 
CDT. It is assumed that it induces the formation of microtubule-based protrusions on 
epithelium cells (Shen 2012; Popoff et al. 1988). Figure 3 shows the regulation of the 
pathogenic cycle of C. difficile spanning from the above-mentioned induction of germi-
nation, the toxin formation leading to a strong immune response up to the generation 











Figure 3: Schematic illustration of the pathogenesis process of C. difficile (after Shen 2012). The patho-
genesis of the bacterium C. difficile in the human small intestine begins with the induction of germination 
of ingested spores by bile acids. The colonisation of the germ takes place in the colon, which has a dis-
turbed microflora due to e.g. antibiotic treatment. The bacteria can then adhere to the epithelial cells. 
Strains that form the binary toxin CDT, which induces the formation of microtubule protrusions, can thus 
increase their adherence to the epithelium via the formed protrusions. Glucosylating toxin-producing 
(TcdA and TcdB) C. difficile strains block cytoskeleton formation and induce cellular disintegration. These 
processes stimulate inflammation of the mucosa of the colon, resulting in the release of inflammatory 
cytokines. At this point, the tight junctions are also interrupted, which leads to rounding of the epithelial 
cells and the formation of cell gaps. This in turn causes lymphocytes and mast cells to release further 
cytokines. This leads to a strong inflammatory reaction by the aggregation of neutrophils and lympho-







1.2.2 Regulation of toxin gene expression in C. difficile 
The production of toxins in C. difficile depends, among other factors, on nutrient availa-
bility, a change in temperature and differences in redox potential (Onderdonk et al. 
1979; Bouillaut et al. 2013; Karlsson et al. 2003). Therefore, certain metabolizable car-
bon sources and amino acids can inhibit the expression of the toxin genes. A significant 
reduction of the toxin amount occurs, when certain amino acids such as cysteine, leu-
cine, isoleucine, threonine, valine, methionine, tryptophan, proline and glycine are 
added to the medium during the logarithmic growth phase. Generally, toxins are only 
produced in the stationary phase when there is a nutrient deficiency (Bouillaut et al. 
2013; Dupuy and Sonenshein 1998; Karlsson et al. 1999). 
It has previously been shown that the toxin genes tcdA and tcdB are genetically orga-
nized together in a ~19 kb pathogenicity locus (PaLoc). The genes tcdR (for an alternative 
sigma factor), tcdE (for a holin-like protein) and tcdC (for an anti-sigma factor) are also 
located at the same locus (Braun et al. 1996; Dineen et al. 2010; Fortier and Sekulovic 










Figure 4: The pathogenicity locus (PaLoc) of C. difficile (modified after Fortier and Sekulovic 2013). The 
PaLoc of C. difficile is illustrated in which the toxin genes tcdB and tcdA, the genes of the alternative sigma 
factor TcdR, the anti-sigma factor TcdC and the potential holin gene tcdE are encoded. The green arrows 
represent an activation of gene expression of the target gene whereas the red line indicates the inactiva-





It was also shown that the expression of genes in the PaLoc is repressed by CodY, a global 
transcriptional regulator. CodY represses the toxin gene transcription by binding to the 
promoter sequence of the alternative sigma factor TcdR, which induces the transcription 
of the toxin genes tcdA and tcdB to promotes of the tcdR gene (Dineen et al. 2007; Di-
neen et al. 2010; Mani and Dupuy 2001; Martin-Verstraete et al.  2016). 
 
 
1.3 Energy metabolism of the anaerobic bacterium C. difficile   
In nature the energy metabolism is classified after the employed energy source (light = 
phototroph, chemical redox reaction = chemotroph), the used energie donor (inorganic 
= lithotroph, organic = organotroph) and the utilized electron source (inorganic = auto-
troph, organic = heterotroph) (Jahn et al. 2020; Präve et al. 1994). Some Clostridia 
strains are able to perfom a CO2- assimilation by using different energy- and carbon sub-
strates as acetate, ethanol and bicarbonate (Jungermann et al. 1967). Hence, C. difficile 
was identified as one of the first autotrophic pathogen (Köpke et al. 2013).  
For many years C. difficile was considered as a strict fermentative organism, generating 
energy via substrate level phosphorylation and generating the essential proton gradient 
at the membrane using a reverse ATPase. However, only a few years ago ion-gradient 
formation via the ion-gradient generating Rnf-complex coupled fermentative reaction 
was discovered. C. difficile can use diverse sugars and amino acids for fermentative pro-
cesses (Neumann-Schaal et al. 2019; Neumann-Schaal et al. 2015; Jahn et al. 2020).  
 
 
1.3.1 Stickland fermentation reaction 
In various Clostridium species including C. sticklandii and C. sporogenes, the primary en-
ergy source are amino acids utilized via the Stickland reaction which was first discovered 
in 1935. This reaction is the linked metabolism of amino acid pairs, with one amino acid 
serving as an electron donor, which gets oxidatively deaminated and decarboxylated. A 
second amino acid acts as an electron acceptor and is reductively deaminated. The oxi-
dative and reductive metabolism is coupled with an electron transfer process to the 




1934, 1935a, 1935b; Bouillaut et. al 2013; Fonknechten et al. 2010; Jahn et al. 2020). 
The next figure gives a schematic representation of the reductive and oxidative path-















Figure 5: Coupled amino acid fermentation and respiration via the Rnf complex (modified after Jahn et 
al. 2020). The Stickland metabolism is based on the oxidation and reduction of amino acid pairs (oxidative 
and reductive metabolism). In this process classical fermentation (subrate-level phosphorylation) is com-
bined with an electron transfer process to the membrane to produce an ion-gradient for ATP generation. 
The process shows the production of acetate by substrate utilization of alanine in the oxidative metabo-
lism and glycine in the reductive metabolsim. In both processes, intermediates such as pyruvate and  
acetyl-CoA (in the oxidative metabolic pathway) and acetyl phosphate (in the oxidative and reductive 
metabolic pathway) are formed. Here, generated NADH can be re-oxidized by coupling both pathways. 
Within the reductive pathway, D-proline is converted to 5-aminovalerate by oxidation of NADH. Electrons 
can be transferred to the Rnf complex by means of reduced ferredoxin (also from other electron bifurca-
tion pathways), and NAD+ is generated in the Stickland pathway, whereby ions are transferred across the 










The amino acids that serve as the mostly efficient electron donors are isoleucine, leucine 
and alanine (oxidative metabolism), while the most efficient acceptors are glycine, hy-
droxyproline and proline (reductive metabolism). It is well-known that in the Clostridia 
species the reduction of the acceptors proline and glycine is catalysed by two selenium-
dependent reductases, the D-proline reductase and the glycine reductase. The last en-
zyme is responsible for the reductive deamination of glycine to acetyl phosphate and 
ammonium. In contrast, the D-proline reductase converts the substrate D-proline into 
5-aminovalerate (Stadtman 1956; Stadtman and Elliott 1957; Cone et al. 1977; Seto and 
Stadtman 1976; Bouillaut et al. 2013). In the oxidative metabolism alanine is converted 
by alanine dehydrogenase to pyruvate and ammonium, which then reacts via acetyl-
SCoA to acetyl phosphate. Figure 5 shows that acetyl phosphate is generated to acetate 
and ATP via the classical fermentation pathway (substrate-level phosphorylation (SLP)). 
The coupling of both metabolism reactions shows that formed NADH is re-oxidized, 
whereby formed NAD+ is also reduced at the membrane-bound Rnf complex. Addition-
ally, reduced ferredoxin is converted at the Rnf complex, which generates the ion-gradi-
ent by electron transfer. Finally, the ATPase is able to use the proton gradient to form 
ATP (Jahn et al. 2020; Bouillaut et al. 2013).  
 
 
1.3.2 CO2 -assimilation and energy generation via the Wood-Ljungdahl pathway  
An old pathway for CO2-assimilation discovered in 1980 is the reductive acetyl-CoA path-
way and called the Wood-Ljundahl pathway (WLP). The net reaction of 
 4 H2 + 2 CO2              CH3COO- + H+ + 2H2O requires a complex and highly-sensitive enzyme 
machinery. Overall, one CO2 gets fixed in the pathway and an additional CO2 get assim-
ilated, which results no net ATP gain during SLP (Drake et al. 2008; Schuchmann and 
Müller 2014). Moreover, acetate is a major product in energy metabolism. In C. difficile 
and other clostridial species e.g. C. ljungdahlii and C. carboxidivorans the genes for the 







However, in the context of WLP it was postulated that the clinical isolate C. difficile 630 
is able to use CO2 + H2 autotrophically as sole carbon and energy source when growing 
in defined medium (Köpke et al. 2013). The contrast to real acetogens such as Clostrid-
ium ljungdahlii or Acetobacterium woodii, whose genomes contain genes for acetate 
formation like acetate kinase (ack) and phosphotransacetylase (pta), only the acetate 
kinase gene was found in C. difficile (Köpke et al. 2013; Köpke et al. 2010; Poehlein et al. 
2012). Using the database Kyoto Encyclopedia of Genes and Genomes (KEGG) a putative 
phosphotransacetylase was detected (CD630DERM_19200), which could convert the ac-
etyl-CoA into the acetyl-phosphate.  
 
 
1.3.3 Ion-gradient formation during butyrate fermentation in C. difficile  
The clostridial butyrate fermentation pathway converts acetyl-CoA, which is the oxida-
tion product after glycolysis, to butyrate. During the butyrate pathway, crotonyl-CoA is 
formed from acetyl-CoA via the conversation of several intermediates. The bifurcating 
butyryl-CoA dehydrogenase complex (BcdA/Etf), coupled reduced ferredoxin to an ion-
gradient generating process at the membrane, converts crotonyl-CoA into butyryl-CoA. 
The conversion combines an exergonic reduction (NADH-driven) of crotonyl-CoA into 
butyryl-CoA and the ferredoxin endergonic reduction (NADH-driven). Finally,  
butyrate and ATP are formed by SLP (Aboulnaga et al. 2013; Neumann-Schaal et al.  
2019; Bertsch et al. 2013; Buckel and Thauer 2013; Li et al. 2008). The next figures show 
the conversion of acetyl-CoA to butyrate in the butyrate fermentation pathway (figure 
6) and the principle of electron bifurcation exemplified by the butyryl-CoA dehydrogen-






































Figure 6: The butyrate fermentation pathway (modified after Aboulnaga et al. 2013). The figure shows 
the butyrate fermentation pathway based on acetyl-CoA, which is converted by the acetoacetyl-CoA thi-
olase 1 (THIA1) into acetoacetyl-CoA. Subsequently, S-3-hydroxybutyryl-CoA is formed by 3-hydroxy-
butyryl-CoA dehydrogenase (HBD) which is converted into crotonyl-CoA by 3-hydroxybutyryl-CoA dehy-
dratase (CRT2). Crotonyl-CoA reacts via the bifurcating complex Bcd2/Etf (butyryl-CoA dehydrogenase / 
electron transfer flavoprotein) and NADH into butyryl-CoA. Here, the bacteria are able to change and 
conserve further energy by an exergonic reduction and a ferredoxin (Fd) endergonic reduction (with a 
further NADH molecule) and by the enzymes ferredoxin-NADP+ reductase (FNR) and NAD(P)+ transhydro-
genase (PntB). Butyryl-CoA can be converted by phosphate butyryltransferase (PTB) into butyryl-phos-
phate and then into butyrate by substrate-level phosphorylation via butyrate kinase (BUK), which results 












Figure 7: The principle of electron bifurcation at the butyryl-CoA dehydrogenase complex (after Buckel 
and Thauer 2013). During the NADH coupled electron bifurcation reactions one electron gets transferred 
to the crotonyl-CoA (high redox potential) and one to ferredoxin (low redox potential), respectively. 
 
 
1.3.4 Ferredoxin:NAD+-oxidoreductase - Rnf complex  
Although different metabolic pathways ultimately provide energy in the form of ATP via 
SLP like during Stickland fermentation, the WLP or via the last step of butyrate fermen-
tation pathway, significant amounts of ATP are produced by a membrane-localized and 
ion-gradient driven phosphorylation process (Bouillaut et al. 2013; Müller and Wiech-
mann 2017; Aboulnaga et al. 2013). From genome sequences it was deduced that aceto-
genic bacteria possess the F1F0-ATP synthase for ADP phosphorylation by an Na+/ H+ ion-
gradient. In this context, two complexes are well-known, which are able to couple the 
energy released by exergonic electron transfer and thus build the gradient chemiosmot-
ically: 1. Ech (energy-conserving hydrogenase) complex and 2. the NAD+ dependent Rnf 
complex (Müller and Wiechmann 2017; Müller et al. 2001).  
Initially, the Rnf (Rhodobacter nitrogen fixation) complex was discovered in Rhodobacter 
capsulatus, whose genes rnfA, rnfB, rnfC, rnfD, rnfE and rnfF encode for six membrane-
associated proteins that are involved in nitrogen fixation (Schmehl et al. 1993). The rnf 
operon was described for the first time in 2009 for acetogenic bacteria A. woodii. With 
a membrane-spanning ferredoxin:NAD+-oxidoreductase activity it is simililar to the 




able to catalyze the reduction of NAD+ by ferredoxin (Müller and Wiechmann 2017; Bie-









Figure 8: The clostridial Rnf complex in C. ljungdahlii (modified after Köpke et al. 2010). It is shown the 
membrane-based Rnf complex with its six subunits RnfB, RnfA, RnfD, RnfE, RnfG and RnfC. These complex 
drives electron transfer using the resulting free energy to pump ions, most likely H+, to build up a chemi-
osmotic ion-gradient at the membrane. The gradient is used by the ATP synthase to phosphorylate ADP. 
Ferredoxin in its reduced form can be produced in several clostridial species e.g. via bifurcating complexes 
(e.g. Bcd2/Etf), pathways to conserve energy (Bertsch et al. 2013; Aboulnaga et al. 2013), and converted 
by RnfB. The RnfC subunit can reduce NAD+. During the entire process electrons are transferred from the 
ferredoxin to the NAD+. 
 
 
The employed reduced ferredoxins are generated by various pathways: e.g. via oxidore-
ductases which are ferredoxin-dependent like in the oxidative Stickland fermentation 
reaction or via alternative pathways which are depending on bifurcating complexes 
(Bcd2/Etf) (Bertsch et al. 2013; Neumann-Schaal et al. 2019; Aboulnaga et al. 2013). 
Moreover, in several Clostridia species, including C. ljungdahlii or C. difficile, ions can be 
transported through the Rnf complex, to form an ion-gradient and to finally foster phos-
phorylation of ADP via the ATP synthase. Therefore, it is conceivable that the reductive 
pathway of Stickland fermentation, in particular the D-proline reductase might interact 




1.4 Protein-protein interactions (PPIs) 
Proteins in living cells never act alone and rather work in complexes. They form dynamic  
“molecular nanomachines” to perform biological functions to fullfill their function in  
biochemical pathways or membrane-associated complexes. Therefore, it is crucial to an-
alyze these “interactions” and their time-resolved dynamics more precisely. The disci-
pline that endeavors to elucidate cellular protein-protein interactions (PPIs) (interac-
tomes) is the so-called interactomics (De Las Rivas and Fontanillo 2010; Cusick et al. 
2005; Feng et al. 2014). Experimental verification in orthogonal systems together with 
projects to identify PPIs can produce data sets with high significance to understand the 
authenic complex formation and function. Research using model organisms like Caeno-
rhabditis elegans or Saccharomyces cerevisiae has provided the fundamental know how 
for “interactome” mapping. Not only basic functional mechanisms of PPIs can be eluci-
dated, furthermore, these data sets might be helpful to investigate the development of 
malfunction and consequently diseases (Cusick et al. 2005; Fromont-Racine et al. 1997; 
Walhout et al. 2000).  
 
1.4.1 Interactomics for the determination of cellular protein-protein networks 
Deep interactomic analysis aims at the holistic elucidation of protein-protein interaction 
of a living system. In general, PPIs are described as physical contacts between protein 
partners. These associations occur in vivo in all living organisms. Noteworthily, the spe-
cial efforts are needed to distinguish between protein interactions which occur specifi-
cally and others which are randomly. Moreover, the interactions that a protein encoun-
ters during production, folding, quality checking and degradation are normally excluded. 
These include specific contacts to ribosomes, chaperones and the degradation machin-
ery. Thus, PPIs should be intentional and not random and the interaction should be non-
generic (generic functions = e.g. protein production or degradation) (De Las Rivas and 
Fontanillo 2010). As a dynamic system, the cell is subject to constant change. Some pro-
tein compounds, such as ATP synthase or cytochrome oxidase, are stable for longer 
terms. Other proteins are required short term for specialized functions in the cell. Con-




cell cycle phase, metabolic state and the cell type (De Las Rivas and Fontanillo 2010). 
The in vitro characterization of PPIs relies on well-established biophysical up to genetic 
methods comprising NMR, X-ray crystallography, surface plasmon resonance (SPR) or 
yeast two-hybrid system. The holistic interactomic approach combines affinity purifica-
tion of cellular protein complexes with the mass spectrometrical elucidation of the com-
position (Meyer and Selbach 2015; Gingras et al. 2007). That method offers the possibil-
ity of a wide characterization of protein complexes up to the identification of large pro-
tein interaction networks. In this context protein complexes are isolated directly from 
cell lysates and get further purified in one (or more) steps, followed by proteolytic frag-
mentation. Resulting peptides can subsequently be identified by tandem mass spec-
trometry (MS/MS). The peptides and the corresponding proteins can be identified by 
coupling the appropriate databases in suitable proteomic softwares (figure 9) (Gingras 










Figure 9: Schematic illustration of the holistic interactomics approach (after Gingras et al. 2007). The 
target protein (bait protein, blue), which is produced in the cell, can be purified from the cell lysate with 
its interaction partners attached (prey proteins, orange/green) by affinity chromatography using the tag 
on the bait (a). Isolated protein complexes can be resolved by SDS-PAGE (b) and corresponding proteins 
can be extracted from the gel and digested with e.g. trypsin (c). It is also possible to analyze isolated 
complexes directly (gel-free method), which is a generic and quicker method. The individual peptides are 
separated by liquid chromatography (LC) and identified by tandem mass spectrometry (MS/MS) (d). Ob-
tained masses are assigned to the respective protein using a proteomics software and database matching 
(e). The interpretation of the data allows to identify the bait protein with its prey bound proteins. Back-






Usually, strong native PPIs of the intact protein complexes are required to survive the 
stringent purification conditions. Therefore, a chemical cross-linking step can be used to 
stabilize transient protein-protein interactions. These cross-linker have two reactive 
groups, which form a covalent bond with the target protein and proteins in the direct 
neighbourhood (Gingras et al. 2007). Formaldehyde, for instance, which is widely used 
as an in vivo cross-linker, generates covalent cross-links between proteins as well as pro-
teins and nucleotides which are reversible by heating (Larance et al. 2016; Tayri-Wilk et 
al. 2020; Metz et al. 2004). Hence, the cross-linker has the ability to connect proteins by 
the production of a stable methylene bridge between two amino acids (Metz et al. 2004; 
Tayri-Wilk et al. 2020) (figure 10). A major advantage of using formaldehyde is the small 
size of the compound that allows to penetrate the membrane into intact cells as well as 













Figure 10: Formaldehyde reaction for the cross-linking of proteins (modified after Metz et al. 2004). In 
the first step [1], the reaction between the amino group of the protein and the formaldehyde begins with 
the production of a methylol adducts. Subsequently, in [2] a partial dehydration of the methylol adduct 
at the primary amino group is performed and a labile intermediate product (Schiff-base) is formed. In the 
final step [3], the Schiff-base can form cross-links with other amino acid residues. 
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2 Aim of this study 
The general aim of this work was to identify the protein-protein interactions of mem-
brane-residing and cytosolic proteins involved in the Stickland fermentation of  
C. difficile 630Δerm. Focusing on the reductive metabolism of the Stickland fermenta-
tion, the interaction partners of two key players the D-proline reductase and the Rnf 
complex had to be investigated. 
For this purpose, various bait protein (PrdA, PrdB, RnfB and RnfC) production strains 
based on C. difficile 630Δerm had to be constructed. They provided the basis for the 
isolation of protein complexes formed in the presence and absence of the cross-linker 
formaldehyde. The composition of these complexes had to be elucidated by proteomics 
in cooperation with our partners of the HZI. Obtained results were than used to predict 
the Rnf-Prd interactions in great detail. Finally, the in vivo function of Rnf during the  
C. difficile infection process was of interest and had to be tested with a corresponding 
rnfC mutant strain in a mouse model. Obtained results should provide detailed insights 
into the dynamic protein-protein interaction underlying a central energy metabolic pro-
cess of the gut pathogen C. difficile.   
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The equipment used for this work is listed in Table 1. 
 
Table 1: Used equipment 
INSTRUMENT MODEL COMPANY 
Agarose gel documentation 
system 
CoolSnap™ HQ2  
Photometrics 
Decon Science Tec GmbH 
(Hohengandern, Germany) 
 
Agarose gel electrophoresis Mini-Sub Cell GT Cell 
Wide Mini-Sub Cell GT Cell 
Bio-Rad Laboratories GmbH 
(Feldkirchen, Germany) 
 
Anaerobic chamber  Coy Laboratory Products inc. 
(Michigan, USA) 
 
Anaerobic system  Voltcraft  
 
Autoclave LVSA 50/70  ZIRBUS technology GmbH 
(Bad Grund, Germany) 
 
Bioanalyzer Agilent 2100 Bioanalyzer  
Instrument 
Agilent Technologies 
(Santa Clara, USA) 
 
Blotter Tetra Blotting Module 
 
Bio-Rad Laboratories GmbH 
(Feldkirchen, Germany) 
 
Centrifuges Avanti® J-26XP Centrifuge 
with the rotor: JLA 8.100  
Beckman Coulter GmbH 
(Krefeld, Germany) 
 
 Megafuge 1.0R  
 
 








 Optima®L-90K  
Ultrazentrifuge,  
Rotor: TI 70.1   
Beckman Coulter GmbH 
(Krefeld, Germany) 
 





SCD 500 (SEM preparation) BAL-TEC AG 
(Balzers, Liechtenstein) 
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Critical Point Dryer 
and coating rate measuring 
device 
 




MiniProteanIII™ Bio-Rad Laboratories GmbH 
(Feldkirchen, Germany) 
 
FastPrep® FastPrep®-24 MP Biomedicals™ Germany  
GmbH (Eschwege, Germany) 
 








With Everhart Thornley 
HESE2 detector and the 
inlens SE detector in a 25:75 
ratio with an acceleration 
voltage of 5 kV 
Carl Zeiss Microscopy GmbH 
(Jena, Germany) 
Fluorescence Spectrometer FP-8500 JASCO Deutschland GmbH 
(Pfungstadt, Germany) 
 
GC-MSD system and  
multi-omics equipment 
Agilent GC-MSD system 
(7890B coupled to a 5977 GC) 
equipped with a high-effi-
ciency source (HES) and an 
Agilent VF-5ms column / PAL 
RTC system (CTC Analytics 
AG; Zwingen, Switzerland) 
(Seperationsystem: Agilent 




(Santa Clara, USA) 
HPLC system and  
multi-omic equipment 
Agilent 1260 Infinity II HPLC 
system equipped with a FLD 
and an Agilent Poroshell HPH-
C18 column (4.6 mm x 100 
mm, particle size 2.7 mm) 
 
Agilent Technologies 
(Santa Clara, USA) 
LC-MS/MS instruments Dionex™ UltiMate™ 3000 n-
RSLC system connected to an  
Orbitrap Fusion™ Tribrid™ 
mass spectrometer ESI Or-
bitrap Fusion; 
(Separation: C18 precolumn 
(3 μm RP18 beads, Acclaim, 
0.075 mm × 20 mm) and C18 
analytical column (3 mm, Ac-
claim PepMap RSLC, 0.075 
mm × 50 cm, USA)); the efflu-
ent was electro-sprayed by a 
stainless-steel emitter 
 
Thermo Fisher Scientific 
(Waltham, USA) 
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LC-QTOF system and  
multi-omic equipment 
Agilent LC-QTOF system 
(6545 coupled to a 1290 Infin-
ity II UHPLC) equipped with 
an electrospray interface 
(Seperation: C18 analytical 
column (Gemini® 2.0 x 150 




(Santa Clara, USA) 
Microplate reader Infinite® 200  
Serial number: 906000759 
 
Tecan Group Ltd. 
(Männedorf, Switzerland) 




Power supply  
electrophorese 
PowerPac™ Basic Power  
Supply 
Bio-Rad Laboratories GmbH 
(Feldkirchen, Germany) 
 
Software Bowtie2 v 2.3.4 (Langmead and Salzberg 
2012) 
 





 Chromeleon™ software Ver‐
sion 6.8, Thermo Scientific™ 
Dionex™ 
Thermo Fisher Scientific  
(Waltham; MA, USA) 
 
 
 MS Excel®  Microsoft® Corporation 
(Washington, USA) 
 
 Prism (version 8.4.3) GraphPad 
 
 Proteome Discoverer 2.2/2.3 Thermo Fisher Scientific 
(Schwerte, Germany) 
 
 Peaks® X+ Bioinformatics Solutions Inc. 
(Waterloo, Canada) 
 





(McClure et al. 2013; Tjaden 
2015) 
 
 SnapGene® GSL Biotech LLC 
(San Diego, CA, USA) 
 
 Spectra Manager™ II  
Software 
JASCO Deutschland GmbH 
(Pfungstadt, Germany) 
 
 Tecan i-control™ 1.11.1.0 
 
Tecan Group Ltd. 
(Männedorf, Switzerland) 
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 Xcalibur™ software version 
3.0.63 
 
Thermo Fisher Scientific  
(Waltham; MA, USA) 
 
Qubit Qubit® 3 fluorometer Thermo Fisher Scientific – 










 Infors CH-4103 Infors AG 
(Bottmingen, Germany) 
 
Transmission Electron  
Microscope (TEM) 
Libra® 120 Plus  
(WinTEM software) 
Carl Zeiss Microscopy GmbH 
(Jena, Germany) 
 
Thermocycler ProFlex PCR System Thermo Fisher Scientific 
(Schwerte, Germany) 
 
Thermomixer Thermomixer compact Eppendorf AG 
(Hamburg, Germany) 
 
Ultrasonic bath USR57 Merck KGaA 
(Darmstadt, Germany) 
 





Table 2 shows the consumables used for this work.  
 
Table 2: Resources 
RESOURCES MODEL COMPANY 
Anaerobe flask Transfusion bottle  Gerresheimer Essen GmbH 
(Essen, Germany) 
 
Falcon 15 mL 
50 mL 
Sarstedt AG & Co. KG 
(Nümbrecht, Germany) 
 
Filter Filtropur BT50 500 mL  
Bottle Top Filter 
Sarstedt AG & Co. KG 
(Nümbrecht, Germany) 
 
 No. 83.1826             
0.45 µm  
Sarstedt AG & Co. KG 
(Nümbrecht, Germany) 
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 No. 83.1826.001      
0.20 µm 
Sarstedt AG & Co. KG 
(Nümbrecht, Germany) 
 
Cuvettes Polystyrene 10x4x45 mm Sarstedt AG & Co. KG 
(Nümbrecht, Germany) 
 
 Precision cuvettes of Quartz 
glass SUPRASIL® Typ-Nr. 115F-
QS SD 10 mm 
 
Hellma GmbH & Co. KG 
(Osnabrück, Germany) 







size 70 – 110 μm  
Hungate tubes 16×125 mm VWR™ International GmbH 
(Darmstadt, Germany) 
 
Needle  Sterican® 0.90 x 40 mm Braun Melsungen AG 
(Melsungen, Germany) 
 
PVDF Membran PVDF Western Blotting  
Membrane 
0.45 μm pore size 
Carl Roth GmbH + Co. KG 
(Karlsruhe, Germany) 
 
Pipettes 0.1  -    2.5 µL Research 
0.5  -     10 µL Research plus 
   2   -     20 µL Research plus 
 10   -   100 µL Research plus 
 20   -   200 µL Research plus 
100  - 1000 µL Research plus 
    1  -     10 mL Research plus 
Eppendorf AG 
(Hamburg, Germany) 
Column material Strep-Tactin® Superflow high 
capacity affinity purification 
IBA GmbH  
(Göttingen, Germany) 
 
Whattman Paper Rotilabo®-Blottingpapiere  
Size: 0.35 mm 





Amicon® Ultra -0.5 mL Centri-










Materials and methods 
23 
 
3.1.3 Chemicals, enzymes and kits 
Table 3 lists the chemicals, enzymes and kits employed in this study. All other chemicals 
not listed herein were purchased from Fluka, Merck, Roth or Sigma-Aldrich 
Table 3: Chemicals, enzymes and kits  
 PRODUCT COMPANY 










Carl Roth GmbH + Co. KG 
(Karlsruhe, Germany) 
 
 Brain-Heart-Infusion medium Carl Roth GmbH + Co. KG 
(Karlsruhe, Germany) 
 
 Chloramphenicol Carl Roth GmbH + Co. KG 
(Karlsruhe, Germany) 
 
 Cystein Carl Roth GmbH + Co. KG 
(Karlsruhe, Germany) 
 
 d-Desthiobiotin IBA GmbH 
(Göttingen, Germany) 
 
 Dithiothreitol (DTT) Sigma-Aldrich Chemie GmbH  
(Taufkirchen, Germany) 
 
 Erythomycin Carl Roth GmbH + Co. KG 
(Karlsruhe, Germany) 
 
 Formaldehyde Carl Roth GmbH + Co. KG 
(Karlsruhe, Germany) 
 
 Nitrotetrazolium blue (NTB) Merck KGaA 
(Darmstadt, Germany) 
 
 Proline Sigma-Aldrich Chemie GmbH  
(Taufkirchen, Germany) 
 
 ROTIPHORESE®Gel 30 (37,5:1) 
Acrylamid solution 
 
Carl Roth GmbH + Co. KG 
(Karlsruhe, Germany) 
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 Protease inhibitor tablet: cOm-
plete Protease Inhibitor Cocktail® 
EDTA-free, EASYpack 
 
Roche Deutschland Holding GmbH 
(Mannheim, Germany) 
 Strep-Tactin® AP conjugate 
 
IBA GmbH (Göttingen, Germany) 
 InstantBlue® Protein Stain 
 




Quick-Load® Purple 1 kb Plus DNA 
Ladder 
(or 1 kb Plus DNA Ladder) 
New England Biolabs GmbH  
(Frankfurt am Main, Germany) 
 
ENZYMES BamHI-HF® (5`-GGATCC-3`) 
 
 
New England Biolabs GmbH  
(Frankfurt am Main, Germany) 
 BsaI (5`-GGTCTC(N1) /(N5) -3`) 
 
New England Biolabs GmbH  
(Frankfurt am Main, Germany) 
 
 BsrGI (5`-TGTACA-3`) 
 
New England Biolabs GmbH  
(Frankfurt am Main, Germany) 
 
 EcoRI-HF® (5`-GAATTC-3`) 
 
 
New England Biolabs GmbH  
(Frankfurt am Main, Germany) 
 
 HindIII (5`-AAGCTT-3`)  
 
 
New England Biolabs GmbH  
(Frankfurt am Main, Germany) 
 
 T4 DNA Ligase 
 
 
New England Biolabs GmbH  
(Frankfurt am Main, Germany) 
 
 Q5® High-Fidelity DNA  
Polymerase 
 
New England Biolabs GmbH  
(Frankfurt am Main, Germany) 
COMMERCIAL 
KITS 
Agilent RNA 6000 Pico Kit Agilent Technologies 
(Santa Clara, USA) 
 
 CloneJET™ PCR Cloning Kit 
 
Thermo Fisher Scientific  
(Schwerte, Germany) 
 
 ELISA for the separate detection 
of Clostridium difficile Toxin A OR 





 Gibson Assembly®  
Cloning Kit 
New England Biolabs GmbH  
(Frankfurt am Main, Germany) 
 
 High Sensitivity DNA Analysis Kit 
(Bioanalyzer) 
Agilent Technologies 
(Santa Clara, USA) 
 
 Monarch® Plasmid Miniprep Kit 
 
New England Biolabs GmbH  
(Frankfurt am Main, Germany) 
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 Monarch® Total RNA Miniprep Kit 
 
New England Biolabs GmbH  
(Frankfurt am Main, Germany) 
 
 NAD+/NADH Glo Assay kit  Promega GmbH 
(Madison, Wisconsin, USA) 
 
 NEBNext® Ultra™ II Directional 
RNA Library Prep with Sample  
Purification Beads 
 
New England Biolabs GmbH  
(Frankfurt am Main, Germany) 
 
 NextSeq 500/550 High Output Kit 
v2.5 (75 cycles) 
 
Illumina Inc  
(San Diego, USA) 
 QIAprep Spin Miniprep Kit QIAGEN GmbH  
(Hilden, Germany) 
 
 QIAquick Gel Extraction Kit 
 
QIAGEN GmbH  
(Hilden, Germany) 
 
 QIAquick PCR Purification Kit 
 
QIAGEN GmbH  
(Hilden, Germany) 
 
 Ribo-off rRNA Depletion Kit  
(Bacteria);  
Protocol after Absource Diagnos-
tics GmbH (Munich, Germany) 
 
Vazyme Biotech Co. 
(Nanjing, China)  
 RNase-free DNase Set / RNeasy 
Mini Spin Columns 
QIAGEN GmbH  
(Hilden, Germany) 
 
 VAHTS™ RNA Clean Beads Absource Diagnostics GmbH  
(Munich, Germany) 




PageRuler™ Plus Prestained Pro-
tein ladder; 10 to 250 kDa 
Thermo Fisher Scientific 
(Schwerte, Germany) 
 PageRuler™ Prestained Protein 
Ladder, 10 to 180 kDa 





PAB against 3 synthetic peptides 
(15 mer each *):  
- PrdA PAB-2107 
- RnfB PAB-2107 
- RnfC PAB-2107 
Metabion international AG  
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3.1.4 Strains of bacteria, plasmids and primers 
Bacterial strains, plasmids and primers that were used in this work are listed in Table 4 
and 5. All primers were purchased from Invitrogen (Thermo Fisher Scientific, Schwerte, 
Germany).  
 
Table 4: Strains of bacteria and plasmids  












































F- mcrA Δ(mrr-hsdRMS-mcrBC) 
Φ80dlacZΔM15 ΔlacX74 recA1 endA1  
araD139Δ(ara, leu) 7697 galU galK-rpsL 
nupG λ- 
 

























S17 λpirΔhemA (pro thi hsdR+ Tpr Smr; 
chromosome::RP4-2 Tc::Mu-
Kan::Tn7/λpir) (DSM 22074) 
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Wildtype, Synonym: Clostridium dif-
ficile, DSM 28645, α-proteobacteria, 
((Hall and O'Toole 1935) Prévot 1938) 
 
Carries pMTL82151; Tmr 
 
 




















Group II intron based C. difficile rnfC 
mutant strain; intron 636/637s; Clos-
Tron® technology (Heap et al. 2007; 






















(Hussain et al. 2005; Lawson 





































































































size: 2974 bp 
features: pJET1.2/blunt cloning vector, 
T7 promoter, rep(pMB1), Ampr 
 
size: 4197 bp 
prdB gene with corresponding natural 
Rnf promoter sequence (461 bp up-
stream + 723 bp prdB gene of C. difficile 
630∆erm); Strep-tag®II (24 bp); stop co-
don TGA (3 bp); restriction sites: BamHI-
HF®/EcoRI-HF® (12 bp); cloning strat-
egy: Multiple PCR and CloneJET™  
further features: see pJET1.2® 
 
size: 4495 bp 
rnfB gene with corresponding natural 
Rnf promoter sequence (502 bp up-
stream + 980 bp rnfB gene of C. difficile 
630∆erm); Strep-tag®II (24 bp); stop co-
don TGA (3 bp); restriction sites: BamHI-
HF®/EcoRI-HF® (12 bp); cloning strat-
egy: Golden-gate cloning (BsaI 
methode) and CloneJET™ 
further features: see pJET1.2® 
 
size: 5254 bp 
ColE1 + tra; catP (= Tmr); pBP1 
 
 
Size: 9034 bp 
Ori_pBr; traJ_*;M_LtrA_*; MRepH_*; 
catP (= Tmr); ermB; Term_rrnBT1T2; 
P_fdx; Cdi_rnfC intron 636/637s;Clos-
Tron® system 
 
size: 7566 bp 
prdA gene with corresponding natural 
Prd promoter sequence (428 bp up-
stream) + 1878 bp prdA gene of C. dif-
ficile 630∆erm; Strep-tag®II (24 bp); stop 
codon TGA (3 bp); cloning strategy: Gib-



































(Heap et al. 2009)/ 
CHAIN Biotechnplogy Ltd 
(Nottingham, UK) 
 
(Heap et al. 2007; Heap et al. 





















































size: 6450 bp 
prdB gene with corresponding natural 
Prd promoter sequence (461 bp up-
stream) + 723 bp prdB gene of C. difficile 
630∆erm; Strep-tag®II (24 bp); stop co-
don TGA (3 bp); restriction sites: BamHI-
HF®/EcoRI-HF® (12 bp); cloning strategy: 
T4 Ligation; further features: see 
pMTL82151 
 
size: 6731 bp 
rnfB gene with corresponding natural 
Rnf promoter sequence (496 bp up-
stream) + 969 bp rnfB gene of C. difficile 
630∆erm; Strep-tag®II (24 bp); stop co-
don TGA (3 bp); restriction sites: BamHI-
HF®/EcoRI-HF® (12 bp); cloning strategy: 
T4 Ligation; further features: see 
pMTL82151 
 
size: 6795 bp  
rnfC gene with corresponding natural 
Rnf promoter sequence (200 bp up-
stream) + 1335 bp rnfC gene of C. difficile 
630∆erm; Strep-tag®II (24 bp); stop co-
don TGA (3 bp); cloning strategy: Gibson 
Assembly® (therefore: overlapping end  


































1Host for cloning steps and carrying all of the pMTL shuttle vector; 2Donor strain in mating experiments 
and carrying all of the pMTL shuttle vector; 3Expression strain with the respective pMTL82151 vector 
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3.2 Microbiological methods 
 
3.2.1 Sterilisation 
The sterilisation of solutions and media was conducted using heating steam at 121 °C 
and 1 bar overpressure for 20 min. Heat-sensitive media supplements and solutions 
were sterilized using sterile filters (SARSTEDT, Nümbrecht, Germany) with a pore size of  
0.2 µm and 0.45 µm. 
 
 
3.2.2 Media and media supplements 
Lysogeny broth (LB) complex medium 
E. coli DH10b and ST18 strains were cultivated in LB medium (Bertani 1951, 2004). Stated 
media supplements were added (table 6). For cultivation on agar plates 15 g/L agar was 
added to the medium. 
 
 
LB-medium:      Trypton  10 g/L 
       Yeast extract      5 g/L 
       NaCl    10 g/L 
 
 
Brain Heart Infusion medium with supplements (BHI(S)): 
The commercially available Brain Heart Infusion medium (BHI) supplemented with  
10 mL per 1 L medium of a 10 % (w/v) cystein stock solution was used for C. difficile 
630Δerm strains. For the cultivation on agar plates 15 g/L agar-agar were added sepa-
rately to the medium. Additionally, commercially available CHROMID® C. difficile plates 
(bioMérieux GmbH, Nürtingen, Germany) were used to grow bacteria for subsequent 
glycerol stock preservation.  
 
BHI(S):       BHI   37 g/L 
       Yeast extract      5 g/L 
Cysteine   0.1 % (v/v)  
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Clostridium difficile minimal medium (CDMM): 
This C. difficile specific defined minimal medium (after Neumann-Schaal et al. 2015; ori-
gin: Cartman and Minton 2010) was used for growth of C. difficile for multi-omic exper-
iments. In general, the components were autoclaved. Heat-sensitive substances were 
sterilized by filtration. 
 
 
10 x Salt mix: Na2HPO4 50 g/L 
 NaH2PO4 x H2O 20 g/L 
 KH2PO4    9 g/L 
 NaCl    9 g/L 
 
 
5 x Casamino Mix: Casamino acids 50 g/L 
 L-Cystein                        2.5 g/L 
 L-Tryptophan                 0.5 g/L 
 
 
100 x Trace salts: (NH4)2SO4 4 g/L 
 CaCl2 x 2 H2O 2.6 g/L 
 MgCl2 x 6 H2O 2 g/L 
 MnCl2x 4 H2O 1 g/L 
 CoCl2 x 6 H2O 0.1 g/L 
 NaHSeO3 0.015 g/L 
 
500 x Iron: FeSO4 x 7 H2O 2 g/L 
 
 




 Pyridoxine (B6) 0.2 g/L 
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All components described below correspond to 1 L of the final minimal medium CDMM:  
10 x Salt mix:  100 mL 
5 x Casamino Mix:  200 mL 
100 x Trace salts:  10 mL 
500 x Iron:  2 mL 
200 x Vitamins:  5 mL 
20 x Glucose:  50 mL 




Media supplements were prepared as concentrated stock solution with dH2O or  
EtOH/MeOH and sterile filtered. The stock solutions were stored at -20 °C. The media 
supplements were added after heat sterilization of the corresponding medium. The final 
concentrations are shown in table 6. 
 
Table 6: Final concentrations of media supplements 
Media supplement Stock solution Final  
concentration 
Bacterial strains 
ALA   50 mg/mL in dH2O  50 µg/mL E. coli ST18 
Ampicillin  100 mg/mL in dH2O 100 µg/mL E. coli strains 
Chloramphenicol    34 mg/mL in ethanol   34 µg/mL E. coli strains 
Erythromycin     5 mg/mL in ethanol   2.5 µg/mL C. difficile 630∆erm 
Thiamphenicol   15 mg/mL in methanol    15 µg/mL C. difficile 630∆erm 
Cysteine   10 % (w/v) in dH2O   0.1 % (v/v) C. difficile 630∆erm 
 
 
3.2.3 Anaerobisation of solutions 
The anaerobisation of sterile BHI(S) medium with supplements was accomplished in 
transfusion bottles with septum in an anaerobisation system. The apparatus ensures the 
gas exchange against nitrogen by the 2-minute change between vacuum phase and ni-
trogen gassing (1 bar). The solutions were anaerobized for 2 h to 4 h depending on the 
volume. 
 
3.2.4 Determining the cell density 
Optical density was measured by a spectrophotometer at a wavelength of 578 nm for  
E. coli and 600 nm for C. difficile 630Δerm.  
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3.2.5 Cultivation of E. coli DH10B and E. coli ST18 strains 
The cultivation of E. coli strains in liquid culture was performed by inoculating the bac-
terial cells from an LB agar plate. Cells were transferred to normally 10 mL fresh LB liquid 
medium with the specific media supplements and cultivated overnight at 200 rpm and 
37 °C. For the cultivation of E. coli strains on agar plates, biomass was transferred from 
a glycerol stock or an overgrown agar plate and transferred onto LB agar plate with spe-
cific media supplements. The plates were cultivated overnight at 37 °C. 
 
 
3.2.6 Cultivation of C. difficile 630∆erm 
C. difficile 630∆erm cells were transferred from a glycerol stock to a commercial 
CHROMID® plate (bioMérieux GmbH, Nürtingen, Germany), if necessary, with media 
supplements and incubated anaerobically at 37°C for 2 - 3 days. Cell biomass was inoc-
ulated in anaerobic BHI(S) liquid medium with media supplements and allowed to grow 
anaerobically at 37°C, for 12 h. Main cultures were inoculated from the preculture with 
an initial OD600 nm of 0.05. Afterwards, the main culture was cultivated anaerobically at 




3.2.7 Characterization of the growth behavior of C. difficile 630Δerm 
To determine the growth behavior of the constructed C. difficile strains a preculture was 
prepared as described above. The main culture inoculated likewise and grown in 10 mL 
BHI(S) in Hungate tubes (VWR™ International GmbH, Darmstadt, Germany). The cultures 
were measured every hour at an OD600 nm until the stationary growth phase was achieved  
(16 - 24 h growth).  
 
 
3.2.8 Bacteria storage 
Glycerol stocks were prepared for long-term storage of bacterial strains. For this pur-
pose, 700 µL were taken from an E. coli liquid culture and mixed with 300 µL 80 % (w/v) 
glycerol under steril conditions. C. difficile 630Δerm glycerol stocks were prepared by 
withdrawing 10 mL of liquid culture and centrifuging at 4`000 rpm for 3 min. The bacte-
rial pellet was resuspended with 800 µL fresh bacterial cells from the liquid culture and 
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3.3 Molecular biological methods 
 
3.3.1 Preparation of chemocompetent E. coli strains using CaCl2 
For the preparation of E. coli CaCl2-competent cells a 30 mL preculture was grown over-
night in LB at 37°C by 200 rpm. The preculture was used to inoculate 100 mL main culture 
at an OD578 nm of 0.05. The culture was further cultivated at 37 °C and 200 rpm to  
OD578 nm 0.5 to 0.6. After cell density determination the cells were chilled on ice for  
10 min. Cells were harvested at 4 °C by 4`000 x g for 10 min. The cell pellet was resus-
pended with 10 mL ice-cold CaCl2 buffer and centrifuged again at 4 °C, 4`000 x g for  
10 min. Afterwards, the pellet was resuspended in 1 mL CaCl2 buffer. Aliquots of the 
competent cells were prepared and stored at -80 °C. 
 
CaCl2 buffer  CaCl2 100 mM 




3.3.2 Transformation of E. coli cells 
The transformation of chemocompetent E. coli cells (50 µL) with the different constructs 
was performed by adding 0.2 - 1 µg plasmid DNA or 5 µL of a ligation mixture. After-
wards, the mixture was chilled on ice for 30 min followed by a heat shock for 45 sec at 
42 °C. Subsequently, 500 µL fresh LB-medium were added to the sample and incubated 
at 37 °C by 300 rpm for 1 h. Finally, 50 µL, 150 µL and 250 µL of the transformation 
mixture were plated onto LB agar plates with the corresponding antibiotic concentra-
tion. The plates were incubated overnight at 37 °C. 
 
 
3.3.3 Transfer of plasmid DNA in C. difficile 630Δerm (conjugation) 
Plasmid DNA was introduced into the C. difficile 630∆erm recipient strains by conjuga-
tion employing an aminolevulinic acid auxotrophic E. coli donor strain. The protocol used 
for this is based on Bouillaut et al. 2011 with minor modifications. 
 
One mL was taken from an overnight E. coli ST18 preculture, centrifuged at 16`000 x g 
for 5 min and the pellet was washed twice in 500 µl 1x PBS. A further centrifugation step 
was performed as previously described. The pellet containing the donor cells was trans-
ferred into the anaerobic chamber and mixed with the recipient strain at a ratio of 1:5 
(recipient : donor). For this purpose, the E coli ST18 pellet was resuspended with 200 µl 
of a C. difficle preculture and the bacterial suspension was dropped onto BHI(S) agar 
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plates with the corresponding media supplements. The conjugation plate was then in-
cubated anaerobically at 37 °C for 6 h. After the incubation step, the visible cell biomass 
was scraped off and transferred onto a selection plate (in this case BHI(S) with supple-
ments and devoid of ALA to suppress E. coli ST18 growth). The selection plates were 
then incubated anaerobically at 37 °C for 2 - 3 days. The resulting colonies were tested 
by PCR using the genomic or plasmidial DNA as templates. 
 
 
10x PBS-Puffer, pH 7.4: NaCl 137 mM 
 KCl 27 mM 




KH2PO4 20 mM 
1x PBS-Puffer, pH 7.4: 10 x PBS-
Puffer 
10 % (v/v) 
 
 
3.3.4 Isolation of DNA from C. difficile 630Δerm 
The quick protocol of Bouillaut et al. 2011 was slightly modified for the isolation of ge-
nomic and plasmidial DNA. The clone of interest was taken from a plate and transferred 
onto a BHI(S) plate with corresponding supplements. The plate was cultivated overnight 
anaerobically 37 °C. Abundant material was scrapped off from C. difficile 630Δerm over-
night grown plate to inoculate a preculture. 2 mL of the preculture was withdrawn and 
centrifuged at 16`000 x g for 5 min. The pellet was washed twice with 1 mL 1x PBS.  
Afterwards, the pellet was dissolved in 500 µl dH2O. Cell disruption was performed in a 
subsequent heating step. The cell suspension was incubated at 95 °C for 15 min. 2 µL 
from the cell lysate was used for a specific PCR. 
 
 
3.3.5 Isolation of RNA from C. difficile 630∆erm 
The RNA isolation procedures were based on the protocol by Monarch Total RNA Mini-
prep Kit Protocol (New England Biolabs®, Frankfurt am Main, Germany). Cells were pel-
leted and mechanical disruption was performed as follows: The harvested cells (1.5 g 
wet weight) were washed with 1 mL 1x PBS and centrifuged at 16`000 x g, 4 °C for  
15 min. Subsequently, the pellets were dissolved in 800 µL 1x Protection Reagent (New 
England Biolabs®, Frankfurt am Main, Germany) and 0.7 g glass beads were added. The 
cell disruption was performed by FastPrep®-24 (MP Biomedicals™ Germany GmbH, 
Eschwege, Germany) in two rounds at 6.5 m/s, 4 °C for 30 s. The separation of cell debris 
and glass beads was performed by a centrifuging at 16`000 x g, 4 °C for 10 min. The 
supernatant was treated with RNA lysis buffer (New England Biolabs®, Frankfurt am 
Main, Germany) in a ratio of 1:1 (v/v) and prepared according to the previously specified 
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protocol. The RNA was eluted with 50 µL nuclease-free water from the column and the 
concentration was determined with the Qubit® 3 fluorometer (Thermo Fisher Scientific 
– Life Technologies GmbH, Schwerte, Germany). The samples were then stored at -80 °C 
until further usage. 
 
3.3.6 Isolation of plasmid DNA from E. coli cells 
Plasmid DNA was isolated from E. coli cells using the commercially available QIAprep® 
Spin Miniprep Kit (QIAGEN GmbH, Hilden, Germany) or Monarch® Plasmid Miniprep Kit 
(New England Biolabs®, Frankfurt am Main, Germany). For this purpose, 8 mL of an  
E. coli liquid culture were prepared and incubated at 37 °C by 200 rpm overnight.  
Four mL were collected from this culture and centrifuged at 16`000 x g for 3 min at room 
temperature. The pellet was handled as specified by the manufacturer. The elution of 
plasmid DNA from the silica membrane was performed with 20 - 30 µL Buffer EB. 
 
3.3.7 Determination of the DNA or RNA concentration by using Qubit® 3 fluorometer 
The determination of the DNA or RNA concentration was performed on a Qubit® 3 fluo-
rometer (Life Technologies; Thermo Fisher Scientific, Schwerte, Germany). This method 
is selective for measuring double-stranded DNA (dsDNA)/single-stranded DNA (ssDNA) 
in a range of 0.01 - 1000 ng/μL. The Qubit® assay dyes bind selectively to DNA/RNA fa-
cilitating fluorescence-based quantification. The procedure was performed according to 
the specifications of the manufacturers.  
 
3.3.8 Agarose gel electrophoresis 
A common molecular biological method for the separation of high molecular nucleic  
acids is the agarose gel electrophoresis. Various agarose concentrations (0.3 to  
2 % (w/v)) can be used for the separation of DNA according to the molecular weight. 
Routinely, DNA fragments were separated in a 1 % (w/v) agarose gel. The DNA samples 
were mixed with gel loading dye® (purple (6X), New England Biolabs®, Frankfurt am 
Main, Germany) and transferred onto the gel. The commercially available length stand-
ard e.g. 1 kb Plus DNA Ladder (New England Biolabs®, Frankfurt am Main, Germany) was 
used for sizing. The samples were separated for 50 min at a voltage of 100 V. Subse-
quently, the gel was stained with ethidium bromide and the separated fragments were 
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TAE-buffer, pH 8.0: Tris-acetate 40 mM 
 EDTA 1 mM 
 
 
Agarose gel: Agarose in TAE-
buffer 
1 % (w/v) 
 
 
Ethidium bromide: Ethidium bromide in 
dH2O 
0.1 % (w/v) 
 
 
3.3.9 Polymerase chain reaction (PCR) 
The polymerase chain reaction is a molecular method that allows DNA amplification by 
applying different temperatures in multiple cycles using specific primers and a thermo-
stable DNA polymerase. This method was used for the verification of a pure culture sta-
tus of C. difficile 630Δerm cultivations, for the amplification of C. difficile 630Δerm genes 
as inserts for specific cloning methods (e.g. Gibson Assembly® Cloning Kit, New England 
Biolabs®, Frankfurt am Main, Germany) and for the verification of various plasmids. The 
PCR mixture based on the Q5® High-Fidelity DNA-Polymerase protocol (New England 
Biolabs®, Frankfurt am Main, Germany) was prepared as shown in table 7 and the PCR 
program was individually customized to amplify the specific DNA sequence in the Pro 
Flex PCR System (Thermo Fisher Scientific, Schwerte, Germany). 
 




 Volume per mixture [µL] Final concentration 
Template DNA 2 <1000 ng 
Primer Forward [10 µM] 1.25 0.5 µM 
Primer Reverse [10 µM] 1.25 0.5 µM 
5x Q5 Reaction Buffer 5 1x 
10 mM dNTPs 0.5 200 µM 
Q5 High-Fidelity DNA Polymerase 0.25 0.02 U/µl 
dH2O 14.75 - 
Final volume  ∑ 25 - 
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Verification of C. difficile 630Δerm pure cultures with the 16S rRNA PCR analysis  
To verify the absence of contaminations in C. difficile 630Δerm strains, sterile colonies 
were taken from a grown agar plate and the genomic DNA was isolated (see chapter 
3.3.4). 16S rRNA primers were used of C. difficile 630Δerm showing a clear band of  
800 bp on an agarose gel. The mixture was prepared as referred to in table 7 with the 
Primer CDiff16S_fw and CDiff16S_rev. The specific PCR program is shown in table 8. 
 
  
Table 8: PCR program for the verification of a pure culture of C. difficile 630Δerm 
 Temperature [°C] Time Cycles 
Initial denaturation 95 3 min 1 
Denaturation 95 30 s  
 30 Annealing 48 1 min 
Elongation 72 1 min 
Final Elongation 72 5 min 1 




3.3.10 Construction of Prd and Rnf bait protein production vectors  
The bait genes prdA, prdB, rnfB and rnfC from C. difficile 630∆erm lacking the stop codon 
were amplified via PCR. Approximately 200 - 500 bp upstream region of the first gene of 
the operon was amplified together or separately and subsequently fused to the 5´of 
each gene. These regions putatively contained the native promoter for each genetic 
unit. Therfore, a 10 mL C. difficile 630∆erm overnight culture was grown and the ge-
nomic DNA isolated (see chapter 3.3.4) and used as a template for PCR-amplification 
(table 7). The primers were designed to suit each fragment amplification and/or differ-
ent cloning strategies. Additionally, the Strep-tag® II sequence was fused to the  
C-terminal. After amplification, proper size of the fragments was verified by electro- 
phoresis (see chapter 3.3.8) and finally cloned into the shuttle vector pMTL82151. 
 
Construction of the PrdA and RnfC bait protein production vectors  
The bait genes prdA (master thesis, Ilka Pusch 2018) and rnfC were cloned into the  
vector pMTL82151 using the cloning strategy of the Gibson Assembly® Cloning Kit (New 
England Biolabs®, Frankfurt am Main, Germany). For this purpose, the above-mentioned 
gene amplification and subcloning steps were perfomed with a 15 - 30 bp overhang at 
the 5`and 3` ends complementary to the shuttle vector pMTL82151. And the Strep- 
tag® II sequence was fused to the C-terminal. The program and primers in table 9 and 
10 were used, respectively. The purified final fragment called prdA-strep II with a size of 
~2300 bp and rnfC-strep II with a size of ~1500 bp.  
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The concentration of the purified fragments was determined via the Qubit® 3 fluorom-
eter (Thermo Fisher Scientific – Life Technologies GmbH, Schwerte, Germany) (see chap-
ter 3.3.7). Finally, the bait insert was stored until further use at -20 °C.  
 
Table 9: PCR program for prdA-strep II (master thesis, Ilka Pusch 2018) 
 Temperature [°C] Time Cycles 
Initial denaturation 95 3 min 1 
Denaturation 95 30 s  
            30 Annealing 571 | 652 | 593 1 min 
Elongation 72 1 min 45 s1 | 1min 30 s2,3 
Final Elongation 72 5 min 1 
Hold 4 ∞  
1Annealing temperature for the first PCR with the primers Upstream_prdA_fw and Down-
stream_prdA_rev, 2Annealing temperature for the second PCR with the primers Upstream_prdA_fw and 
prdA_Strep_rev 3Annealing temperature for the third PCR with the primers NEB_pprdA_fw and 
NEB_pprdA_rev 
 
Table 10: PCR program for rnfC-strep II  
 Temperature [°C] Time Cycles 
Initial denaturation 95 3 min 1 
Denaturation 95 30 s  
 30 Annealing 571 | 702,3  1 min 
Elongation 72 1 min 
Final Elongation 72 5 min 1 
Hold 4 ∞  
1Annealing temperature for the first PCR with the primer RnfC_for and RnfC_rev_ohne_ stop, 2Annealing 
temperature for the second PCR with the primer NEB_pRnfC_for and NEB_strep_rev, 3Annealing temper-
ature for the third PCR with the primer NEB_pRnfC_for and NEB_pstrep_rev 
 
The construction of the final vector pMTL82151prdA-strep II (master thesis, Ilka Pusch 
2018) and pMTL82151rnfC-strep II was achieved using the Gibson Assembly® Cloning 
Kit, (New England Biolabs®, Frankfurt am Main, Germany) (figure 11). The above-men-
tioned purified inserts were further employed for subsequent cloning. Therefore, the 
target vector pMTL82151 was digested with BamHI® and EcoRI® (New England Biolabs®, 
Germany) (table 11) and purified with the QIAquick PCR Purification Kit (QIAGEN GmbH, 
Hilden, Germany). The concentration was determined by using Qubit® 3 fluorometer 
(Thermo Fisher Scientific – Life Technologies GmbH, Schwerte, Germany). The Gibson 
Assembly® Mix was prepared in a ratio of approximately 1:3 (vector : insert) and with a 
minimum concentration of 50 ng of the vector as specified by the Gibson Assembly® 
Protocol (New England Biolabs®, Frankfurt am Main, Germany) (table 12). Finally, the 
mix were transformed into E. coli DH10b cells (see chapter 3.3.2).  
 
 





















Figure 11: Cloning strategy based on Gibson Assembly® (modified after New England Biolabs®, Frankfurt 
am Main, Germany). The inserts with the complementary sequence (15 - 20 bp) to the vector ends were 
used for the Gibson Assembly® approach. Three enzymatic activities in one single reaction step were im-
plemented: a 5' exonuclease activity, DNA polymerase (3`extension activity) and DNA ligase activity  
(at 50 °C for 15 - 60 min). The exonuclease digests the 5' end sequences to expose a sticky end overhang 
which is complementary to the vector. The DNA polymerase fills the gaps and a DNA ligase closes the gaps 
and binds the DNA fragments together.  
 
 
Table 11: General restriction digestion (modified after New England Biolabs®), 1 h by 37 °C  
 
 




 Volume per mixture [µL] Final concentration 
Restriction Enzyme 1 10 units 
DNA X 1-2 µg 
10X NEBuffer 5 1x 
dH2O Add to 50 - 
Total reaction volume ∑ 50  
 Volume per mixture [µL] Final concentration 
Gibson Assembly Master Mix (2X) 10 1x 
Vector DNA X ~ 0.020 pmol 
Insert DNA X ~ 0.060 pmol 
dH2O Add to 20 - 
Total reaction volume ∑ 20  
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Clones were transferred from the selective plates into 10 mL LB medium with 34 µg/mL 
chloramphenicol and were cultivated at 200 rpm, 37 °C overnight. The culture was used 
to isolate the plasmid which were checked via double digestion using the corresponding 
enzymes (table 11). Positive clones were also corroborated by DNA sequencing at  
Eurofins Genomics Germany GmbH (Ebersberg, Germany). For this, the primers 
Seq2_fw/Seq2_rev and Seq_prdA_fw/Seq_prdA_rev were used. The competent E. coli 
ST18 cells were transformed seperately with the final constructs pMTL82151prdA-strep 
II (master thesis, Ilka Pusch 2018) and pMTL82151rnfC-strep II and used for the mating 
into C. difficile 630∆erm (see chapter 3.3.3).   
 
 
Construction of the PrdB and RnfB bait protein production vectors  
The bait genes prdB and rnfB were amplified and cloned finally into the vector 
pMTL82151. For this, the amplification of the genes fused to their corresponding pro-
moter sequences and the addition of a C-terminal Strep-tag® II were achieved using  
separate PCR programs (table 13 and 14).  
The Golden Gate method relying on the BsaI restriction was used as a strategy for the 
cloning of rnfB-strep II. The type IIs restriction enzyme BsaI cuts 5 nt upstream its recog-
nition sequence. With the help of this enzyme and the T4 DNA ligase, a simultaneous 
assembly of several DNA fragments is feasible. The annotated recognition sequence for 
this enzyme is 5′-GGTCTC(N1)/(N5)-3′, which was included within the rnfBRv primer se-
quence. Afterwards the amplified rnfB and the corresponding upstream sequence con-
taining the promoter region were assembled using BsaI. The Strep-tag® II sequence was 
spliced to the C-terminal of each insert by PCR (table 14). The purified final fragments 
called prdB-strep II (~ 1220 bp) and rnfB-strep II (~ 1500 bp) and the concentration was 
determined on the Qubit® 3 fluorometer (Thermo Fisher Scientific – Life Technologies 
GmbH, Schwerte, Germany) (see chapter 3.3.7). Afterwards, the bait inserts were stored 
at -20 °C until further use.  
 
 
Table 13: PCR program for prdB-strep II  
 Temperature [°C] Time Cycles 
Initial denaturation 95 3 min 1 
Denaturation 95 30 s  
 30 Annealing 531,2,3,4  1 min 
Elongation 72 1 min 
Final Elongation 72 5 min 1 
Hold 4 ∞  
1Annealing temperature for the promoter amplification with the primers prdBPmFw and prdBPmRv, 2An-
nealing temperature for the amplification of prdB with the primer pair prdBFw and prdBRV, 3Annealing 
temperature for the fusion PCR with the primer prdBPmFw and prdBRV; 4Annealing temperature to add 
the C-terminal Strep-tag® II with the primer prdBPmFw and prdBRV2 
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Table 14: PCR program for rnfB-strep II  
 Temperature [°C] Time Cycles 
Initial denaturation 95 3 min 1 
Denaturation 95 30 s  
 30 Annealing 511 | 502 | 603 1 min 
Elongation 72 1 min 
Final Elongation 72 5 min 1 
Hold 4 ∞  
1Annealing temperature for the promoter amplification using the primer rnfBPmFw and rnfBPmRv, 2An-
nealing temperature for amplification of the rnfB sequence employing the primers rnfBFw and rnfBRv, 




The respectively bait insert prdB-strep II and rnfB-strep II were further transferred into 
the pJET1.2® as a subcloning step (Thermo Fisher Scientific, Schwerte, Germany). The 
CloneJET™ PCR Cloning Kit protocol was carried out as specified in the manufacturer´s 
guidelines. E. coli DH10b cells were employed to propagate the plasmids.  
The resulting constructs pJET1.2®prdB-strep II and pJET1.2®rnfB-strep II were digested 
using BamHI® and EcoRI® (New England Biolabs®, Frankfurt am Main, Germany). The 
final digested fragments prdB-strep II and rnfB-strep II were subsequently cloned into 
the target vector pMTL82151 using the T4 ligase (New England Biolabs®, Frankfurt am 
Main, Germany). For this purpose, the target vector was also digested with the enzymes 
BamHI® and EcoRI® (New England Biolabs®, Frankfurt am Main, Germany) (table 11).  
Afterwards the samples were purified using the QIAquick PCR Purification Kit (QIAGEN 
GmbH, Hilden, Germany) and the concentration was determined using a Qubit® 3 fluo-
rometer (Thermo Fisher Scientific – Life Technologies GmbH, Schwerte, Germany). The 
purified fragments were then ligated using the Ligation Protocol with T4 DNA ligase 
(New England Biolabs®, Germany) (table 15) and finally the ligation mixture was trans-
formed into E. coli DH10b cells (see chapter 3.3.2). 
 
Table 15: General Ligation Protocol with T4 DNA Ligase (after New England Biolabs®) at 16 °C  
 
 
Clones were transferred from the selective plates into 10 mL LB medium with  
34 µg/mL chloramphenicol or 100 µg/mL ampicillin (depending of the plasmid) and were 
cultivated by 200 rpm at 37 °C overnight. Afterwards, the culture was used to isolate the 
 Volume per mixture [µL] Final concentration 
T4 DNA Ligase Buffer (10X) 2 1x 
Vector DNA  X 0.020 pmol 
Insert DNA X 0.060 pmol 
T4 DNA Ligase 1 20.000 units 
 dH2O Add to 20 - 
Total reaction volume ∑ 20 overnight 
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plasmid which were checked via double digestion using the corresponding enzymes  
(table 11). Positive pJET1.2® clones were used for DNA sequencing at Eurofins Genomics 
Germany GmbH (Ebersberg, Germany). For this, the primers pJET1.2_fw/pJET1.2_rev 
were used. The competent E. coli ST18 cells were transformed with the final bait protein 
production vector pMTL82151prdB-strep II and pMTL82151rnfB-strep II, respectively 
and used for the mating into C. difficile 630∆erm (see chapter 3.3.3).   
 
Confirmation of the constructed C. difficile pMTL82151 strains by PCR 
The successful mating of C. difficile 630∆erm which finally harbors the different bait pro-
tein production constructs based of the vector pMTL82151 was PCR confirmed by using 
the primers M13_fw and M13_rev. The empty vector pMTL82151 was used as a control. 
After the mating, different clones were picked from the BHI(S) selection plates contain-
ing 15 µg/mL thiamphenicol and inoculated in 10 mL fresh supplemented BHI(S) me-
dium. The cultures were grown anaerobically at 37 °C overnight. Two mL of these were 
taken and the plasmid DNA of C. difficile 630∆erm was isolated (see chapter 3.3.4). The 
PCR master mix was prepared as described in table 7. Additionally, table 16 shows the 
implemented PCR program. After PCR-amplification the mixture was resolved by aga-
rose gel electrophoresis and the products were visualized (see chapter 3.3.8). A DNA 
band with the length of 153 bp corresponded to the empty vector pMTL82151 while 
larger DNA bands matching the expected size of each insert in this vector. The PCR  
observation confirmed the proper construction of the C. difficile 630∆erm recombinant 
strains. 
 
Table 16: PCR program for the confirmation of recombinant C. difficile 630∆erm strains  
 Temperature [°C] Time Cycles 
Initial denaturation 95 3 min 1 
Denaturation 95 30 s  
 30 Annealing 50 1 min 
Elongation 72 1 min – 1 min 30 s1 
Final Elongation 72 5 min 1 
Hold 4 ∞  
1Elongation time depends on the amplicon product size  
 
 
3.3.11 Mutagenesis in C. difficile 630∆erm using ClosTron® technology 
Mutagenesis is a classical tool of genetic research. For directed mutagenesis strategies 
molecular biology-based approaches are needed. Various molecular biology tools have 
been developed to mutagenize distinct bacteria in this context. A customized molecular 
approach for genetic engineering has been developed for C. difficile to modify genes in 
a targeted manner.  
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The most widely employed genome engineering technique in the Clostridia scientific 
community is termed ClosTron® (Heap et al. 2007, Heap et al. 2010a; Kuehne and Minton 
2012). In recent years, novel strategies have been explored such as the CRISP-CAS9 sys-
tem (Wang et al. 2018).  
In this work the ClosTron® approach was used to mutate the rnfC gene, which encodes 
for a subunit of the Rnf complex. The ClosTron® system is based on an intron puntual 
mutagenesis strategy, during which the intron integrates specifically into a preselected 
insertion sequence. Thus, an insertional, but not a knock out mutant are generated. This 
intron belongs to the mobile group II intron family (Mohr et al. 2000). The intron pos-
sesses a retrotransposition activated marker (RAM) based on the ermB gene. Acquired 
resistance to erythromycin is used for the selection of clones harboring an intron-based 
gene disruption (Heap et al. 2007; Kuehne and Minton 2012). A commercially synthe-
sized shuttle vector pMTL007C-E2 (Heap et al. 2010b), which contains the pre-designed 
intron targeting sequence and the group II intron is introduced into C. difficile 630∆erm 
by conjugal gene transfer (Heap et al. 2007; Heap et al. 2010a; Kuehne und Minton 
2012). Figure 12 shows the strategy of intron insertion. 
 
 
Figure 12: Representation of the ClosTron® technique for the generation of mutants in C. difficile (after 
Kuehne and Minton 2012). The ClosTron® plasmid pMTL007C-E2 (Heap et al. 2010b) carrying a group II 
intron [yellow] with the td sequence (own splicing activity) [black] that inactivated ermB gene [blue] and 
the ltrA gene [green] is shown. The mRNA transcript of ermB contains the td intron without an own  
splicing effect. That mechanism leads to an erythromycin sensivity at first. Next, the transcription of the 
lagging DNA strand, which includes the group II intron region, is generated and a ribonuclear protein com-
plex [RNP] is formed by the binding of the LtrA protein and the transcript [1], whereby the td is now in 
the correct orientation and the splicing effect is elicited [2]. The complex RNP binds specifically to the 
target gene within the chromosome [3], and the LtrA cleaves the target region of the chromosome and 
the RNA can be inserted [4]. LtrA has reverse transcriptase activity and synthesizes the DNA strand [5,6], 
whereby the nucleases of the host degrade the inserted RNA [7]. A DNA polymerase reconstitutes the 
complementary strand [8]. Finally, ligases fill the gaps [9,10]. 
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The rnfC mutant strain (hereafter termed CD630∆erm_rnfC636/637s::ermB) was gener-
ated by using this system of ClosTron®. The group II intron was designed to be integrated 
in the middle of the rnfC sequence of the wildtype strain C. difficile 630Δerm. Using the 
intron targeting design tool by ClosTron®, the program identified possible intron target 
sites (Perutka method (Perutka et al. 2004)). Based on the algorithm of the exon target 
site of the rnfC sequence (CD630DERM_11370 (KEGG)), the position with the highest 
score of 8.401 was selected: 
636|637s (5`-ATTGAAACGAATAAACCAGATGCTATAGAAGCAATTCAAAATGTA-3`) (digital 
appendix). Afterwards, the plasmid for mutagenesis on the basis of the vector 
pMTL007C-E2 was designed and synthesized with the tool DNA2.0 from ATUM (US) 
(Heap et al. 2007; Heap et al. 2010a; Heap et al. 2010b; Kuehne and Minton 2012).  
E. coli DH10b cells were transformed with the purchased plasmid pMTL007C-E2:316671 
(CDi_rnfC) and selected on LB with 34 µg/ml chloramphenicol overnight at 37 °C. The 
plasmid was isolated from the resulting clones and the DNA concentration was deter-
mined on a Qubit™ 3 fluorometer (Thermo Fisher Scientific – Life Technologies GmbH, 
Schwerte Germany). Once the intron targeting sequence (CDi_rnfC) was present, the 
plasmid pMTL007C-E2:316671 (CDi_rnfC) was digested with the enzymes BsrGI and 
HindIII at 37 °C for 1 h. The digested DNA fragment was loaded onto an 1 % agarose gel 
and checked for presence at ~340 bp DNA fragment lenght. Afterwards, the plasmid was 
transferred into E. coli ST18 cells and finally into the wildtype strain C. difficile 630Δerm. 
Bacteria cells which are carrying the target vector were selected twice onto BHI(S) plates 
with 15 µg/mL thiamphenicol. Clones were then selected on BHI(S) with 2.5 µg/mL 
erythromycin to ensure the insertion of the intron. Clones grown on this selection plate 
were used for DNA isolation. The presence of the insertion of the group II intron was 
determined by PCR. With that aim, rnfC gene specific primers (RnfC_for and 
RnfC_rev_ohne_stop) were used. The expected lenght of the DNA fragment product was 
1535 bp for the intron-free chromosome and 3335 bp when the group II intron  
(~1800 bp) was integrated within the rnfC gene. A second PCR was conducted with 
erythromycin gene specific primers (Erm_fw and Erm_rev). The PCR product with a 
lenght of ~1700 bp and ~1500 bp confirmed the intron insertion. The final verification 
of the proper construction of the rnfC mutant strain was carried out by DNA sequencing 
(Eurofins Genomics Germany GmbH, Ebersberg, Germany) using the amplified DNA frag-
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Table 17: PCR program for the control of the group II intron insertion in CD630∆erm 
 Temperature [°C] Time Cycles 
Initial denaturation 95 3 min 1 
Denaturation 95 30 s  
30 Annealing      551 |602| 623 1 min 
Elongation 72 2 min1 |1 min 30 s2,3 
Final elongation 72 5 1 
Hold 4 ∞  
1Conditions for the rnfC specific PCR employing the primers RnfC_for and RnfC_rev_ohne_stop; 2Condi-
tions for the PCR with erythromycin gene and rnfC gene primers Erm_fw and RnfC_rev_ohne_stop; ex-
pected length of PCR product ~1500 bp; 3Annealing temperature for the PCR by using erythromycin and 




3.4 Affinity purification coupled with mass spectrometry – Protein pro- 
duction and bait-prey purification  
An interactomic approach based of affinity purification coupled with mass spectrometry 
was used for the identification of in vivo protein-protein interactions in C. difficile 
630Δerm (see chapter 1.4). This method was employed to analyse in depth the inter-
action partners (preys) of the target proteins (baits). This approach encompassed the 
genomic part and the interactomic methodology. Figure 13 shows the generic workflow 
illustrating the process of the method. The host native organism C. difficile 630∆erm was 
chosen as a production strain. Thereby, the naturally occuring interactions were ob-
served without artifacts derived from exogenous proteins. Firstly, the strains were puri-
fied in absence of an in vivo cross-linker for qualitative analysis of the baits and the  
determination of a bait-prey interaction. Additionally, formaldehyde-driven in vivo 
cross-linking was carried out to capture transient interactions. The wildtype strain  
C. difficile 630∆erm harboring the empty vector pMTL82151 was included as a back-
ground control and subjected to the complete affinity chromatography process to rule 




























Figure 13: Schematic representation of the interactomic workflow based of affinity chromatography 
coupled with LC-MS/MS in C. difficile 630Δerm. The figure shows stepwise the workflow of the interac-
tomic technique encompassing affinity chromatography coupled with LC-MS/MS. The methods are  





3.4.1 Recombinant bait protein production and cross-linking in C. difficile 630∆erm  
Strains C. difficile 630Δerm_pMTL82151prdA-strep II (master thesis, Ilka Pusch 2018),  
C. difficile 630Δerm_pMTL82151prdB-strep II, C. difficile 630Δerm_pMTL82151rnfB-
strep II and C. difficile 630Δerm_pMTL82151rnfC-strep II, and the background control 
(wildtype harboring the empty plasmid pMTL82151) were grown anaerobically in 40 mL 
BHI(S) supplemented with 15 µg/mL thiamphenicol at 37 °C for 12 h and used as 
preculture. The main culture was inoculated to an OD600 nm of 0.05 in 2 L BHI(S) contain-
ing 15 µg/mL thiamphenicol and further grown anaerobically at 37 °C over 12 h. One 
protein-protein interaction experimental set up included the formaldehyde treatment 
to accomplish in vivo cross-linking (OD600 nm = 1, addition of 0.156 % cross-linker). After 
addition of formaldehyde, the cultures were incubated anaerobically at 37 °C for 20 min 
to allow the cross-linker to penetrate the cell membrane and react with proteins. The 
reaction was quenched by adding 270 mM glycine and incubating the culture for addi-
tional 5 min.  
 
Afterwards, cultures with and without cross-linker treatment were handled similary. 
Cells were harvested anaerobically at 4 °C, 3`000 x g for 20 min. After that, the cells were 
washed with 20 mL 1 x PBS and centrifuged again at 4 °C, 3`000 x g for 15 min. Finally, 
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Resuspension buffer: Tris-HCl, pH 7.5 100 mM 
 EDTA 1 mM 
 NaCl 150 mM 
 DTT 5 mM 
 1 tablet protease inhibitor per  




3.4.2 Cell disruption and separation of the insoluble and soluble fraction  
Cell disruption was accomplished by the FastPrep®-24 (MP Biomedicals™ Germany 
GmbH, Eschwege, Germany) with in total 12 g glass beads per resuspended cell suspen-
sion. The disruption was carried out at 4 °C and 6.5 m/s for 30 s in two cycles. Following 
by an ultrasonic bath (Merck KGaA, Darmstadt, Germany) treatment for 5 min. The sep-
aration of cell debris and spores from the residual cell free extract was achieved by  
centrifugation at 4 °C, 2`000 x g for 20 min. Subsequent separation of the soluble and 
insoluble phase of the cell free extracts was performed by ultracentrifugation at 4 °C,  
40`000 rpm for 65 min (Optima®L-90K ultracentrifuge, Rotor: TI 70.1, Beckman Coulter 
GmbH, Krefeld, Germany).  
 
3.4.3 Affinity chromatography of the bait-prey complexes  
The soluble fractions of the cell free extract from cultures without the cross-linker for-
maldehyde containing the tagged baits PrdA, PrdB and RnfC were treated with 300 µL 
Avidin (2 mg/mL), incubated for 10 min and subjected to the affinity chromatography, 
respectively. In contrast, the insoluble fraction isolated by ultracentrifugation was used 
after solubilization for the isolation of the membrane-bound RnfB. For this purpose,  
0.3 g insoluble fraction was resolved in 5 ml solubilization buffer containing detergent. 
The proteins were isolated from the membrane at 4 °C for 1.5 h with gentle rotation. 
Afterwards, the dissolved membrane associated proteins were separated by further 
centrifugation at 16`000 x g for 10 min. The following affinity chromatography steps 
were similar for insoluble and the soluble fractions. The protein complexes were immo-
bilzed on an affinity Strep-Tactin® column (Strep-Tactin® Superflow® high capacity, IBA 
Lifesciences, Göttingen, Germany) with a column volume of 0.5 mL (for insoluble frac-
tions) and 1 mL (for soluble fractions). The flowthrough was collected and the matrix 
was washed with 5 x 1 column volume washing buffer and the proteins were eluted from 
the column with 3 x 1 column volume elution buffer after an incubation of 15 min. The 
protein concentration was determined on a Qubit™ 3 fluorometer (Thermo Fisher  
Scientific – Life Technologies GmbH, Schwerte Germany). The eluates were concen-
trated employing a centrifugal concentrator Amicon® Ultra -0.5 mL centrifugal filter 
units (Ultracel® -10K) (Merck KGaA, Darmstadt, Germany) according to the recommen-
dations of the supplies. Elution of the protein from the membrane of the centrifugal 
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concentrator was performed by centrifugation at 2`000 rpm for 2 min. After each frac-
tionation, 40 µL samples were collected and mixed with 15 µL SDS sample buffer and 
stored at -20 °C (for a gel- based LC-MS/MS measurement). 
 
The bait-prey interactions at the membrane level were stabilized by the presence of the 
cross-linker formaldehyde. This facilitates the identification of cytosolic transient inter-
acting proteins. For this purpose, all bait proteins (PrdA, PrdB, RnfB and RnfC) strains 
were treated identically. After the cell fractionation of the cell free extract, 0.3 g of the 
insoluble fraction was solubilized in 5 mL solubilization buffer for at least 1.5 h with gen-
tle rotation at 4 °C and the proteins were solubilized from the membrane using deter-
gent as previously specified. Two hundred µL samples from the solubilized membranes 
were analyzed by LC-MS/MS and used as an abundance control for the proteomics  
approach. The remaining insoluble fraction was strep-tagged affinity chromatoghaphed. 
For this purpose, 0.5 mL of the Strep-Tactin® matrix (Strep-Tactin® Superflow® high ca-
pacity, IBA Lifesciences, Göttingen, Germany) was used. The flowthrough was collected 
and the column was washed with 5 x 1 column volume washing buffer. The elution of 
each bait protein was performed by adding 3 x 1 column volume elution buffer to the 
column and incubated for 15 min. Two hundred µL samples were taken from each eluate 
for LC-MS/MS analysis. The protein concentration was determined using a Qubit™ 3 flu‐
orometer (Thermo Fisher Scientific – Life Technologies GmbH, Schwerte, Germany). The 
samples were stored at -80°C until further use.  
The remaining eluate was concentrated using a centrifugal concentrator Amicon® Ultra 
-0.5 mL centrifugal filter units (Ultracel® -10K; Merck KGaA, Darmstadt, Germany)  
according to the recommendations of the company. A 40 µL sample were taken from 
the elution fraction and 15 µL SDS sample buffer were added. The SDS samples were 




Solubilization buffer (pH 8.0): K2HPO4 18.8 mM 
 KH2PO4 1.2 mM 
 Triton X-100 1.8 % (v/v) 
   
 
Washing buffer: Tris-HCl, pH 7.5 100 mM 
 EDTA 1 mM 
 NaCl 150 mM 
 DTT 5 mM 
 
Elution buffer: Tris-HCl, pH 7.5 100 mM 
 EDTA 1 mM 
 NaCl 150 mM 
 DTT 5 mM 
 d-desthiobiotin 2.5 mM 






3.4.4 Storage and regeneration of the Strep-Tactin® column 
After protein purification the column material was washed 5 x 1 column volume with 
washing buffer and stored in 1 x Haba solution (IBA Lifesciences, Göttingen, Germany) 
at 4 °C until usage. The column was regenerated with 5 x 1 column volume Strep-wash 
buffer I and 10 x 1 column volume Strep-wash buffer II. Thereby, the column material 
was optimally regenerated for next protein purification. 
 
 
Strep-wash buffer I: 
 
Tris-HCl (pH 10.5) 
 
100 mM 
 NaCl 150 mM 
 EDTA 1 mM 
 
Strep-wash buffer II: Tris-HCl (pH 8) 100 mM 
 NaCl 150 mM 
 EDTA 1 mM 
 
 
3.4.5 Determination of protein concentration with Qubit® 3 fluorometer 
The determination of the protein concentration was performed on a Qubit® 3 fluorom-
eter (Life Technologies; Thermo Fisher Scientific, Schwerte, Germany). The Qubit® assay 
dyes contained in the kit bind selectively to proteins. Afterwards, a fluorescence-based 
quantification was performed. The procedure was conducted following the recommen-






4x SDS sample buffer: Tris-HCl, pH 6.8 100 mM 
 Glycerol 40 % (v/v) 
 SDS 110 mM 





Bromphenol blue 3 mM 
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3.5 Biochemical methodes for the characterization of protein-protein  
interactions  
 
3.5.1 Discontinuous SDS-PAGE 
The characterization of proteins in terms of their relative molecular masses the sodium 
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) was used. In brief, the 
proteins were denatured by the SDS detergent and heating, and separated electropho-
retically. SDS allows to mask the intrinsic charge of proteins with the negative charge of 
the detergent and subsequently the separation of the proteins is only dependent on 
their relative molecular mass. An electrical currency was applied to the gel chamber and 
the negatively charged „SDS-protein complexes“ moved towards the anode and were 
separated according to their mass in a polyacrylamide gel. Thereby, larger proteins mi-
grate slower than smaller proteins. The gel consisted of a stacking gel and a separation 
gel. In the stacking gel the pores of the gel were larger and the ionic intensity lower than 
in the separation gel, which means that the proteins moved faster. In the interface be-
tween both gel types, the ratio of pore size and ionic intensity were inverted and the 
proteins were concentrated. Subsequently, the proteins were separated according to 
their molecular masses in the separation gel. Afterwards, migration of proteins was 
compared to those of a reference marker and the relative molecular masses were in-
ferred.  
 
For SDS-PAGE analysis 40 µL protein samples were mixed with 15 µL 4 x SDS sample 
buffer and heated up at 95 °C for a maximum of 30 min. The samples were centrifuged 
at 16`000 x g for 5 min. The proteins were normally separated in a 15 % SDS gel. The 
electrophoresis was performed for 45 min at a constant amperage of 45 mA per gel. The 
resulting protein bands were stained using commercially available InstantBlue® Protein 
Stain (Expedeon Ltd, Cambridge, UK). The gel was treated with the staining solution for 
30 min and was destained with water until the individual protein bands became visible. 
The PageRuler™ (Plus) Prestained Protein Ladder (Thermo Fisher Scientific, Schwerte, 
Germany) was used as reference marker. 
 
 
 Solutions and buffer for the SDS-PAGE (per gel): 
Stacking gel (6 %): Acrylamide (30 % w/v) 0.5 mL 
 0.5 M Tris-HCl, pH 6.8 0.625 mL 
 dH2O 1.375 mL 
 Ammonium peroxodisulphate 
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Separation gel (15 %): Acrylamide (30 % w/v) 2.5 mL 
 1.5 M Tris-HCl, pH 8.8 1.75 mL 
 dH2O 1.75 mL 
 Ammonium peroxodisulphate 
(APS) solution (10 %) 
50 µL 










Tris-HCl, pH 8.8 1.5 M 
Stacking gel buffer: SDS 0.4 % (w/v) 
 Tris-HCl, pH 6.8 0.5 M  
 
 
10 x SDS running buffer: Glycine 192 mM 
 SDS 1 % (w/v) 
 Tris-HCl, pH 8.8 50 mM 
 
 
3.5.2 Detection of bait proteins by Western blot analysis 
After the purification of the bait-prey protein complex via affinity chromatography, the 
presence of each tagged bait protein was analyzed by Western blot analysis. For this 
purpose, Strep-Tactin® AP conjugate was used to bind to the Strep-tag® II of the bait 
proteins (Strep-tag® detection in Western blots, IBA GmbH, Göttingen, Germany). As 
described in the previous chapter, the samples were loaded onto a 15 % SDS-PAGE and 
the proteins were separated. Afterwards, the SDS-PAGE was incubated for 10 min in 
blotting-transfer buffer. In parallel a methanol activated PVDF membrane and Whatman 
paper were incubated for 5 min in the same buffer. The Western blot was built up in a 
sandwich model in the Tetra Blotting Module (Bio-Rad Laboratories GmbH, Feldkirchen, 
Germany) and protein transfer towards the PVDF membrane was conducted at 4 °C,  
30 V overnight. After blotting, the membrane was treated according to the protocol for 
the chromogenic detection via an alkaline phosphatase reaction by using Strep-Tactin® 
AP conjugate (Strep-tag® detection in Western blots, IBA GmbH, Göttingen, Germany).  
The Western blot membrane was subsequently blocked with 20 mL TBS-blocking buffer 
for 60 min and washed for 3 times with 20 mL TBS-Tween buffer. Afterwards, 10 mL TBS-
Tween containing 2.5 µL Strep-Tactin® AP conjugate (1:4000) was added to the mem-
brane and incubated over 60 min at room temperature by gently shaking. Next, the 
Western blot membrane was washed with TBS-Tween buffer followed with TBS buffer 
and each step was repeated twice. For the development of the chromogenic reaction 
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the membrane was transfered in 20 mL reaction buffer until the expected protein bands 
became visible.  
Finally, the relative molecular masses of Strep-tag® II recombinant proteins compared 
to the protein lenght ladder PageRuler™ (Plus) Prestained Protein Ladder (Thermo Fisher 
Scientific, Schwerte, Germany) were observed on the Western blot membrane. 
 
 
Blotting-transfer buffer: Tris-HCl, pH 8.5 25 mM 
 Glycine 150 mM 
 Methanol 10 % (v/v) 
 
 





NaCl 140 mM 
TBS-blocking buffer: TBS buffer 20 mL 
 BSA 3 % (w/v) 




TBS-Tween buffer: TBS buffer 20 mL 
 Tween20 0.1 % (v/v) 
 
 
Reaction buffer: Tris-HCl, pH 8.8 100 mM 
 NaCl 100 mM 
 MgCl2 5 mM 
 7.5 % (w/v) nitrotetrazolium blue 
in 70 % (v/v) dimethylformamid 
(NTB solution) 
10 µL 
 5 % (w/v) 5-bromo-4-chloro-3-
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3.5.3 Preparation of gel-based LC-MS/MS samples  
The concentrated protein eluates of the tagged baits PrdA, PrdB, RnfB and RnfC were 
transferred onto a 15 % SDS gel, seperated and stained with InstantBlue® Protein Stain 
(Expedeon Ltd, Cambridge, UK). After 30 min incubation the reaction was quenched with 
water. Afterwards, the prominent protein bands were cut out of the gel and prepared 
for LC-MS/MS analysis.  
For this purpose, the gel bands were fixed in a solution with 30 % ethanol and 10 % 
acetic acid. The InstantBlue® stain was treated with 50 mM ammonium hydrogen car-
bonate with 30 % acetonitrile until the dye was no longer visible. Finally, 100 % aceto-
nitrile (ACN) was added. Remaining solvent was entirely withdrawn. The samples were 
further processed for LC-MS/MS by Dr. Josef Wissing and Hedwig Schrader at the Helm-
holtz Centre for Infection Research (HZI) in Braunschweig (group of Prof. Dr. Lothar  
Jänsch; Cellular Proteome Research). For that, the gel pieces were dried in a SpeedVac 
and treated with 5 mM Tris (2-carboxyethyl) phosphine (TCEP) at 56 °C for 30 min, de-
hydrated in 100 % acetonitrile and rehydrated and with 10 mM methyl methanethiosul-
fonate (MMTS) containing trypsin (Promega GmbH, Walldorf, Germany) in a 10:1 pro-
tein/protease ratio. Afterwards, gel pieces were incubated at 37 °C overnight. Peptides 
were eluted with a 10 gel volume of H2O, 0.1 % trifluoroacetic acid (TFA) in 3 % ACN and 
finally with 0.1 % TFA in 30 % ACN for 2 h at 1`000 rpm and room temperature. The 
observed supernatants were dried separately in a SpeedVac. The dried peptides were 
resolubilized with 0.1 %/ 3 % (TFA/ACN) and desalted on a RP18 column and treated 
with 60 % ACN in 0.1 % TFA for elution. Finally, peptides were dried in a SpeedVac and 




3.5.4 Preparation of gel-free LC-MS/MS samples  
The gel-free LC-MS/MS analysis of the complete 200 µL cross-linked bait-prey complex 
eluates and a corresponding control of 200 µL of the total insoluble fraction-derived 
proteins prior the affinity chromatography (see chapter 3.4.3) was performed as follows. 
The samples were prepared for LC-MS/MS analysis as previously described by Dr. Josef 
Wissing and Hedwig Schrader at the HZI in Braunschweig (group of Prof. Dr. Lothar  
Jänsch; Cellular Proteome Research). The protein eluates were incubated for 30 min 
with 5 mM TCEP at 56 °C. For the reduction and protection of cysteine residues, the 
solution was treated with 10 mM MMTS for 15 min respectively. Afterwards, protein 
purification, protein digestion as well as peptide purification for LC-MS/MS measure-
ments were performed according to a slightly adapted „Single-Pot Solid-Phase-en-
hanced Sample Preparation“ (SP3) protocol (Hughes et al. 2014; Sielaff et al. 2017).  
Sequencing grade trypsin (Promega GmbH, Walldorf, Germany) was added in a ratio of 
1:50 (w/w) in 50 mM HEPES, pH 8 and incubated at 37 °C overnight. The beads which 
harbored the digested peptides were acidified, shaken and incubated overnight at room 
temperature after raising the ACN concentration to 95 %. The adsorbed peptides were 
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washed with 100 % ACN and air dried. Finally, peptides were eluted with 20 µl 2 % DMSO 
for 30 min and afterwards with water for 30 min. The peptides were vacuum dried and 
dissolved in 0.2 % TFA/3 % ACN for subsequent ultracentrifugation at 50`000 × g, 30 min 
and room temperature.  
 
 
3.5.5 LC-MS/MS measurements of gel-based and gel-free samples 
The LC-MS/MS measurements of purified and desalted peptides were performed by  
Dr. Josef Wissing at the HZI in Braunschweig (group of Prof. Dr. Lothar Jänsch; Cellular 
Proteome Research) on a Dionex™ UltiMate™ 3000 n-RSLC system connected to an Or-
bitrap Fusion™ Tribrid™ mass spectrometer (Thermo Fisher Scientific™, Waltham, USA). 
Peptides were loaded onto a C18 precolumn and washed for 3 min with a flow rate of  
6 µl/min. Afterwards, the samples were separated on a C18 analytical column with a flow 
rate of 200 µl/min over a linear 120 min gradient from 97 % MS buffer A to 25 % MS 
buffer B and following by a gradient from 25 % MS buffer B to 62 % MS buffer B for  
30 min. 
 
The effluent was electro-sprayed by a stainless-steel emitter (Thermo Scientific™, Wal-
tham, USA). The LC system was run with the software Chromeleon™ (Version 6.8, 
Thermo Scientific™ Dionex™, Waltham, USA) embedded in the Xcalibur™ software suite 
(version 3.0.63, Thermo Scientific™, Waltham, USA). During the use of Xcalibur™ soft-
ware, the MS was controlled and operated in a “top speed” mode. Here, that mode al‐
lows the automatic selection of many doubly/triply charged peptides (in 3 sec) and a 
subsequent fragmentation of peptides. The peptide fragmentation was carried out by 
using the higher energy collisional dissociation mode and peptides were measured in 
the ion trap (HCD/IT). 
 
MS buffer A: Formic acid (FA) 0.1 % 
 
MS buffer B: Formic acid (FA) 0.1 % 
 Acetonitrile (ACN) 80 % 
 
 
3.5.6 Analysis of the LC-MS/MS data  
For the *.raw data evaluation of the LC-MS/MS results, the Proteome discoverer™ 
2.2/2.3 software (Thermo Fisher Scientific™, Schwerte, Germany) (MMTS fixed; oxida-
tion of methionine: variable modification) was used. The parameters were set to: one 
missing cleavage and a false positive rate of 1 %. The mass errors were allowed to 7 ppm 
for MS and 0.4 Da for MS/MS data. The m/z spectra were matched to the FASTA files of 
the actual UniProt database version of C. difficile. The data were processed by Dr. Josef 
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Wissing at the HZI in Braunschweig (group of Prof. Dr. Lothar Jänsch; Cellular Proteome 
Research). The list of identified proteins from each sample were further processed with 
the same program. Only the gel-based bait sample RnfB was analysed with Peaks® X+ 
(Bioinformatics Solutions Inc., Waterloo, Canada).  
Processing of gel-based samples (qualitative analysis of prominent covalent interaction 
partners) was performed using the proteins present in single gel protein bands. The pro-
teins were sorted and evaluated according to their abundance (three most prominent 
peaks). Cut-off criterias for exclusion of poorly determined proteins were set to: unique 
peptides > 2, coverage > 5 % and an abundance > 1E+05. A comparison with the wildtype 
harboring the empty vector pMTL82151 which served as background control allowed to 
exclude unspecifically bound proteins from further analysis. This gel-based interactomic 
approach was carried out for all bait proteins in presence and absence of the cross-linker 
formaldehyde. The procedure allows to enquire the quality of the bait production and 
elucidate possible bait-prey interactions. 
 
For the gel-free method the above-mentioned process was performed analogously. The 
data sets included baits and potential preys. After setting the cut-off criteria (unique 
peptides ≥ 2 and the coverage ≥ 5 %) the data were exported into MS Excel® (Microsoft® 
Corporation, Washington, USA). Subsequently, the data were normalized to the same 
protein concentration of 0.24 mg/mL and enrichment factors were calculated by using 
the following formula: abundance of protein in eluate/abundance in the control (insol-
uble fraction overall proteomics). The value indicated the enrichment of proteins after 
affinity chromatography in comparison to their natural abundance in the cell. The mean 
value of the enrichment factor was determined from three biological replicates. Proteins 
absent in one of the three replicates or those having an enrichment factor below 1 were 
eliminated. Proteins that were not the focus of the study i.e. unrelated to the Stickland 
fermentation, electron transport or specific energy generation process and possible con-
taminants from background control were also eliminated until further notice. Proteins 
which were highly enriched (enrichment factor > 1) in the bait-prey eluates after affinity 
chromatography were considered as potential interaction partners and were further dis-
cussed in the upcoming sections. 
 
 
3.5.7 Double immunogold labeling detecting by transmission electron microscopy  
This method was used to determine co-localization of two proteins and simultaneously 
analyze their subcellular location (figure 14). For this purpose, commercially generated 
and purified polyclonal antibodies in combination with protein A coupled to gold parti-
cles of different sizes were used. Three-peptide mixtures covering different epitopes of 
each protein of interest were used to raise specific antibodies. Thus, rabbit polyclonal 
antibodies specific for the baits PrdA, RnfB and RnfC were produced employing synthetic 
peptides (15mers*) (digital appendix) by the company Metabion international AG and 
Primm (Planegg, Germany). The obtained immune sera from rabbits were then purified 
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by Ina Schleicher at the HZI in Braunschweig (group of Prof. Dr. Manfred Rohde; Central 
Facility for Microscopy). 
A prepared preculture of C. difficile 630Δerm was used to inoculate a main culture with 
an OD600 nm of 0.05. The main culture was cultivated anaerobically at 37 °C for 12 h. 
Subsequently, 5 mL of the grown culture were removed and centrifuged at 16`000 x g 
for 5 min. The cells were fixed with 3 % formaldehyde in 100 mM EM-HEPES buffer and 
stored at 4° C overnight. Following immunogold labeling experiment steps, TEM images 
and the semi-quantitative image analyses were performed by Dr. Mathias Müsken and 
Ina Schleicher at the HZI in Braunschweig (group of Prof. Dr. Manfred Rohde; Central 
Facility for Microscopy). After the fixation, the samples were exposed to glycine with 
EM-HEPES buffer for 30 min at room temperature and washed with buffer. Afterwards 
the samples were dehydrated on ice in EtOH (10 %, 30 % and 50 % steps and >50 % EtOH 
steps, - 28° C). Subsequently, the samples were infiltrated at - 28 °C onto a K4M resin 
(K4M:EtOH (1:1, 2:1, 2x 100 %)) and with an incubation times of 8 h respectively over-
night. Finally, the samples were polymerized at - 40 °C and suspended to UV light  
( 366 nm) for 30 h, followed by additional 48 h UV light step at room temperature.  
 
 
EM-HEPES buffer, pH 6.9: HEPES 100 mM 
 Sucrose 90 mM 
 CaCl2 10 mM 
 MgCl2 10 mM 
 
Prior to labeling, ultrathin sections (70 - 80 nm) were collected on droplets of dH2O. For 
this purpose, the sections were overlaid with droplets of 1:20 PBS-diluted antibodies 
against RnfB, RnfC and PrdA for the single labeling and incubated at 4° C overnight. Fol-
lowing by a series of PBS washing steps (15 s with spray bottle, 3 times droplets of PBS, 
5 min each) and a blocking step with 0.1 % skim milk (5 min). Next, protein A-gold  
(15 nm; 1:75 diluted in PBS supplemented with 0.5 mg/mL PEG20000) was incubated for 
30 min at room temperature and the samples were washed with a spray bottle contain-
ing PBS with Tween 20 (15 s) as well as 2 times of PBS droplets, 1 x TE droplet and 1 x 
dH2O droplet (5 min each). To conduct the second labeling, two labeling steps were per-
formed in series as mentioned above separated by a 30 min incubation time with protein 
A solution to avoid cross reactions. Both primary antibodies were diluted in a ratio of 
1:10 and the incubation time of the second antibody reduced to 3 h. The protein A-gold 
(10 nm) solution directed against the first antibody was diluted 1:200 and the protein  
A-gold (15 nm) solution against the second antibody 1:75. All samples were counter-
stained with 4 % aqueous uranyl acetate for 3 min. Finally, all images were acquired with 
Libra® 120 Plus (Carl Zeiss Microscopy GmbH, Jena, Germany) at an acceleration voltage 
of 120 kV and at calibrated magnifications. The contrast, brightness adjustments and 

















Figure 14: General principle of the immunogold labeling method for the co-localization of two proteins. 
The so-called double immunogold labeling method to determine the co-localization [left] or non-co-local-
ization [right] of two target proteins [triangle] is shown (here without the protein-A treatment). For this 
method, purified polyclonal antibodies conjugated with gold nanopaticle of two different sizes [10 nm 
and 15 nm] against specific epitopes of the bait proteins were used. These antibodies were incubated on 
ultrathin sections of previously fixed bacterial cells [grey band] and were analyzed using transmission 
electron microscopy (TEM). A low distance [arrow] of two different size of gold particles indicates a co-
localization event of two different target proteins. In comparison, larger distances suggest that both target 
proteins are not co-localized to each other.  
 
For a semi-quantitative image analysis of single and double labeling events the area of 
cells in respect to the background (in µm2) was determined. For this purpose, the cell 
area was devided into two fractions: cytoplasm 75 % and membrane 25 %. The gold 
particles were counted in each image and assigned to the three compartments: cyto-
plasm, membrane and background (for example between cells). For single labeling of 
PrdA, RnfB and RnfC (gold particle 15 nm), respectively, more than 80 images/label out 
of 10 image series were averaged out (analyses of mean values of the series were plot-
ted). Double labeling analyses of protein pairs (PrdA and RnfB, RnfB and RnfC, RnfC and 
PrdA) were performed in three data sets (each combination covered by 21 - 25 images). 
Co-localization events were counted when a 10 nm and a 15 nm gold particle were in 








15 nm 10 nm 
Polyclonal antibodies  
with gold nanopaticle 
Fixed bacteria cell 
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3.6 Characterization of the rnfC mutant strain and multi-omic experiments 
The previously generated rnfC mutant strain (CD630∆erm_rnfC636/637s::ermB) was 
employed for further inspection. A holistic multi-omics study encompassing tran-
scriptomics, proteomics and metabolomics was implemented to better characterize the 
cellular effects resulting from the absence of the Rnf complex. Furthermore, pheno- 
typical characterization of the rnfC mutant strain were conducted by electron micro-
scopy, growth behavior experiments, in vitro enzymatic assays and toxin quantification.  
 
3.6.1 Growth behavior and phenotypic characterization by scanning electron  
microscopy 
Firstly, the rnfC mutant strain CD630∆erm_rnfC636/637s::ermB was compared to the 
wildtype strain in terms of growth behavior and cell morphology. The rnfC mutant strain 
and the wildtype CD630∆erm were grown in BHI(S) and the OD600 nm was measured 
hourly to follow the growth of each strain in five biological replicates as descriped in 
chapter 3.2.7. The bacterial morphology was determined using the scanning electron 
microscopy (SEM) technique performed by Dr. Mathias Müsken and Ina Schleicher 
(group of Prof. Dr. Manfred Rohde; Central Facility for Microscopy) at the HZI in Braun-
schweig. 
 
For this purpose, precultures of the corresponding strain were used (see chapter 3.2.6). 
As described previously, the main cultures were inoculated to an initial OD600nm of 0.05 
and cultivated under anaerobic conditions at 37 °C for 12 h. Bacterial cultures were fixed 
by addition of fixation solution with a final volume of 2 mL and stored at 4 °C overnight. 
The cells were washed twice in TE buffer and a 50 µl aliquot added to a round, poly-L-
Lysine pretreated coverslip and incubated for 10 min at room temperature. The  
coverslip was transferred to TE buffer including 1 % (v/v) glutaraldehyde and incubated 
for an additional 10 min at room temperature and washed twice in TE buffer. The sam-
ples were dehydrated on ice with a graded series of acetone (10%, 30%, 50%, 70%, and 
90%) for 10 min each, followed, by two steps in 100 % (v/v) acetone at room tempera-
ture and subjected to manual critical-point drying with liquid CO2 (CPD 030, Bal-Tec AG, 
Balzers, Liechtenstein). The coverslips were mounted onto aluminum stubs with carbon 
adhesive discs (Plano GmbH, Wetzlar, Germany) and covered with a gold palladium film 
by sputter coating for 55 sec at 45 mA (SCD 500 Bal-Tec AG, Balzers Liechtenstein). Ex-
amination was performed with a field emission scanning electron microscope Zeiss Mer-
lin (Carl Zeiss Microscopy GmbH, Jena, Germany) using the Everhart Thornley HESE2 de-
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Fixation solution (in HEPES buffer): Paraformaldehyde 5 % (v/v) f.c. 
 Glutaraldehyde 2 % (v/v) f.c. 
 
HEPES buffer, pH 6.9: HEPES 0.1 % (v/v) 
 Sucrose 90 mM 
 CaCl2 10 mM 
 MgCl2 10 mM 
 
TE buffer, pH 6.9: TRIS 20 mM 
 EDTA 1 mM 
   
 
 
3.6.2 Bacteria cell preparation for the D-proline reductase activity assays, NAD+/NADH 
ratio determination, toxin ELISA and Omic experiments 
Comparative Omic experiments encompassing transcriptomic, proteomic and metabo-
lomic contrasting the wildtype CD630∆erm to the rnfC mutant strain 
CD630∆erm_rnfC636/637s::ermB were conducted to obtain information about gene 
regulatory networks and metabolic pathways in the cell, dysfunctional or rewired by 
missing rnfC. With this aim, the rnfC mutant strain and wildtype were cultivated in a 
defined CDMM medium (see chapter 3.2.2). Hundred mL of each preculture were inoc-
ulated in CDMM and cultivated anaerobically at 37 °C overnight. The main culture was 
inoculated to an OD600 nm of 0.05 in a total volume of 220 mL. Bacteria cells were further 
cultivated anaerobically at 37 °C until 1/3 of the maximum optical cell density (after  
~5 h, exponential growth phase, T1) and the maximum cell density (~14 h, stationary 
growth phase, T2) of the culture were reached. At these time points the bacterial cells 
were harvested at 4 °C, 4`000 x g for 10 min. Afterwards, 2 mL were removed from the 
corresponding supernatant for the measurement of the exometabolome and further  
2 mL for the toxin ELISA assay. The bacterial cell pellet from 45 mL of the corresponding 
culture from T1 and T2 was quenched and washed with 10 ml 50 % MeOH/0,9 % NaCl. 
After centrifugation at 10`000 x g for 5 min the bacterial cell pellets were frozen in liquid 
nitrogen for the metabolome experiments. Forty-five mL bacterial culture was pelleted 
and used for the measurement of CoA-esters. Likewise, 45 mL bacterial culture pellets 
were employed for transcriptome analyses. Finally, the bacterial cell pellet derived from 
15 mL culture was employed for the determination of D-proline reductase activity and 
the measurement of the NAD+/NADH ratios. All bacterial cell pellets were frozen in liquid 
nitrogen and stored at - 80 °C until further measurements. The bacterial cell preperation 
were performed with Dr. Sabine Will and Dr. Meina Neumann-Schaal (group of  
Dr. Meina Neumann-Schaal; Bacterial Metabolomics; DSMZ in Braunschweig) at the 
BRICS in Braunschweig.  
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3.6.3 Fluorometric assay of the D-proline reductase activity  
To elucidate the functionality of the cytosolic enzyme D-proline reductase in the absence 
of the RnfC subunit of the Rnf complex, an assay based on the fluorometric product 
detection was performed. Based of the work of Seto 1979 and the dissertation of 
Kabisch 2001 the fluorometric assay for measuring the production of 5-aminovalerate 
was slightly modified as follows. One g wet weight of the harvested bacterial cell pellets 
of the rnfC mutant strain and the wildtype from both growth time points (T1 and T2) 
and of three biological replicates were analyzed. The bacterial cell pelltes were washed 
with 1 mL 1 x PBS and centrifuged at 4 °C and 3`000 x g for 15 min. The resulting bacterial 
cell pellets were resuspended with 1.5 mL resuspension buffer (see chapter 3.4.1), 0.5 g 
glass beads were added to the bacterial cell suspensions and cells were disrupted by 
using the FastPrep®-24 (MP Biomedicals™ Germany GmbH, Eschwege, Germany). After-
wards, the beads were separated by centrifugation at 4 °C and 16`000 x g for 20 min. 
The cell free extracts were separated into cytosolic and membrane fractions by ultra-
centrifugation at 4 °C, 40`000 rpm for 65 min. The total protein concentration of the 
cytosolic extracts was determined on the Qubit™ 3 fluorometer (Thermo Fisher Scien‐
tific – Life Technologies GmbH, Schwerte, Germany) and used to perform the assay.   
 
The enzymatic reaction was started with 5 µg of each cytosolic extract in a given reaction 
mixture and incubated at 30 °C for 60 min. For the measurements a negative control 
consisting dH2O instead of D-proline in the reaction mixture was used. The control sam-
ples were prepared identically. The reaction was stopped with 300 µL 5 % (v/v) perchlo-
ric acid and the samples were centrifuged at 4 °C, 16`000 x g for 10 min. In parallel, for 
calibration a standard solution of 20 nM to 80 nM 5-aminovalerate was prepared and 
dissolved in the reaction buffer. Fifty µL from the supernatant of each sample and in 
parallel from the 5-aminovalerate standard solution were mixed with 4 mL o-phthaldial-
dehyde solution and filled into a glass cuvette. Subsequently, the fluorescence was de-
termined using a FP-8500 Fluorescence Spectrometer (JASCO Deutschland GmbH, 
Pfungstadt, Germany) and the Spectra Manager™ II Software (JASCO Deutschland 
GmbH, Pfungstadt, Germany). The excitation wavelenght was set at 330 nm (Ex wave-
lenght) and the fluorescence emission was measured with a scan speed of 200 nm/min 
from 400 nm until 500 nm. A blank correction with o-phthaldialdehyde solution was 
prepared.  
 
The data obtained by these measurements were exported as a txt file format. The high-
est emission peak value was determined around 450 nm. After subtraction of the nega-
tive background control from the sample datasets the emissions of the samples showed 
the normalized relative fluorescence intensity at 450 nm. The concentration of  
5-aminovalerate in the sample was determined using the 5-aminovalerate standard. The 
emzymatic production of 5-aminovalerate observed for the cytosolic extract from 
CD630∆erm_rnfC636/637s::ermB were plotted versus those of CD630∆erm over an as-
say reaction time of 60 min.  
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Reaction buffer: 500 mM K3PO4 100 µL 
 100 mM MgCl2 50 µL 
 200 mM DTT 50 µL 
 dH2O 250 µL 
 
Reaction mixture: 500 mM K3PO4 100 µL 
 100 mM MgCl2 50 µL 
 200 mM DTT 50 µL 
 100 mM D-proline 50 µL 
 dH2O Add to 500 µL 
 
o-phthaldialdehyde solution: 400 mM K3BO3-buffer, pH 9.7 100 mL 
 ß-mercaptoethanol 0.2 mL 
 o-phthaldialdehyde  




3.6.4 NAD+/NADH ratio determination 
The rnfC mutant CD630∆erm_rnfC636/637s::ermB and wildtype CD630∆erm bacteria 
cells were harvested at the two time points specified in the previous chapter. Five bio-
logical replicates were used for the determination of the NAD+/NADH ratio in the bacte-
rial cells. The ratio was quantified with the NAD+/NADH Glo Assay kit (Promega GmbH, 
Madison, USA). For this purpose, the pellets of the bacteria cells were resuspended in 
0.6 ml 1 x PBS and transferred into a 2 mL screw cap microtubes harboring 0.4 g glass 
beads with 0.3 mL chloroform. The samples were thoroughly mixed before being ho-
mogenized and disrupted with the FastPrep®-24 (MP Biomedicals™ Germany GmbH, 
Eschwege, Germany) for three times 30 s using a CoolPrep™ sample holder (MP Biomed-
icals™ Germany GmbH, Eschwege, Germany). Afterwards, the bacterial cell lysates were 
centrifuged at 4 °C and 16`000 x g for 10 min. The supernatants were collected and cen-
trifuged again under identically conditions. The assay was conducted using the aqueous 
phase following company instructions. The luminescence was measured in a white  
384 well plate (Greiner AG, Kremsmünster, Austria) after 45 min of incubation at room 
temperature on a microtiter plate photometer Infinite® M200 (Tecan Group Ltd., 
Männedorf, Switzerland). The aqueous phase was diluted to match the area of the cali-
bration range (0.01 - 4 µM). All the measurements were performed by Dr. Petra Henke 
and Dr. Sabine Will (group of Dr. Meina Neumann-Schaal; Bacterial Metabolomics) at 
the DSMZ in Braunschweig. 
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3.6.5 Determination of the concentration of the toxins TcdA and TcdB via sandwich 
ELISA  
To determine the concentration of the toxins TcdA and TcdB in the supernatant of the 
mutant strain CD630∆erm_rnfC636/637s::ermB and the wildtype CD630∆erm at the 
outlined two time points in five biological replicates bacteria cells were harvested as 
described previously. The sandwich ELISA was performed for each bacterial cell sample 
using a commercially available kit (ELISA for the separate detection of Clostridium dif-
ficile Toxin A OR Toxin B in suspensions kit; tgcBIOMICS GmbH, Bingen, Germany). In this 
experiment the samples were used undiluted. Before performing the sandwich ELISA, a 
standard calibration curve for TcdA and TcdB in the range of 0.31 ng/mL to 40 ng/mL 
(stock solution of 80 ng/mL TcdA and TcdB included in the kit) was generated by using 
the including dilution buffer. The sandwich ELISA was performed according to the "Two 
step protocol" described in the kit´s guidelines. 
The sandwich ELISA allows to detect toxins by a colometric reaction step mediated by 
horseradish peroxidase (HRP). Microtiter plates coated with captured antibodies spe-
cific to TcdA and TcdB were provided in the kit. After the immobilization of TcdA or TcdB 
the second antibody coupled to HRP was added. Addition of the TMB-substrate 
(3,3',5,5'-tetramethylbenzidine substrate; included in the kit) permitted the enzyme 
HRP to generate the colorimetrically detectable product.  
 
After quenching the reaction with 50 µL stop solution (included in the kit) ODs at  
450 nm and 620 nm (measured twice and averaging out) were measured with the pro-
gram Tecan i-control™ (Tecan Group Ltd., Männedorf, Switzerland) in a microtiter plate 
photometer Infinite® 200 (Tecan Group Ltd., Männedorf, Switzerland) to quantify the 
amount of toxins per sample. Afterwards, the OD450-620 nm values were determined (see 
kit instructions: ELISA for the separate detection of Clostridium difficile Toxin A OR Toxin 
B in suspensions kit; tgcBIOMICS GmbH, Bingen, Germany). Furthermore, the TcdA and 
TcdB standards were measured and used for a calibration curve (concentration [ng/mL] 
versus the corresponding OD450-650 nm). The resulting standard linear equation of both 
standard controls (concentration area of 0 - 20 ng/mL TcdA or TcdB) were used for the 






























Figure 15: Principle of the colorimetric sandwich ELISA for toxin (TcdA and TcdB) concentration deter-
mination. First, a microtiter plate is coated with immobilized antibodies [blue] specifically with affinity to 
a toxin epitope [yellow]. Next, a sample with analyte molecules was added to the plate and the antibody 
binds to the toxins. Unbound material was subsequently washed away. Afterwards, the secondary anti-
body [green], which was coupled with horseradish peroxidase (HRP) [red], was added and binds to the 
toxin. Unbound secondary antibodies were washed away. Subsequently, the substrate [orange] to drive 
the chemical reaction of the HRP was added. Color development was occurring in the microtiter plate. 
The reaction was stopped with the stop solution [grey]. Finally, the extinction at 450 nm (and 620 nm) 





3.6.6 Multi-omic experiments  
GC-MS analysis of polar metabolites 
The cell pellets of the rnfC mutant strain and the wildtype of five biological replicates 
were resuspended in 100 µL methanol (with 2 mg/L ribitol) / mg cell dry weight and the 
extraction was performed as described before (Hofmann et al. 2018). Next, for extracel-
lular metabolite measurements, 8 µL of the supernatant were taken and dried with  
20 µL methanol (including 8 mg/L ribitol). The metabolome sample preparation, anal-
yses, on an Agilent GC-MSD system (Agilent Technologies, Santa Clara, USA), and data 
processing were performed by Dr. Sabine Will and Dr. Meina Neumann-Schaal (group of 
Dr. Meina Neumann-Schaal; Bacterial Metabolomics) at the DSMZ in Braunschweig as 
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GC-MS analysis of volatile compounds 
The volatiles were extracted as described in Neumann-Schaal et al. 2015. Obtained com-
pounds were identified on an Agilent GC-MSD (Agilent Technologies, Santa Clara, USA) 
and a PAL RTC system (CTC Analytics AG, Zwingen, Switzerland). The separation was 
conducted with an Agilent VF-WAXms column (0.25 mm 30 m) as described (Neumann-
Schaal et al. 2015). The sample preparation, measurement and data processing of five 
biological replicates were performed by Dr. Sabine Will and Dr. Meina Neumann-Schaal 
(group of Dr. Meina Neumann-Schaal; Bacterial Metabolomics) at the DSMZ in Braun-
schweig.  
 
LC-MS analysis of coenzyme A esters 
For the analyses of CoA esters frozen cell pellets of the rnfC mutant strain and the 
wildtype were resuspended with 300 µL methanol / 1 mg cell dry weight and 1 mL of the 
suspension were transfered into 2 mL screw-cap tubes harboring 600 mg glass beads. 
250 ng of 13C3-malonyl-CoA was added (internal standard) and the cells were lysed using 
a FastPrep®-24 classic instrument (here with a CoolPrep™ adapter) (MP Biomedicals™ 
Germany GmbH, Eschwege, Germany). The extraction of a solid phase was performed 
as previously described (Wolf et al. 2016; Hofmann et al. 2018). Next, CoA-derivatives 
were measured on an Agilent LC-QTOF system (Agilent Technologies, Santa Clara, USA). 
Afterwards, the separation was carried out on a C18 analytical column (Gemini® 2.0 x 150 
mm, particle size 3 mm; Phenomenex®) as described (Wolf et al. 2016). Here, the sample 
preparation, measurement and data processing of five biological replicates were per-
formed by Dr. Meina Neumann-Schaal and Dr. Sabine Will (group of Dr. Meina Neu-
mann-Schaal; Bacterial Metabolomics) at the DSMZ in Braunschweig.  
 
HPLC analysis of amino acids 
The amino acids were determined using an Agilent 1260 Infinity II HPLC system (Agilent 
Technologies, Santa Clara, USA). The sample preparations and the HPLC analyses were 
based on the protocol described in Trautwein et al. 2016; Dannheim et al. 2017; Hof-
mann et al. 2018 and with a sodium acetate concentration of 25 mM. The sample prep-
aration/measurement of five biological replicates was performed by Dr. Meina Neu-
mann-Schaal as well as Dr. Sabine Will (group of Dr. Meina Neumann-Schaal; Bacterial 
Metabolomics) at the DSMZ in Braunschweig. 
  
 
Transcriptomics and proteomics analyses 
The harvested rnfC mutant cultures CD630∆erm_rnfC636/637s::ermB and wildtype  
cultures CD630∆erm at the two time points T1 and T2 were placed at 4 °C overnight. The 
RNA isolation was performed after the protocol of the Monarch Total RNA Miniprep Kit 
Protocol (New England Biolabs®, Frankfurt am Main, Germany) (see chapter 3.3.5).  
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The RNA/DNA ratios were determined with the Qubit® 3 fluorometer (Life Technologies; 
Thermo Fisher Scientific, Schwerte, Germany). The rRNA depletion was performed with 
the Ribo-off rRNA depletion kit (Bacteria) (Vazyme Biotech Co., Nanjing, China) followed 
by the Absource protocol (Absource Diagnostics GmbH, Munich, Germany) using  
1 - 5 µg RNA. The residual DNA was removed with an RNase-free DNase Set and the 
RNeasy Mini Spin Columns (QIAGEN GmbH, Hilden, Germany) (modification: elution 
step in 2 times of centrifugation of 15 µl). The quantity and quality post-depletion of the 
RNA was determined on an Agilent 2100 Bioanalyzer with the kit Agilent RNA 6000 Pico 
(Agilent Technologies, Santa Clara, USA). Afterwards, the cDNA libraries were produced 
with the NEBNext® Ultra™ II Directional RNA Library Prep Kit with Sample Purification 
Beads (New England Biolabs GmbH, Frankfurt am Main, Germany) following the instruc-
tions of the manufacturers for a purified mRNA / rRNA depleted input RNA. Here, the 
PCR enrichment of adaptor ligated DNA (7 cycles) and an RNA fragmentation time of  
7 min were used. The following PCR reaction purification step was performed with the 
kit containing beads and qualities as assessed on the Bioanalyzer with the High Sensitiv-
ity DNA Analysis Kit (Agilent Technologies, Santa Clara, USA). Finally, the transcriptome 
RNA sequencing was performed on the Illumina NextSeq system using the NextSeq 
500/550 High Output Kit v2.5 (75 cycles) (Illumina Inc, San Diego, USA).  
After RNA isolation the further RNA preparation and processing and RNA sequencing of 
five biological replicates for transciptomics were performed by Dr. Petra Henke and  
Dr. Sabine Will (group of Dr. Meina Neumann-Schaal; Bacterial Metabolomics) at the 
DSMZ in Braunschweig. 
 
To map the rRNA sequences the software Bowtie2 v 2.3.4 (Langmead and Salzberg 2012) 
was applied and rRNA sequences were removed from the data of total RNA transcrip-
tome. Afterwards, the Rockhopper software version 2.03 (McClure et al. 2013; Tjaden 
2015) was used for mapping the reads to the archived Peptoclostridium difficile 630 ref-
erence genome. Here the following parameter settings were used: reverse complement 
reads, strand specific and verbose output mapped. The transcriptome data was analysed 
with expression values of each transcript (reported by Rockhopper). After that, the 
mean value of the gene expression values and the corresponding false discovery rate as 
the q-value of five replicates were calculated (see digital appendix). Based on that cal-
culation the log2 fold change values of the rnfC mutant strain against the wildtype at the 
time points T1 and T2 were determined. These analyses were performed by Dr. Petra 
Henke (group of Dr. Meina Neumann-Schaal; Bacterial Metabolomics, DSMZ). 
 
The samples for proteomic analyses of the rnfC mutant strain in comparison to the 
wildtype in T1 (exponentielle growth phase) and T2 (stationary growth phase) were pre-
pared according to the gel-free LC-MS/MS measurement protocol (see chapter 3.5.4, 
3.5.5) by Dr. Josef Wissing and Hedwig Schrader at the HZI in Braunschweig (group of 
Prof. Dr. Lothar Jänsch; Cellular Proteome Research). For this purpose, the cell-free ex-
tacts (soluble fraction) of three biological replicates were used for that approach after 
ultracentrifugation of the samples prepared using the similar protocol of protein purifi-
cation outlined before (see chapter 3.4.2).  
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3.7 In vivo characterization of the rnfC mutant strain 
Comparative mouse infection experiments with the rnfC mutant and wildtype strain 
were performed to gain further insights into the consequences of the rnfC gene deletion 
on adaptation to a host intestinal environment in vivo. 
 
3.7.1 Mice infection experiments with C. difficile 630Δerm 
To analyse the behavior of the rnfC mutant strain CD630∆erm_rnfC636/637s::ermB in a 
mouse model spore suspensions were prepared from the respective strains 
CD630∆erm_rnfC636/637s::ermB_pMTL82151(rnfC-mutant), 
CD630∆erm_rnfC636/637s::ermB_pMTL82151rnfC-strep II (complemented strain) and 
CD630∆erm_pMTL82151 (wildtype). Therefore, commercially available CHROMID®  
C. difficile plate of bioMérieux GmbH (Nürtingen, Germany) were used for an anaerobi-
cally cultivation of the strains at 37 °C for 2 - 3 days. The fresh cultures were used to 
prepare spore suspensions of the C. difficile 630Δerm strains which were used for mouse 
infection. The mouse wildtype (WTBL/6-SPF1) line from the HZI in Braunschweig was 
used under the specific pathogen free conditions (SPF).  
All animal experiments, e.g. mice infection and organ sampling (colon, cecum and feces), 
and the preparation of the spore suspension were performed by Dr. Nathiana Smit at 
the HZI in Braunschweig (group of Prof. Dr. Till Strowig; Microbial Immune Regulation). 
At that time point all experiments were performed under the strict animal permission 
of the local government following the protocol of the „Niedersächsisches Landesamt für 
Verbraucherschutz und Lebensmittelsicherheit “.  
 
The infection is based on single infections of the mice with the one of the mentioned  
C. difficile strains. In additional experiment, mice were co-infected with the rnfC-com-
plemented mutant strain and the rnfC mutant strain. All the strains were carrying the 
plasmid pMTL82151 for comparability. The PCR protocol „Confirmation of plasmid DNA“ 
(see chapter 3.3.10) using the primer M13_fw/M13_rev was determined to reveal the 
presence of the pMTL82151 plasmid and was therefore used to analyze for the presence 
of the different strains (haboring pMTL82151 or pMTL82151rnfC-strep II (see appendix)) 
during co-infection in the samples of colon, cecum and feces.  
 
For the in vivo experiment, mice were treated with 10 mg/kg clindamycin antibiotic  
24 h before infection and infected (oral) with 1000 spores/mice. The behavior of the 
mice and the body weight were monitored daily. Feces, colon and cecum samples were 
collected on day 1 (D1) or/and day 3 (D3) after infection. Samples of colon and cecum 
content were washed with 5 mL 1 x PBS. One mL of the sample was used for elimination 
the vegetative cells (incubated at 65 °C, 25 min). Spores will survive this heat-treatment 
and thus only spores will be able to grow out. All samples were homogenized before 
plating. 
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Afterwards, heated and non-heated samples were spread on commercially available 
CLO plates (bioMérieux GmbH, Nürtingen, Germany) added with 0.1 % taurocholate for 
germination of spores in the heated samples and without taurocholate for vegetative 
bacteria cells in the non-heated samples. The plates were incubated under anaerobic 
conditions at 37 °C for 72 h and after that time colony forming units (CFU) of the bacteria 
were counted and the log CFU of the different single infection samples was determined. 
After co-infection 100 clones were tested in the above-mentioned PCR to determine the 
rnfC-complemented mutant strain or the rnfC mutant strain in the specific organ sample 
onto the corresponding plates. The infection, sample preparation and determination of 
the log CFU values were performed by Dr. Nathiana Smit at the HZI in Braunschweig 























4 Results  
4.1 Identification of protein-protein interactions during Stickland  
fermentation in C. difficile 630∆erm – rationale of the approach 
 
For the identification of protein-protein interactions involved in the Stickland fermenta-
tion of the anaerobic bacterium C. difficile 630∆erm, protein baits that play an essential 
role in the reductive part of the fermentation process were selected. These were the 
subunits PrdA (CD630DERM_32440) and PrdB (CD630DERM_32410) of the cytoplasmic 
D-proline reductase, and the subunits RnfB (CD630DERM_11420) and RnfC 
(CD630DERM_11370) of the membrane ferredoxin-NAD+: oxidoreductase Rnf complex. 
For a qualitative analysis of the bait protein interaction partners (preys) a combined af-
finity purification, gel-based separation and LC-MS/MS analyses approach was used (see 
chapter 3.5.3). The LC-MS/MS measurements and data generation were performed by 
Dr. Josef Wissing at the HZI in Braunschweig (group of Prof. Dr. Lothar Jänsch; Cellular 
Proteome Research). The analysis of the generated data was conducted as described in 
chapter 3.5.5 and 3.5.6. 
Firstly, the wildtype genes of the baits PrdA, PrdB, RnfB and RnfC from  
C. difficile 630∆erm and the corresponding promoter sequences were amplified and 
fused in frame to the target gene to a C-terminal Strep-tag® II encoding DNA sequence 
for subsequent affinity chromatography purification (see chapter 3.3.9). The resulting 
DNA-fragments prdA-strep II, prdB-strep II, rnfB-strep II and rnfC-strep II were ligated 
into the shuttle vector pMTL82151 using various cloning strategies (e.g. Gibson assem-
bly or T4 ligation) respectively (see chapter 3.3.10). The resulting constructs harboring 
the bait genes were finally verified using the DNA sequencing by Eurofins Genomics Ger-
many GmbH (Ebersberg, Germany). The constructs were individually transferred into 
the wildtype strain C. difficile 630∆erm by conjugation employing the E. coli ST18 cells 
harboring the above-mentioned constructs (see chapter 3.3.3). After proper establish-
ment of an interactomic workflow with and without cross-linking treatment (see chapter 
3.4) for C. difficile 630∆erm the different bait strains and the wildtype harboring the 
pMTL82151 empty vector as a control were all subjected to worked out procedure to 




Figure 16: Background control of the interactomics approach. Shown is a stained SDS-PAGE [left 
lane] and Western blot membrane [right lane] of the affinity chromatography elution fraction of the 
soluble [left panel] and insoluble fraction [right panel] of the wildtype strain C. difficile 630∆erm 
carrying the empty vector pMTL82151, respectively. The 60-fold (soluble fraction) and 30-fold (in-
soluble fraction) concentrated elution samples (10 µL) were loaded onto a 15 % SDS-PAGE and sep-
arated for 45 min at 45 mA. The SDS-PAGE was stained with InstantBlue® Protein Stain (Expedeon 
Ltd, Cambridge, UK) solution and the relative molecular masses of absorved proteins were deter-
mined using the PageRuler™ Plus Prestained Protein Ladder (Thermo Fisher Scientific, Schwerte, 
Germany). The Western blot analysis was performed with a Strep-Tactin® AP conjugate (IBA GmbH, 
Göttingen, Germany). The blot development was in general 30 min. Images were grayscaled and the 


















4.1.1 Background control for the used interactomics approach 
The cell free extracts of the wildtype strain harboring the cloning vector pMTL82151 
(empty vector, control) were chromatographed and served as a quality control to sort 
out proteins unspecifically bound to the column material. The elution fractions were 
concentrated with a centrifugal concentrator (Amicon® Ultra -0.5 mL centrifugal filter 
units (Merck KGaA, Darmstadt, Germany)) and separated on SDS-PAGEs following by a 
Western blot analyses. After staining the SDS-PAGE all visible proteins were cut out (fig-






































The stained SDS-PAGE of the concentrated elution fraction after affinity chromato-
graphic treatment of soluble fraction of all free cell extracts (figure 16, left lane) from 
the wildtype C. difficile 630∆erm pMTL82151 (empty vector, control) revealed proteins 
of different relative molecular masses. Three major bands with proteins were observed 
at the relative molecular mass (Mr) of 15.000, 22.000 and 55.000. Importantly, Strep-
Tactin® AP conjugate (Strep-tag® detection in Western blots, IBA GmbH, Göttingen, Ger-
many) failed to detect any protein (figure 16, right lane). Nevertheless, the three prom-
inent protein bands found in the SDS-PAGE were cut-out (figure 16, C1-C3) and analyzed 
by LC-MS/MS. In the average 145 different proteins were found with the highly sensitive 
LC-MS/MS technique. Unique peptides > 2, an abundance > 1E+05 and a protein cover-
age > 5 % were the settings used for the analyses with the software Proteome  
discoverer™ 2.2/2.3 (Thermo Fisher Scientific, Schwerte, Germany) to filter out not se-
curely identified proteins or measurement-derived artifacts. After applying the above-
mentioned settings most of the identified contaminants were 30S/50S ribosomal pro-
tein, chaperones, aminotransferases, peptidase or elongation factors (see digital appen-
dix). Beside the mentioned contaminats the most present proteins of 56 proteins in the 
bands C1-C3 are shown in table 26 in the appendix. Consequently, these proteins were 
excluded from the following interactome analyses. 
 
 
4.1.2 Interaction partners of the D-proline reductase subunits PrdA and PrdB in the ab-
sence of the cross-linker formaldehyde 
After the determination of the unspecific binding capacity of the employed Strep-Tac-
tin® affinity chromatography material, first bait-prey experiments for determination of 
the interaction partners of the D-proline reductase subunits PrdA and PrdB were per-
formed. For this purpose, the soluble fraction from a cell free extract obtained from  
C. difficile cells without cross-linker treatment were affinity chromatographed using the 
C-terminal Strep-tag® II of the bait protein. The concentrated elution fraction was ana-
lyzed by SDS-PAGE and Western blotting using Strep-Tactin® AP conjugate for bait visu-



























Several protein bands were observed for the elution fractions. During the analysis of the 
PrdA interaction partners an intensive protein band became visible at the relative mo-
lecular mass of ~70.000 on the SDS-PAGE (figure 17, left panel). The corresponding 
Western blot loaded with the identical sample as the SDS-PAGE revealed for the chro-
mogenic detection of the Strep-tag® II using Strep-Tactin® AP conjugate (IBA GmbH, Göt-
tingen, Germany) three protein bands with a relative molecular mass of ~70.000, 
~40.000 and ~25.000 (figure 17, left panel, right lane). After cutting out the visible pro-
teins out of the SDS-PAGE (∑ 15 bands) and preparing them according to the gel-based 
LC-MS/MS analysis protocol, in total 188 proteins were found. The mass spectrometry 
settings for the identification of the analyzed proteins were unique peptides > 2, an 
abundance > 1E+05 and a protein coverage > 5 % enabled with the software Proteome 
 PrdA* 
Figure 17: Interaction partners of the D-proline reductase subunits PrdA and PrdB without the cross-
linker formaldehyde treatment. The stained SDS-PAGE [left lane] and Western blot analysis [right lane] 
of the PrdA [left panel] and PrdB [right panel] interaction partner after affinity chromatographic purifi-
cation. The bait proteins PrdA and PrdB were recombinantly produced in C. difficile 630∆erm without 
treatment of the cross-linking agent formaldehyde, respectively. The soluble fraction of cell free ex-
tracts containing the Strep-tagged proteins were chromatographed through the Strep-Tactin® affinity 
column. Formed bait-prey complexes were eluted and 10 µL of the 60-fold concentrated elution frac-
tion were loaded onto a 15 % SDS-PAGE and separated according to their relative molecular mass with 
45 mA for 45 min. The gel was stained with InstantBlue® Protein Stain (Expedeon Ltd, Cambridge, UK) 
solution. The relative molecular masses were deduced from the PageRuler™ (Plus) Prestained Protein 
Ladder (Thermo Fisher Scientific, Schwerte, Germany). For the Western blot analysis, the bait protein 
was detected via Strep-Tactin® AP conjugate (IBA GmbH, Göttingen, Germany). The blot development 
was in general 15 - 30 min. Image quality was improved by colorizing all images in grayscale and setting 
the image of the Western blot of PrdB to a brightness of 30 % to avoid background noise. The PrdA 









































discoverer™ 2.2/2.3 (Thermo Fisher Scientific, Schwerte, Germany). Next, proteins that 
are highly abundant in the cell, such as chaperones, ribosomal proteins or cell wall bind-
ing proteins and some column contaminants (see chapter 4.1.1 and 4.1.6) were ex-
cluded. Overall, 32 PrdA bound proteins were determined (original protein list see digital 
appendix). Firstly, with its relative molecular mass of ~70.000 this way the bait protein 
PrdA (Mr 68.000), a subunit of the D-proline reductase from C. difficile 630∆erm, was 
identified. In agreement, the Western blot also identified this protein band as the Strep-
tagged bait PrdA. A significant amount of PrdA (PrdA*) was also detected in the Mr of 
~25.000 protein band. This PrdA fragment is the product of a proteolytic cleaving of the 
major PrdA subunit into two different sized subunit fragments (Mr 23.000 and 45.000) 
(Kabisch et al. 1999; Jackson et al. 2006). The second enzyme subunit PrdB (Mr 26.000) 
was also detected in the identical region of the SDS-PAGE as PrdA* indicating heterodi-
mer formation. Furthermore, the membrane-associated Rnf complex subunit RnfC  
(Mr 48.000) was found in the protein band at an Mr of ~53.000 by gel-based LC-MS/MS.  
 
The stained SDS-PAGE loaded with the concentrated elution fraction of the bait PrdB 
derived from the soluble fraction of the C. difficile 630∆erm_pMTL82151prdB-strep II 
strain (figure 17, right panel) showed several protein bands of different relative  
molecular masses with different band intensities. Three bands at a Mr of ~25.000 to 
~30.000 and at ~70.000 were more prominent than the other protein bands. All visible 
SDS-PAGE protein bands (∑19 bands) were cut-out and analyzed by LC-MS/MS and  
finally identified with the software Proteome discoverer™ 2.2/2.3 (Thermo Fisher Scien‐
tific, Schwerte, Germany). The total number of detected proteins were 855. Afterwards, 
the same cut-off criteria as mentioned before were used and 128 proteins were ob-
served and closely inspected (original protein list see digital appendix). The protein band 
between a Mr of ~25.000 and ~30.000 contained the purified bait protein PrdB  
(Mr 26.000) of the D-proline reductase. In agreement, the Western blot analysis showed 
one single visible band in the range between ~25.000 and ~30.000 (figure 17, right panel, 
right lane). The protein band at ~70.000 contained PrdA (Mr 68.000) and at ~25.000 the 
PrdA*. The most prominent mass spectrometry identified interaction partners for the 










overview of these proteins in relation to all four baits and in addition with consideration 
of a cross-linker treatment is given in the chapter 4.1.6. 
 
4.1.3 Interaction partners of the Rnf complex subunits RnfB and RnfC in absence of the 
cross-linker formaldehyde 
After the determination of the D-proline reductase interactions further bait-prey exper-
iments of the membrane complex subunits RnfB and RnfC were perfomed. First, the sol-
uble fraction containing the membrane-associated but soluble RnfC and the insoluble 
fraction with the membrane-residing RnfB were obtained from a cell free extract from 
C. difficile cells grown without further cross-linking. Both baits were affinity chromato-
graphed using their C-terminal Strep-tag® II. The concentrated elution fractions were 
analyzed by SDS-PAGE, Western blot analyses via Strep-Tactin® AP conjugate (figure 18) 










































Figure 18: Interaction partners of the Rnf complex subunits RnfB and RnfC without the cross-linker for-
maldehyde. Shown are stained SDS PAGEs [left lane] and Western blot analyses [right lane] of the RnfB 
[left panel] and RnfC [right panel] interaction partners after affinity chromatography. Both baits were re-
combinantly produced in C. difficile 630∆erm without the cross-linker. The soluble (RnfC) and insoluble 
fraction (RnfB) of cell free extracts were chromatographed through a Strep-Tactin® affinity column. Bait-
prey complexes were eluted and a volume of 10 µL of the 60-fold (soluble fraction) and 30-fold (insoluble 
fraction) concentrated elution fraction were loaded onto 15 % SDS-PAGE and separated at 45 mA for  
45 min. The PAGEs were stained with InstantBlue® Protein Stain (Expedeon Ltd, Cambridge, UK) solution. 
The relative molecular masses were deduced from the PageRuler™ (Plus) Prestained Protein Ladder 
(Thermo Fisher Scientific, Schwerte, Germany). The Western blot analyses were subjected to Strep-Tac-
tin® AP conjugate (IBA GmbH, Göttingen, Germany) reaction. Blot development: 60 min until overnight. 
Image quality was impoved by grayscaled and the images of the Western blot were set to a color satura-









The stained SDS-PAGE showed several protein bands with different relative molecular 
masses for the elution fractions. For the analysis of RnfB (figure 18, left panel) interac-
tion partners LC-MS/MS analyses for 18 cut-out protein bands were performed. Overall, 
979 individiual proteins were found with the proteomic program Peaks® X+ (Bioinfor-
matics Solutions Inc., Waterloo, Canada). The mass spectrometry settings for the prey 
protein identification were set to unique peptides > 2, a coverage > 5 % and an abun-
dance > 1E+05. Hence, 56 proteins were left for further inspection (original protein list 
see digital appendix). Firstly, in the protein band at a relative molecular mass of 37.000 
the bait protein RnfB (Mr 35.000) was detected via LC-MS/MS analysis, but unfortu-
nately not in the Western blot analysis after a treatment with Strep-Tactin® AP conju-
gate (Strep-tag® detection in Western blots, IBA GmbH, Göttingen, Germany). The Strep-
Tactin® AP conjugate detected two distinct bands in the range between Mr ~15.000 and 
~25.000 of unknown identity (figure 18, left panel, right lane). Nevertheless, the  
LC-MS/MS analyses identified several proteins as RnfB interaction partners including the 
other subunit of the Rnf complex RnfC (Mr 48.000) in the protein band at a Mr of 40.000 
- 55.000 and PrdA (Mr 68.000) and PrdB (Mr 26.000) in the protein bands with a Mr of 
~70.000 and ~25.000, respectively. 
 
For the identification of interaction partners of the bait protein RnfC (figure 18, right 
panel) the SDS-PAGE observed different protein bands with three intensive protein 
bands at a Mr of ~15.000, ~15.000 - 25.000 and ~55.000. Afterwards, 16 cut out protein 
bands were subjected to LC-MS/MS analyses. Overall, 577 proteins were found using 
the program Proteome discoverer™ 2.2/2.3 (Thermo Fisher Scientific, Schwerte, Ger-
many). By setting the same cut-out criteria as described before 40 proteins were identi-
fied for further inspection (original protein list see digital appendix). In the protein band 
at a Mr ~55.000 the bait protein RnfC (Mr 48.000) was identified by LC-MS/MS. The 
Western blot using the Strep-Tactin® AP conjugate (Strep-tag® detection in Western 
blots, IBA GmbH, Göttingen, Germany) detected different proteins which might include 
the RnfC at a Mr ~55.000 (figure 18, right panel, right lane). Furthermore, RnfC interac-
tion partners like PrdA (Mr 68.000) one subunit of the cytoplasmic D-proline reductase 




Moreover, additional abundant interaction partners of RnfB and RnfC without a formal-
dehyde cross-link treatment were identified by mass spectrometry (see appendix). In 
regards to the same LC-MS/MS analysis cut-off criteria which were mentioned before 
detected prey proteins were classified according to function and metabolic classes: elec-
tron transfer proteins, metal ion transport/binding proteins and proteins which are in-
volved in glycolysis/glyconeogenesis, pyruvate metabolism, fatty acid degradation, pen-
tose phosphate pathway, TCA cycle, butanoate metabolism and amino acid metabolism 
(table 28). The overview of these proteins in relation to all four baits (PrdA, PrdB, RnfB 
and RnfC) and in comparison of a cross-linker treatment is given in the chapter 4.1.6. 
 
4.1.4 Interaction partners of the D-proline reductase subunits PrdA and PrdB in pres-
ence of the cross-linker formaldehyde 
In the next experiments the interaction partner of PrdA and PrdB in the presence of the 
cross-linker formaldehyde were analyzed. Cultures were grown likewise but were 
treated with 0.156 % formaldehyde (OD600 nm = 1) as a cross-linker (Fraenkel-Conrat and 
Olcott 1948; Metz et al. 2004) to stabilize transient protein-protein interactions. The 
Strep-tagged based affinity chromatography and data anlayses were conducted as spec-
ified before. In this case, the cross-linked insoluble fraction of the cell free extracts was 
used, which encompassed proteins from all cellular compartments. For this purpose, the 
concentrated bait elution fraction after affinity chromatography was prepared for a  
15 % SDS-PAGE and for a bait detection via Western blot analysis by using Strep-Tactin® 
AP conjugate (Strep-tag® detection in Western blots, IBA GmbH, Göttingen, Germany) 
(figure 19). Visible protein bands in the SDS-PAGE were subjected to a LC-MS/MS anal-
yses. The same cut-off criteria like in the non-cross-linking experiments were selected. 
For all baits, the protein-protein interactions occuring at the membrane were investi-










Figure 19: Interaction partners of the D-proline reductase subunits PrdA and PrdB in pesence of the 
cross-linker formaldehyde. Shown are the stained SDS PAGEs [left lane] and Western blot analyses [right 
lane] of the PrdA [left panel] and PrdB [right panel] interaction partners after purification via affinity 
chromatography. PrdA and PrdB as bait proteins were recombinantly produced in C. difficile 630∆erm. 
The respective strain was treated with 0.156 % formaldehyde (OD600 nm = 1) as a cross-linker before puri-
fication. The insoluble fraction of the cell free extacts containing the Strep-tagged baits was chromato-
graphed through the Strep-Tactin® affinity column. Formed bait-prey complexes were eluted and 10 µL 
of the 30-fold concentrated elution fraction were seperated via 15 % SDS-PAGE with 45 mA for 45 min. 
The SDS-PAGE was stained with InstantBlue® Protein Stain (Expedeon Ltd, Cambridge, UK) solution. The 
relative molecular masses were deduced from the PageRuler™ Plus Prestained Protein Ladder (Thermo 
Fisher Scientific, Schwerte, Germany). The bait detection was performed by Western blot analysis using 
the Strep-Tactin® AP conjugate (IBA GmbH, Göttingen, Germany). The blot development was in general 
15 - 30 min. Image quality was improved in grayscale. The image of the SDS-PAGE of PrdB was set to a 
brightness of 30 % and a color saturation of 355 %. The Western blot image of PrdA was set to a brightness 






































The stained SDS-PAGE of the concentrated elution fraction of the cross-linked PrdA (fig-
ure 19, left panel, left lane) showed several protein bands with different relative molec-
ular masses. Firstly, the protein band at a Mr of 70.000 showed a higher intensity than 
the others. For subsequent LC-MS/MS analyses, 18 protein bands were cut-out and sub-
jected to mass spectrometry. On average, 946 individiual proteins were found with the 
program Proteome discoverer™ 2.2/2.3 (Thermo Fisher Scientific, Schwerte, Germany). 




































> 1E+05 and the consideration of background control proteins determined before (see 
chapter 4.1.1). These settings excluded many proteins from the further analyses. Nev-
ertheless, 140 proteins were considered (original protein list see digital appendix). The 
visible protein band at a Mr ~70.000 contained the bait protein PrdA (Mr 68.000) as con-
firmed by mass spectrometry. In agreement, the Western blot analysis via Strep-Tactin® 
AP conjugate (Strep-tag® detection in Western blots, IBA GmbH, Göttingen, Germany) 
also identified this protein band as the Strep-tagged bait PrdA. Furthermore, the above-
mentioned proteolytically generated smaller subunit PrdA* was identified at a Mr of 
~25.000 (figure 19, left panel, right lane). Other PrdA cross-linked interaction partner 
like PrdB (Mr 26.000), RnfB (Mr 35.000), RnfC (Mr 48.000), RnfD (Mr 35.000) and RnfG 
(Mr 20.000) were detected (figure 19, left panel). 
 
The cross-linked PrdB interaction partner analysis revealed on a stained SDS-PAGE (fig-
ure 19, right panel, left lane) different protein bands. Afterwards, 7 protein bands were 
cut-out and subjected to LC-MS/MS. In total 49 proteins were identified by the software 
Proteome discoverer™ 2.2/2.3 (Thermo Fisher Scientific, Schwerte, Germany). The same 
cut-off criteria as above-mentioned excluded multiple proteins as observed before. Only 
6 proteins were considered for further analyses (original protein list see digital appen-
dix). Unfortunately, the bait protein PrdB (Mr 26.000) was not identified via mass spec-
trometry but was observed during the Western blot analysis at a Mr of 25.000 (figure 
19, right panel, right lane). Furthermore, cross-linked PrdB interaction partners were 
identified e.g PrdA (Mr 68.000) with a relative molecular mass of ~70.000. Moreover, 
further important interaction partners of PrdA and PrdB in presence of the formalde-
hyde cross-linker were identified by LC-MS/MS (see appendix). For this purpose, the cut-
off criteria which were mentioned before were selected and the prey proteins in relation 
to all baits were classified according to function and metabolic classes (table 29). The 







4.1.5 Interaction partners of the Rnf complex subunits RnfB and RnfC in presence of the 
cross-linker formaldehyde 
Further bait-prey experiments of the membrane complex subunits RnfB and RnfC includ-
ing 0.156 % formaldehyde cross-linker treatment were perfomed. Cultures were grown 
as described before and resulting cell free extracts were used for a Strep-tagged based 
affinity chromatography. For this purpose, the solubilized insoluble fraction of the cell 
free extracts was used. The concentrated elution fraction after affinity chromatography 
was separated on a 15 % SDS-PAGE. A subsequent Western blot was used for a bait 
detection (figure 20). Gel slices of protein bands which were visible in the stained SDS-
PAGEs were cut out and contained proteins were subjected to LC-MS/MS analyses. For 
this purpose, the same cut-off criteria as mentioned before were selected. Thus, for the 



















Figure 20: Interaction partners of the Rnf complex subunits RnfB and RnfC in presence of the cross-
linker formaldehyde. The stained (InstantBlue® Protein Stain (Expedeon Ltd, Cambridge, UK)) SDS-
PAGEs [left lane] and the corresponding Western blot analyses [right lane] of RnfB [left panel] and 
RnfC [right panel] interaction partners after the affinity chromatography purification are shown. Both 
baits were recombinantly produced in C. difficile 630∆erm and treated with 0.156 % formaldehyde 
(OD600 nm = 1) to stabilize protein-protein interactions before purification of the solubilized proteins of 
the insoluble fraction of the cell free extracts through the Strep-Tactin® affinity column. The bait-prey 
complexes were eluted and 10 µL of the 30-fold concentrated fraction were separated via 15 % SDS-
PAGE at 45 mA for 45 min. The relative molecular masses were deduced using the PageRuler™  
Prestained Protein Ladder (Thermo Fisher Scientific, Schwerte, Germany). The bait detection was per-
formed via Western blot analyses using the Strep-Tactin® AP conjugate (IBA GmbH, Göttingen, Ger-
many). The blot development was for 15 - 30 min. Images quality was improved in grayscale. The SDS-
PAGE of RnfB was set to a brightness of - 20 %, a color saturation of 400 % and a color temperature of 
7.220. The PAGE of RnfC was set to a brightness of 10 % and the corresponding Blot image to a bright-































The stained SDS-PAGE showed multiple bright protein bands with different molecular 
masses after separation of proteins in the concentrated elution fraction of the cross-
linked RnfB (figure 20, left panel, left lane). All visible protein bands (∑ 13 bands) were 
processed according to the gel-based LC-MS/MS approach. In total, 378 individiual pro-
teins were analyzed with the program Peaks® X+ (Bioinformatics Solutions Inc., Water-
loo, Canada). The conditions of the settings were unique peptides > 2, a coverage > 5 % 

































analyses. After application of these cut-off criteria 36 proteins were considered for fur-
ther analyses (original protein list see digital appendix). The LC-MS/MS analyses de-
tected the bait protein RnfB (Mr 35.000) in the protein band at a relative molecular mass 
of ~35.000. Unfortunately, the Western blot analysis with the Strep-Tactin® AP conju-
gate (Strep-tag® detection in Western blots, IBA GmbH, Göttingen, Germany) showed 
three different protein bands around ~ 25.000 of unknown identity (figure 20, left panel, 
right lane). Furthermore, several expected RnfB interaction partners were found via 
mass spectrometry like the subunits of the D-proline reductase PrdA* and PrdB  
(Mr 26.000) at a Mr of ~25.000. 
 
For further identification of protein-protein interaction partners of the Rnf complex 
Strep-tagged-based affinity chromatography of the subunit RnfC was performed. The 
corresponding prey proteins were detected in the stained SDS-PAGE (figure 20, right 
panel, left lane). Firstly, multiple protein bands with different brightness and various 
relative molecular masses became visible which were subsequently cut-out (∑ 18 pro-
tein bands) and subjected to gel-based LC-MS/MS analyses. Approximatly 300 proteins 
(in 18 single cut out protein band files) were identified with the Proteome discoverer™ 
2.2/2.3 (Thermo Fisher Scientific, Schwerte, Germany). After set up of the above-men-
tioned cut-off criteria approximatly 60 proteins (in 18 single cut outs of protein band) 
were further analyzed. For this purpose, the LC-MS/MS analyses identified the bait pro-
tein RnfC (Mr 48.000) in the protein band with a Mr of ~45.000. The Western blot anal-
ysis via Strep-Tactin® AP conjugate (Strep-tag® detection in Western blots, IBA GmbH, 
Göttingen, Germany) failed to detect this bait protein. Only other protein bands of un-
known identity and with different relative molecular masses became visible (figure 20, 
right panel, right lane). Nevertheless, additional membrane Rnf complex subunits like 
RnfB (Mr 35.000) and RnfG (Mr 20.000) and subunits of the D-proline reductase PrdA  
(Mr 68.000) and PrdB (Mr 26.000) were found during LC-MS/MS analyses. Further im-
portant interaction partners were identified by LC-MS/MS (table 30). An overview of 





4.1.6 Summary of the strong-binary and cross-linked protein-protein interactions of the 
baits PrdA, PrdB, RnfB and RnfC  
In order to obtain cell systematics overview over the contacts between the Rnf complex, 
the D-proline reductase Prd and other proteins obtained results were combined in the 
following table.  For this purpose, these identified proteins were separated into different 
classes: 1. proteins to serve electron transfer and 2. energy production proteins (classi-
fied according the database annotation of KEGG or UniProt). An overview over these 
proteins of high abundance (detail list in the appendix) in relation to all four non-cross-
linked and cross-linked baits is given in table 18 - 21.  The abundance of these prey pro-
teins was defined with following values:  
+++ = > 1E+09 
++ = >1E+07 – 1E+09 
+ = 1E+05 – 1E+07 
- = no hit 
 
Certain previously determined column contaminants of the background control which 
were highly concentrated and might to be enriched in these protein-protein interaction 
experiments were included in the analyses and marked in green.  
 
Table 18: Interaction partners from the Stickland fermentation pathway and related functions of non-
cross-linked (-CL) and cross-linked (+CL) PrdA, PrdB, RnfB and RnfC: D-proline reductase (PrdCDF), glycine 
reductase (GrdBCD), indolepyruvate ferredoxin oxidoreductase (IorAB) and dihydroorotate dehydrogen-
ase electron transfer (PyrK) 
 
 
D-proline reductase Oxidoreductase/Lyases 
Baits/Preys PrdC PrdD PrdF GrdB GrdC GrdD IorA IorB PyrK 
PrdA - CL - - - - - - - - - 
+ CL - ++ ++ ++ - - ++ - ++ 
PrdB - Cl ++ - ++ + - + + - - 
+ CL - - - - - - - - - 
RnfB - Cl ++ - - - ++ - - ++ - 
+ CL - - - - - - - - - 
RnfC - Cl - - - - + - + - - 




Table 19: Subunits of the F-type and V-type ATPase interacting with PrdA, PrdB, RnfB and RnfC in the 




Table 20: Interaction partners from electron bifurcating and iron (-transport) proteins of non-cross-
linked (-CL) and cross-linked (+CL) PrdA, PrdB, RnfB and RnfC: Electron transfer flavoprotein (EtfAB), 

















 V-type ATPase F-type 
Baits/Preys AtpA AtpB AtpD AtpF AtpA1 AtpF1 AtpG 
PrdA - CL - - - - - - - 
+ CL - + ++ - ++ - ++ 
PrdB - Cl - - ++ - ++ - + 
+ CL - - - - ++ - - 
RnfB - Cl ++ ++ ++ ++ ++ - ++ 
+ CL - - ++ ++ ++ - ++ 
RnfC - Cl - - + - ++ - + 
+ CL + - ++ ++ ++ ++ + 
Electron bifurcating and iron (-transport) 
Baits/Preys EtfA1 EtfA3 EtfB1 EtfB3 FeoB1 FeoB2 FldX FtnA 
PrdA - CL - - + - - - + + 
+ CL ++ - ++ - ++ - - - 
PrdB - Cl ++ - ++ - + - + + 
+ CL - - - - - - - - 
RnfB - Cl - ++ ++ ++ ++ ++ - - 
+ CL ++ ++ ++ + ++ - - - 
RnfC - Cl ++ - ++ - + - - - 




Table 21: Interaction partners from different energy metabolism pathways of non-cross-linked (-CL) 
and cross-linked (+CL) PrdA, PrdB, RnfB and RnfC:  3-hydroxybutyryl-CoA dehydratase (Crt2), 3-hydro-
xybutyryl-CoA dehydrogenase (Hbd), 4-hydroxybutyrate CoA-transferase (Cat2), 4-hydroxybutyryl-CoA 
dehydratase (AbfD), acyl-CoA dehydrogenase (AcdB), acryloyl-CoA reductase electron transfer (AcrA), 
aldehyde-alcohol dehydrogenase (AdhE/AdhE1), 6-phosphofructokinase (PfkA), butyrate kinase (Buk), 
butyryl-CoA dehydrogenase (Bcd2), D-lactate dehydrogenase (LdhA), formate acetyltransferase (PlfB), 
fructose-1,6-bisphosphate aldolase (Fba), glucose-6-phosphate isomerase (Pgi), glyceraldehyde-3-phos-
phate dehydrogenase (GapAB), phosphate butyryltransferase (Ptb), pyruvate carboxylase (PycA), 




In conclusion, a manifold of prey proteins were found via gel-based LC-MS/MS analyses 
in the different bait-prey experiments in absence and presence of the cross-linker for-
maldehyde. It is noteworthily that some of identified prey proteins were only present in 
the cross-linking experiments and others only in absence of the cross-linker. Since the 
bait proteins were found by LC-MS/MS, the method shows a suitable procedure for the 
Butanoate-, fatty acid metabolism, glycolysis/glyconeogenesis, pentose phosphate pathway,  
pyruvate metabolism, TCA cycle 
Baits/Preys Crt2 Hbd Cat
2 






PrdA - CL - ++ - + - - + + - - + 
+ CL ++ +++ ++ ++ +++ ++ ++ ++ ++ +++ ++ 
PrdB - Cl ++ ++ ++ ++ - - ++ ++ ++ - ++ 
+ CL - - - - - - - - - - - 
RnfB - Cl ++ ++ ++ - - - ++ ++ ++ - ++ 
+ CL ++ - ++ ++ - - ++ ++ - - ++ 
RnfC - Cl - - + ++ - - - ++ ++ - + 
+ CL + ++ ++ ++ - - +++ ++ ++ - ++ 
Baits/Preys PlfB Fba Pgi GapA GapB Ptb PycA Pfo Pyk Suc
D 
 
PrdA - CL - ++ - - ++ + + - - -  
+ CL ++ ++ + ++ - + ++ ++ ++ +++  
PrdB - Cl - ++ ++ ++ - ++ ++ ++ ++ ++  
+ CL - - - - - - - - - -  
RnfB - Cl - ++ ++ ++ - - - ++ ++ -  
+ CL ++ ++ - ++ - ++ ++ ++ ++ ++  
RnfC - Cl - ++ + ++ - + ++ ++ ++ ++  




interactomic approach of Rnf-Prd in C. difficile. Interestingly, further important proteins 
were found, which are involved in Stickland fermentation, ATP generation, electron 
transfer, iron transport and/or generally in different energy/electron generating meta-
bolic pathways. It is assumed that interaction partners of this type serve for a localized, 
rapid reaction and electron transfer at the Rnf-Prd complex in the Stickland fermenta-
tion pathway. For a more precise information about the protein-protein interactions of 
the individual baits, a quantification of the preys in a gel-free LC-MS/MS analyses of the 
baits PrdA, PrdB, RnfB and RnfC was performed in the following chapter.   
 
 
4.2 Identification and quantification of the bait-prey interactions between 
the Rnf complex and D-proline reductase with a gel-free LC-MS/MS ap-
proach 
 
The gel-based LC-MS/MS approach helped to identify the protein interaction-partner of 
the bait proteins PrdA, PrdB, RnfB and RnfC with and without formaldehyde cross-link-
ing. Afterwards, the determined protein-protein interactions were further analyzed in 
more detail via a quantification approach performed by gel-free LC-MS/MS set up. The 
affinity chromatography-based enrichment of prey proteins via protein interaction to 
the affinity-tagged baits in comparison to their normal abundance in the cell free extract 
(solubilized proteins of the insoluble fraction) was determined. For this purpose, the 
abundance values of identified proteins after attached to affinity chromatographed 
baits PrdA, PrdB, RnfB and RnfC in comparison to the abundance of the cell free extract 
control, were used for the calculation of an enrichment factor (see chapter 3.5.6).  
According to this, a factor > 1 showed an enrichment of LC-MS/MS identified proteins in 
the bait elution fraction. It has to be noted that increasing values of this factor indicate 
either a stronger bait-prey protein interaction or a special polymerization of the prey 





4.2.1 Quantification of protein-protein interactions of the formaldehyde cross-linked 
baits PrdA, PrdB, RnfB and RnfC  
For the quantification of protein-protein interactions of PrdA, PrdB, RnfB and RnfC sim-
ilar growth conditions of C. difficile 630∆erm as used for the gel-based analyses were 
selected followed by a formaldehyde treatment of 0.156 % (OD600 nm = 1), cell fractiona-
tion, and Strep-tag® II affinity chromatography steps (see chapter 3.4.3). Three biologi-
cal replicates were investigated with the gel-free LC-MS/MS method. As mentioned be-
fore 200 µL of the solubilized insoluble fraction as abundance control and of the respec-
tive chromatographed eluted bait protein in the same amount were taken for the fur-
ther calculation of an enrichment factor after LC-MS/MS measurement. Procedures 
were described in detail in chapter 3.5.5 and 3.5.6. All of the samples were analysed 
with the software Proteome discoverer™ 2.2/2.3 (Thermo Fisher Scientific, Schwerte, 
Germany).  
The list of protein interaction partners of the chromatographed bait proteins compared 
to the corresponding abundance control was included in one data set. The total amount 
of LC-MS/MS identified proteins was 1931. The data were exported to MS Excel® (Mi-
crosoft® Corporation, Washington, USA) after narrowing down the candidates according 
to the cut-off criteria: the unique peptides ≥ 2 and the coverage ≥ 5 %. Afterwards the 
data were normalized to a usually meassured chromatographed bait protein concentra-
tion of 0.24 mg/mL as reference and the mean value of the enrichment factor (abun-
dance of proteins in eluate/abundance of proteins in the abundance control) for the 
quantification of prey proteins in the bait sample was calculated (see digital appendix). 
Proteins which were not found in all of the three replicates and proteins with an enrich-
ment factor < 1 were excluded from further analyses. After these settings 1196 proteins 
were found to be enriched in the bait elution fraction (original list in the digital appen-
dix). Furthermore, general proteins which were not specific for energy generation path-
ways and not directly contribute to the Stickland fermentation process in C. difficile were 
withdrawn from this study. Moreover, several proteins were not considered for further 
analyses as they are generic and abundantly found in bacterial cells such as: chaperones, 
ribosomale proteins, not classified enzymes, ligases, polymerases, gyrases, transferases, 




Figure 21: Grouped bar diagram of prey proteins of the baits PrdA, PrdB, RnfB and/or RnfC from  
C. difficile 630∆erm in the total amount of 810 identified proteins. The identified preys of the baits 
PrdA, PrdB, RnfB and RnfC were determined with the program Proteome discoverer™ 2.2/2.3 (Thermo 
Fisher Scientific, Schwerte, Germany). After the settings of unique peptides ≥ 2, protein coverage ≥ 5 %, 
normalization to 0.24 mg/mL protein concentration, excluding non energy generation or Stickland fer-
mentation pathway relevant proteins (e.g. generic proteins) in total 810 proteins were identified via 
mass spectrometry. Firstly, these proteins were grouped into the occurrence in all four, three, two or 
in single bait proteins. Interestingly, 350 prey proteins were present in all four baits.  
 
tor proteins, DNA repair proteins/binding proteins, cold shock proteins, unspecific spor-
ulation or cell surface proteins and cell division proteins. Overall, 810 enriched potential 
prey proteins were encountered (original list in the digital appendix). Among these, sev-
eral proteins were found in in all four, three, two or one of the baits eluates. The next 
figure shows the amount of identified prey proteins according to their occurrence in the 










Afterwards, the prey proteins were sorted according to their enrichment factor value in 
relation to the value of the bait protein. In general, prey proteins with a higher enrich-
ment factor than the bait protein may indicate a strong interaction or that more subunits 
of the preys interact with the bait protein. The following table shows an overview of the 
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the differerent bait protein eluates (original list in the digital apendix). Furthermore, it 
has been subdivided into the categories: Stickland fermentation pathway, ATP synthase, 
electron transfer or iron translocating proteins by the use of the database KEGG or Uni-
Prot.  
 
Table 22: Quantification of formaldehyde cross-linked bait-prey proteins identified via gel-free  
LC-MS/MS approach and dedicated to the Stickland fermentation pathway, ATP synthase and electron 
transfer or ion translocating proteins 
Prey proteins  Enrichment factor of  
preys in the baits 


























CD630DERM_32400  - 6.94  - 10.57 












CD630DERM_32450 41.69  -  -  - 



























CD630DERM_11380 35.65 90.23 229.18 18.17 
Ion-translocating oxi-
doreductase complex 






CD630DERM_11390 - 15.46 37.50 28.05 
Stickland fermentation – Glycine reductase  
Glycine reductase 






















CD630DERM_23480 65.65 28.84 16.56 8.77 
Glycine reductase 
component B subu-
















CD630DERM_34700 10.99 6.13 199.96 5.43 
F-type H+-transport-




CD630DERM_34720 8.92 4.97 19.03 1.86 
F-type H+-transport-




CD630DERM_ 34730  -  - 361.07 8.49 
F-type H+-transport-







CD630DERM_34710 64.62 8.03 11.88 - 
F-type H+-transport-







CD630DERM_34690 11.08 7.19 43.67 1.38 
F-type H+-transport-







CD630DERM_34680 9.33 4.22 68.06 24.60 
Putative ATPase - CD630DERM_22490 - 17.68 46.84 2.26 































































CD630DERM_34050 - - - 15.18 


















CD630DERM_15360 9.73 11.58 81.19 5.00 





CD630DERM_14780 100.15 29.05 7.39 - 
Ferrous iron transport 




CD630DERM_14790 6.44 15.63 78.11 2.28 
Ferrous iron transport 




CD630DERM_32740 7.51 11.22 78.43 18.94 
Fe-s iron-sulfur clus-
ter assembly protein, 





















CD630DERM_16930 10.18 18.35 368.73 10.14 
Putative iron-depen-




CD630DERM_08930 6.57 31.15 390.57 16.04 
Putative iron-sulfur 




CD630DERM_36070 7.72 15.44 94.66 13.80 
Blue-grey color code of the calculated enrichment factor (F) values of the different proteins in the bait 
samples: The enrichment of bait proteins by affinity chromatography versus their abundance in the cor-
responding cell free extract delivered the bait enrichment factor (F) for PrdA= 934.38; PrdB= 32.87;  
RnfB= 41.79 and RnfC= 3.38. If these values showed 100 % enrichment of the respective bait protein, the 
calculated prey enrichment factors for the respective bait were above (> 100 %, dark blue) or below (10 -  
100 %, bright blue; < 10 %, grey) to the corresponding bait factor. The illustration of this high or low ratio 
of prey-bait interaction were highlighted in the above-metioned color code (this shows the enriched prey 
proteins after affinity chromatography versus their abundance in the respective cell free extract (F) and 
compared to the employed bait protein enrichment factor). 
  
 
Other prey proteins (after applying the cut-off) that are also highly abundant, usually 
with an enrichment factor above their respective bait (dark blue marked,  




100 %), were classified according to their pathway or function. Proteins that are very 
prominent but did not obviously directly contribute to the general energy metabolism 
of the bacterial cell were placed into the category cellular processes. The following table 
shows an overview of the proteins that were examined in detail for the analyses (the 
original list is shown in the digital appendix).  
 
Table 23: Quantification of the formaldehyde cross-linked bait-prey proteins identified via gel-free  
LC-MS/MS approach and dedicated to general bacterial cell energy generation pathways 
Prey proteins  Enrichment factor of  
preys in the baits 








Butanoate metabolism, fatty acid metabolism, glycolysis, pentose phosphate pathway  









CD630DERM_10570 27.92 11.11 132.70 - 
4-hydroxybutyrate 




CD630DERM_23390 24.74 16.23 52.43 5.40 
Acetyl-coenzyme A 
carboxylase car-












CD630DERM_30060 12.34 10.18 86.95 3.90 
Biotin carboxyl car-
rier protein of ace-












CD630DERM_03940 14.94 11.20 108.43 6.60 
Fructose-1,6-bis-































CD630DERM_32830 204.06 40.91 8.84 11.84 

































CD630DERM_23420 32.09 14.57 40.24 14.53 
Biosynthesis of amino acids/amino acid metabolism      






CD630DERM_16580 126.81 149.39 45.49 - 


































CD630DERM_23340 11.91 9.91 634.18 3.77 
PTS system, glucose-
































CD630DERM_02330 56.14 72.64 999.73 30.01 























CD630DERM_08260 102.07 - 42.77 9.47 
Putative flagellar 
















CD630DERM_30090 - - 1235.63 - 
Toxin A  TcdA CD630DERM_06630   18.41 12.88 45.29 4.00 
Two-component re-
sponse regulator, 






CD630DERM_36000 2896.21 118.51 21.96 12.13 
Xanthine dehydro-
genase iron-sulfur 






CD630DERM_21000 - 34.16 1401.87 - 
Blue-grey color code of the calculated enrichment factor (F) values of the different proteins in the bait 
samples: The enrichment of bait proteins by affinity chromatography versus their abundance in the cor-
responding cell free extract delivered the bait enrichment factor (F) for PrdA= 934.38; PrdB= 32.87; 
 RnfB= 41.79 and RnfC= 3.38. If these values showed 100 % enrichment of the respective bait protein, the 
calculated prey enrichment factors for the respective bait were above (> 100 %, dark blue) or below (10 - 
100 %, bright blue; < 10 %, grey) to the corresponding bait factor. The illustration of this high or low ratio 
of prey-bait interaction were highlighted in the above-metioned color code (this shows the enriched prey 
proteins after affinity chromatography versus their abundance in the respective cell free extract (F) and 
compared to the employed bait protein enrichment factor). 
 
 
Both tables showed an overview of the abundant preys for the respective bait protein. 
Due to Stickland fermentation, proteins of D-proline reductase, glycine reductase and 
the Rnf complex were found in almost all bait eluates. Various subunits of ATPase  
(F-type and V-type), the Etf complex and iron-dependent proteins were identified in 
most bait eluates and highly enriched in the Rnf subunit bait eluates. In addition, highly 







PrdA AB (15 nm) RnfB AB (15 nm) 
4.3 Verification of bait-prey interactions using transmission electron  
microscopy (TEM)  
In order to verify some of the results obtained by the interactomics approach, a second 
independent method based on electron microscopy was used. For this purpose, a dou-
ble immunogold labeling experiment of the bait and prey proteins and their potential 
co-localization using TEM was performed. This method allows for the cellular co-locali-
zation of the two proteins by means of polyclonal antibodies which carry different-sized 
gold particles. For the generation of the corresponding antibodies three peptide 
epitopes of the target protein were selected based on their soluble nature and their 
exposure to the protein surface according to bioinformatic predictions from the com-
pany Metabion international AG and Primm (Planegg, Germany) (see chapter 3.5.7 and 
appendix). Preparation of the labelled antibodies, images collection and analyses were 
performed using TEM by Dr. Mathias Müsken and Ina Schleicher at the HZI in Braun-
schweig (group of Prof. Dr. Manfred Rohde; Central Facility for Microscopy).  
For the interaction studies of PrdA, RnfB and RnfC corresponding rabbit polyclonal anti-
bodies were raised as mentioned before. Ultrathin sections of C. difficile 630Δerm were 
incubated with pairs of antibodies. Images were taken of the labeled cells via TEM and 
co-localization events of protein pairs (PrdA with RnfB, PrdA with RnfC and RnfC with 
RnfB) were monitored in detail. The binding specificity of each antibody was tested by 
incubating it individually with C. difficile 630Δerm cells. The figure below illustrates the 













RnfB AB (10 nm) + RnfC AB (15 nm)  PrdA AB (10 nm) + RnfC AB (15 nm)  
Figure 22: Interaction studies using antibodies directed against PrdA, RnfB and RnfC coupled with 
gold particles of different size (immunogold co-localization) visualized by TEM. Panels [A] to [C] show 
the control reactions of individually applied antibodies coupled with 15 nm insize gold particles directed 
against the cytoplasmic subunit of D-proline reductase PrdA and the membrane-bound subunits RnfB 
and RnfC as indicated above every image. Panels [D] to [F] show the images of the co-localization stud-
ies for the indicated protein pairs: RnfB and PrdA; RnfB and RnfC; PrdA and RnfC (labeled with gold 
particles size of 10 nm or 15 nm). The specific events occurring localized to the membrane are marked 
with white arrows. The images show a scale of 1 µm for single events and 500 nm for double events. 
The images were provided by Dr. Mathias Müsken at the HZI in Braunschweig (group of Prof. Dr. 



























RnfB AB (10 nm) + PrdA AB (15 nm)  RnfC AB (15 nm) 
[E] [F] 




Figure 23: Semi-quantitative image analyses of single antibody detections of PrdA, RnfB and RnfC in  
C. difficile 630Δerm. The figure shows the counted events out of a 10 images series of antibodies di-
rected to PrdA, RnfB and RnfC coupled with protein A-gold (15 nm). The mean value of the series was 
plotted and the area of the cell respectively backround (in µm2) was measured in advance (gold/µm2). 
The occurring events in each image were counted and assigned to the different (cell)-regions (cytoplasm, 
membrane and background). The figure was provided by Dr. Mathias Müsken at the HZI in Braunschweig 
(group of Prof. Dr. Manfred Rohde; Central Facility for Microscopy). 
In the TEM images shown in panels [A] to [C] of figure 22 the localization of the gold 
particles (15 nm) labeled antibodies directed against PrdA, RnfB and RnfC were tested 
alone. The proteins were observed mainly localized to the bacterial membrane (white 
arrow) and to a minor extent inside the cytoplasm. The co-localization studies shown in 
panels [D] to [F] of figure 22 were mainly observed at the membrane (white arrow). To 
a certain degree, single antibodies were found in the cytoplasm or in the background. In 
addition, the single antibody localization and the co-localization events of PrdA, RnfB 
and RnfC were subjected to semi-quantitative analyses. For this purpose, GraphPad 
prism (version 8.4.3) was applied to plot the data. In detail, the area of cells respectively 
background was measured in µm2 and split in different fractions: cytoplasm (75 %) and 
membrane (25 %). Afterwards, the gold particles in single or double labeling were 
counted (see chapter 3.5.7) and classified into cell cytoplasm, cell membrane and back-
ground. The following figures illustrate the single and double antibody detection in the 












Figure 24: Semi-quantitative image analyses of co-localization events for the protein combinations PrdA 
and RnfB, RnfB and RnfC as well as RnfC and PrdA in C. difficile 630Δerm. The figure shows the counted 
events out of three data sets (each combination covered by 21 - 25 images) for the co-localization of 
antibodies directed to PrdA, RnfB and RnfC coupled with protein A-gold (10 nm and 15 nm). The mean 
value of the series was included and the area of the cell respectively backround (in µm2) was measured in 
advance (gold/µm2). The gold particle events in each image were counted and assigned to the different 
(cell)-regions (cytoplasm, membrane and background). The figure was provided by Dr. Mathias Müsken 







Figure 23 shows the semi-quantitative cell localization of the antibodies directed against 
RnfB, PrdA and RnfC alone in C. difficile 630Δerm. Based on the measured cell area in 
relation to the background, the gold particles were counted and the localization events 
in gold particles/µm2 were determined. The full circles show the occurence of the re-
spective gold particles in the cell (cytoplasm and/or membrane), while the semicircles 
(closed at the top) indicate the presence of the gold particles in the cytoplasm, and the 
semicircles (closed at the bottom) the presence of the gold particles at the membrane. 
The white squares indicate the presence of the gold particles in the background. One 
circle or square represents 1 image series in which the gold particles have been counted. 
The mean values are indicated by the black bar of the respective sample.  
The localization analyses showed that the RnfB alone has a mean value of > 5 gold par-
ticles/µm2 in the cell. Most hits were at the membrane (> 5 gold particles/µm2) and less 
in the cytoplasm (< 5 gold particles/µm2). In the background a mean value below 5 gold 
particles/µm2 was found, indicating a low unspecific binding of antibody against RnfB. 
Antibodies specific for PrdA showed that the mean value of gold particles in the cell was 




below 5 gold particles/µm2, with more events found at the membrane than in the cyto-
plasm. The mean value of the detected gold particles in the background was slightly 
above 0 gold particles/µm2. The same relation was observed for the RnfC specific anti-
bodies. Most of the hits were found at about 5 gold particles/µm2 in the cell and most 
of them were observed at the membrane (> 5 gold particles/µm2) and less in the cyto-
plasm (< 5 gold particles/µm2). The background had the lowest number of events  
(< 5 gold particles/µm2). 
 
Figure 24 shows the semi-quantitative analyses of the co-localization events of PrdA and 
RnfB, RnfB and RnfC as well as RnfC and PrdA in C. difficile 630Δerm. As described above, 
identical conditions for measuring the cell area and nomenclature (circle, semicircle, 
square, bar) were applied. In contrast to the single localization, events were counted 
from three data sets (with 21 - 25 images). On average for all tested double label com-
binations with a co-localization event value of under 5 gold particles/µm2 was found in 
the cell. A more detailed inspection revealed that in all three combinations the co-local-
ization events were mostly found at the membrane (on average > 5 gold particles/µm2) 
and to a lower extent inside the cytoplasm (< 5 gold particles/µm2). Although the co-
localization events were not frequent, the semi-quantitative analyses showed a clear-
cut tendency towards the binary-association of Prd and Rnf. It is also evident that gold 











4.4 In vitro biochemically characterization of the rnfC mutant strain  
In order to gain better functional insights in terms of physiology and biochemistry into 
the pivoting role of the Rnf complex in Clostridioides difficile 630∆erm in the frame work 
of the reductive energy-generating processes of the Stickland fermentation, the RnfC-
encoding locus was truncated using the ClosTron® technique (see chapter 3.3.11). Thus, 
the group II intron harbored into the specific shuttle vector pMTL007C-E2 (tool: DNA2.0 
from ATUM (US)), was designed to be integrated in the middle of the rnfC sequence 
CD630DERM_11370 at position 636|637s (Heap et al. 2007; Heap et al. 2010a; Heap et 
al. 2010b; Kuehne and Minton 2012). After transformation of the E. coli ST18 cells with 
the plasmid pMTL007C-E2:316671 (CDi_rnfC), this strain was used for genetic material 
transfer via mating into the C. difficile 630Δerm wildtype (see chapter 3.3.3). 
Afterwards, erythromycin-resistant clones were PCR-screened and a sanger sequenced 
to monitor proper integration of the group II intron. The resulting rnfC-deficient strain 
was termed CD630∆erm_rnfC636/637s::ermB and employed for further characteriza-
tion. The growth behavior of the newly generated strain was registered spectrophoto-
metrically. The morphological phenotype of this strain was inspected by SEM imaging. 
Furthermore, the strain was biochemically explored in vitro (D-proline activity assay, 
toxin ELISA and NAD+/NADH ratio) and it was studied at diverse omics levels.   
 
 
4.4.1 Growth behavior and morphological characterization of a rnfC mutant 
Firstly, the growth behavior of the constructed rnfC mutant strain 
CD630∆erm_rnfC636/637s::ermB in comparison to the wildtype CD630∆erm as de-
scriped in chapter 3.2.7 was performed. Furhter, the cell morphology was monitored by 
SEM performed by Dr. Mathias Müsken (group of Prof. Dr. Manfred Rohde; Central Fa-
cility for Microscopy) at the HZI in Braunschweig according to the protocol described in 
chapter 3.6.1. For the growth behavior experiment both strains were inoculated at the 
same time point with an optical density of 0.05 and monitored over a 16 h period (figure 
25). Five biological replicates were performed and the average measurements (cell den-




Figure 25: Growth curves of the wildtype (CD630∆erm) (solid line) and the rnfC mutant 
(CD630∆erm_rnfC636/637s::ermB) (dashed line)  in BHI(S) medium over 16 h growth time. Both strains 
were inoculated at a cell density OD600 nm of 0.05 and were grown for 16 hours under anaerobic conditions 
and at 37 °C until the stationary phase was reached. The cell densities of five replicates were measured 
every hour (see appendix) and the mean values with the corresponding standard deviation were deter-







The logarithmic curve in figure 25 represents the observed growth behavior of the 
wildtype (solid line) and the rnfC mutant strain (dashed line). The measured cell densi-
ties (at OD600 nm) were plotted on the Y-axis against the corresponding time points  
[X-axis]. The wildtype strain displayed the distinctive C. difficile growth phases. It 
showed a reduced lag phase and an exponential phase with a maximum cell density in 
terms of OD600 nm value of 1.6 after 9 h. Subsequently, the bacterium entered the sta-
tionary phase. 
In contrast, the rnfC mutant strain revealed an arrested growth behavior characterized 
by an extended exponential phase of over 11 h, reaching a maximum optical density of 
0.76 [OD600 nm]. Clearly, a mutation of a gene for a subunit of the ion-pumping Rnf com-
plex significantly impaired the growth of C. difficile. Besides the growth behavior, SEM 
imaging provided with further insights into morphological divergences between the two 

























































Figure 26: Scanning electron microscopy images of the wildtype and the rnfC mutant strain. Shown are 
the wildtype CD630∆erm in panels [A] and [C] and the corresponding rnfC mutant 
CD630∆erm_rnfC636/637s::ermB in panels [B] and [D]. Images in panels [A] and [B] show both strains at 
a magnification (Mag) of 8.02 K X and [C] and [D] of 31.98 K X. The scale bars were inserted. The images 
were taken at 5.00 kV (EHT) and 2.9 mm (WD) on Merlin (Carl Zeiss Microscopy GmbH, Jena, Germany) 
with the Everhart Thornley HESE2 detector and the inlens SE detector in a 25:75 ratio by Dr. Mathias 


















The SEM images show the wildtype strain CD630∆erm in panels [A] and [C] and the rnfC 
mutant CD630∆erm_rnfC636/637s::ermB in panels [B] and [D]. The figures showed both 
strains in different magnifications. Obviously, the wildtype formed rod-shaped cells, 
which were flagellated peritrichely. Clearly, the rnfC mutant had to an impaired flagel-
lum formation and an attachement of the cells via the flagella and accumulated extra-
cellular material sticking to the flagella. 
 
4.4.2 D-proline reductase activity in dependence of a functional Rnf complex 
To check if the absence of the RnfC subunit of the membrane ferredoxin-NAD+: oxidore-
ductase Rnf complex of C. difficile 630Δerm has an impact on the D-proline reductase a 
fluorometric activity assay was performed based on the work by Seto 1979 and Kabisch 
2001. This assay monitors the activity of the enzyme D-proline reductase by the conver-
sion of its substrate D-proline into the product 5-aminovalerate in a time-dependent 





CD630∆erm_rnfC636/637s::ermB were grown anaerobically in the defined minimal me-
dium CDMM. Samples were taken in the exponential (T1) and the stationary growth 
phase (T2). Afterwards, the cells were harvested and three biological replicates were 
analyzed as described in chapter 3.6.2 and 3.6.3. For this purpose, 5 µg protein of cyto-
solic extract containing the D-proline reductase were mixed with the substrate D-proline 
and incubated for 60 min at 30 °C. Seperately, a negative control carrying solely dH2O 
instead of D-proline was included and the samples were treated identically. Thereby, the 
5-aminovalerate which had already been formed intracellulary during cell growth in 
CDMM was determined and excluded from the data. A 5-aminovalerate calibration 
curve was also performed (see digital appendix). After quenching the reaction with  
5 % perchloric acid, the samples were mixed with the reagent o-phthaldialdehyde. The 
non-fluorescence reagent reacted with 5-aminovalerate producing a fluorescent PH-5-
aminovalerate with a fluorescence excitation peak around 330 nm and an emission peak 
at 450 nm (Seto 1979; Kabisch 2001). Consequently, the relative fluorescence intensities 
were measured at the emission peak point (450 nm) using the FP-8500 Fluorescence 
Spectrometer (JASCO Deutschland GmbH, Pfungstadt, Germany) (see appendix and dig-
ital appendix).  
For both strains (wildtype and rnfC mutant) at T1 and T2 the normalized fluorescence 
intensities were deduced by substraction of the relative fluorescence intensities of PH-
5-aminovalerate in the negative control sample (already formed 5-aminovalerate in the 
cell) from the values obtained for corresponding samples containing reacted D-proline. 
Afterwards, the actual concentrations [nmol] of the enzymatically formed 5-aminova-
lerate were calculated utilizing the calibration curve (linear regression, see appendix). 
The comparison of the product formation (mean values) by the D-proline reductase from 
the wildtype and the rnfC mutant strain cell free extracts at the exponential (T1) and 







Figure 27: The 5-aminovalerate production by D-proline reductase in cell free extracts of the wildtype 
and the rnfC mutant strain. In the activity assay for D-proline reductase 5 µg protein of cytosolic cell free 
extracts of each strain (dark bars: wildtype CD630∆erm and bright bars: rnfC mutant 
CD630∆erm_rnfC636/637s::ermB) were incubated with the substrate (100 mM D-proline) at 30 °C for  
60 min. Before, samples were taken in the exponential (T1) and stationary (T2) growth phases. The emis-
sion at 450 nm was determined after addition of o-phthaldialdehyde using a FP-8500 Fluorescence Spec-
trometer (JASCO Deutschland GmbH, Pfungstadt, Germany). Using a 5-aminovalerate standard, the con-









Figure 27 shows the amounts of 5-aminovalerate [nmol] formed by the cytosolic cell 
free extract containing D-proline reductase from the wildtype (dark grey bar) and the 
rnfC mutant strain (bright grey bar) determined at two different time points during the 
growth phase. The diagram illustrates that the D-proline reductase activity of the 
wildtype cell free extract yielded a total amount of 2.17 nmol 5-aminovalerate at T1 and 
1.45 nmol at T2. In contrast, the values of the 5-aminovalerate formed by the D-proline 
reductase contained in rnfC mutant cell free extract at T1 and T2 were 0.39 nmol and 
0.65 nmol, respectively (see appendix). Obviously, an intact Rnf complex is a functional 

































4.4.3 Cellular NAD+/NADH ratio of the wildtype and the rnfC mutant strain 
The NAD+/NADH ratio in the wildtype CD630∆erm and in the rnfC mutant strain 
CD630∆erm_rnfC636/637s::ermB were determined to test for the physiological conse-
quences of a lack of the RnfC subunit. As mentioned above, both strains were grown 
anaerobically until the time points T1 (exponential growth phase) and T2 (stationary 
growth phase) were reached in defined minimal medium CDMM and the bacteria cells 
were subsequently harvested. The cell pellets of five biological replicates were prepared 
according to the protocol described in chapter 3.6.4 by Dr. Petra Henke and Dr. Sabine 
Will (group of Dr. Meina Neumann-Schaal; Bacterial Metabolomics) at the DSMZ in 
Braunschweig. The mean values of NAD+ and NADH were determined using the 
NAD+/NADH Glo Assay kit (Promega GmbH, Madison, USA). The following table 24 
shows the NAD+ and NADH content of both strains at time point T1 and T2. The values 
were provided by Dr. Petra Henke.  
 
 
Table 24: Determination of the NAD+/NADH ratio in the wildtype CD630∆erm and in the rnfC mutant 
strain CD630∆erm_rnfC636/637s::ermB  in the exponential (T1) and stationary growth phases (T2) 
 
 
The table 24 shows the cellular content of NAD+ [nmol/mg], NADH [nmol/mg] and the 
ratio of both cofactors (NAD+/ NADH) of the wildtype CD630∆erm and the rnfC mutant 
strain CD630∆erm_rnfC636/637s::ermB. The wildtype generated at T1 a total amount of 
924.05 nmol/mg NAD+ and 12.11 nmol/mg NADH. At the time point T2 the values in-
creased up to 2407.58 nmol/mg NAD+ and 195.60 nmol/mg NADH. This led to a 76-fold 
NAD+ excess compared to NADH at the exponential growth phase (T1). This ratio was 












CD630∆erm T1 924.05 12.11 76 
T2 2407.58 195.60 12 
CD630∆erm_rnfC636/637s::ermB T1 977.28 26.48 37 




In contrast, the mutant strain showed 977.28 nmol/mg NAD+ and 26.48 nmol/mg NADH 
at T1, whereas in the stationary growth phase (T2) the NAD+ level increased to  
1686.73 nmol/mg and the NADH level decreased to 10.31 nmol/mg. These values re-
sulted in a NAD+/NADH ratio of 37 at T1 and a clearly detectable accumulation of the 
NAD+ in the mutant strain cells at the stationary growth phase T2 by a factor of 164. 
Clearly, the rnfC mutant had to deficient NADH formation with an overall decreased 
NAD+ amount. A disturbed central energy metabolism can be concluded.  
 
4.4.4 Influence of the rnfC mutant on the formation of the toxins TcdA and TcdB 
The human pathogenic bacterium C. difficile has the ability to produce the toxins TcdA 
and TcdB. The production is strictly linked to the reductive part of the Stickland fermen-
tation (Bouillaut et al. 2013). The impact of RnfC subunit absence on toxin production 
was tested using the kit: „ELISA for the separate detection of Clostridium difficile Toxin 
A OR Toxin B in suspensions kit” (tgcBIOMICS GmbH; Bingen, Germany). The production 
of both toxins was determined seperately. For the test, both strains were grown in de-
fined CDMM until they reached the exponential (T1) and the stationary growth phase 
(T2) according to chapter 3.6.2. Afterwards, cells were separated from the growth me-
dium via centrifugation. The cell-free growth medium expected to contain secreted tox-
ins of both strains obtained at indicated time points was tested immunologically for the 
presence of toxins using a sandwich ELISA kit as described in chapter 3.6.5. In this test 
the toxins were detected by a colometric chemical reaction step driven by horse radish 
peroxidase coupled to antibodies specific for TcdA or TcdB. Afterwards the colometric 
reaction was stopped and the ODs at 450 nm and 620 nm were measured spectropho-
tometrically in a microtiter plate photometer Infinite® 200 (Tecan Group Ltd., Männe-
dorf, Switzerland). A standard and a negative control were also tested likewise. After-
wards, OD450-620 nm values were determined. The TcdA and TcdB concentration in each 
sample of five biological replicates was calculated using the standard in linear equation 






Figure 28: Toxin formation in the wildtype and the rnfC mutant strain. The toxin content (TcdA and 
TcdB) in the growth medium of the wildtype (CD630∆erm) (dark bar) and the rnfC mutant strain 
(CD630∆erm_rnfC636/637s::ermB) (bright bar) were determined in the exponential (T1) and stationary 
growth phase (T2). Using a colometric horse radish peroxidase-driven reaction in a sandwich ELISA by the 
measurement of OD450-620 nm the TcdA or TcdB concentrations were determined in the samples. The TcdA 
concentration in the growth medium of the wildtype at T1 was 0.016 ng/mL and 0.160 ng/mL at T2. In 
the rnfC mutant strain growth medium the TcdA concentration at T1 was 0.474 ng/mL and 0.164 ng/mL 
at T2. The TcdB concentration in the wildtype growth medium was 0.102 ng/mL at T1 and 0.094 ng/mL 
at T2. In comparison the TcdB concentration of the rnfC mutant strain at T1 was 0.099 ng/mL and  

















































































Figure 28 shows the amount of toxin TcdA and TcdB, which is released into the growth 
medium during cell growth of the different strains in CDMM. The concentrations of TcdA 
and TcdB in the medium of the wildtype (dark grey bar) and the rnfC mutant strain 
(bright grey bar) at the time points T1 and T2 are shown. The TcdA concentrations in the 
wildtype CD630∆erm growth medium were 0.016 ng/mL at T1 and 0.160 ng/mL at T2. 
In contrast, the TcdA concentrations in the growth medium of the rnfC mutant at T1 was 
0.474 ng/mL and 0.164 ng/mL in T2. Strikingly, the values measured at T1 show that the 
TcdA concentration in the growth medium of the mutant strain was 30-fold higher as of 
the wildtype. The figure also shows that the concentrations of TcdB formation did not 
vary significantly between the two strains. TcdB concentrations of 0.102 ng/mL at T1 
and 0.094 ng/mL at T2 were determined for the wildtype strain. The TcdB concentra-
tions in the growth medium of the rnfC mutant were 0.099 ng/mL at T1 and 0.083 ng/mL 
at T2. Obviously, the rnfC mutant strain leads to the re-programming of the central en-
ergy metabolism causing a drastic increase in TcdA formation. 
 
 
4.4.5 Changes in the metabolism of the rnfC mutant holistically measured by  
metabolomics, transcriptomics and proteomics 
Measured D-proline reductase activity levels, the NAD+/NADH ratio and the TcdA values 
indicated a major re-organization of the energy metabolism of C. difficile by the rnfC 
mutation. To obtained detailed insights into underlying data products and intermediate 
metabolites including cytoplasmatically metabolites, CoA derivates, exometabolites and 
volatile derivatives from different metabolic pathways were measured for both strains. 
For this purpose, both strains were grown under anaeobic conditions at 37 °C in defined 
medium CDMM as described above and the bacteria cells were harvested in the expo-
nential (T1) and in the stationary growth phase (T2). The resulting cell pellets were used 








The measurements of polar metabolites, volatile compounds and coenzyme A deriva-
tives were performed by GC-MS (Agilent GC-MSD system (Agilent Technologies, Santa 
Clara, USA)/ PAL RTC system (CTC Analytics AG; Zwingen, Switzerland)) or Agilent LC-
QTOF system (Agilent Technologies, Santa Clara, USA). Here, the measurements and the 
corresponding analyses of the resulting raw data were performed by Dr. Meina Neu-
mann-Schaal and Dr. Sabine Will (group of Dr. Meina Neumann-Schaal; Bacterial  
Metabolomics) at the DSMZ in Braunschweig. The data were provided in a MS Excel® file 
(Microsoft® Corporation, Washington, USA) (see digital appendix). Free amino acids in 
the growth medium were measured on a HPLC system (Agilent Technologies, Santa 
Clara, USA) following the protocol described by Trautwein et al. 2016; Dannheim et al. 
2017; Hofmann et al. 2018 (see chapter 3.6.6). The measurements and corresponding 
values were also performed and provided by Dr. Meina Neumann-Schaal and Dr. Sabine 
Will in MS Excel® (Microsoft® Corporation, Washington, USA). 
 
 
The analyzed metabolites in the wildtype and the rnfC mutant strain 
A total amount of 84 metabolites were found in the cell free extracts of both strains 
(wildtype CD630∆erm and rnfC mutant strain CD630∆erm_rnfC636/637s::ermB) at the 
time points T1 and T2 during the different growth phases. The data represent the mean 
values of five biological replicates and the fold changes were extracted (mean values of 
the peak areas of the rnfC mutant devided to mean values of the peak areas of the 
wildtype) at the time points T1 and T2. Subsequently, the compounds that were within 
a fold change threshold range of 0.67 to 1.5 at both time points were ruled out. Fold 
change values of compounds above 1.5 indicated a significant accumulation and values 
below the limit of 0.67 indicated a reduced presence in the rnfC mutant strain compared 
to the wildtype strain at T1 or T2 (see appendix and digital appendix). After applying this 








Figure 29: Heatmap of the determined fold changes (FC) of the values for metabolites extracted from 
the rnfC mutant strain CD630∆erm_rnfC636/637s::ermB in comparison to the wildtype CD630∆erm at 
time points T1 and T2. Shown are the fold change (FC) values (rnfC mutant versus wildtype) of the 56 GC-
MS measured metabolites of the rnfC mutant strain compared to the wildtype in the exponential growth 
phase T1 (upper row) and in the stationary growth phase T2 (lower row). By using the threshold values 
of FC 0.67 to 1.5 (grey) (indicating no significant change between mutant strain and wildtype) the  
metabolites were sorted according to their relative amount. The coloration shows the accumulation  
(FC > 1.5 and 2, red color) and the reduced amounts (FC < 0.67 and 0.2, blue color) of metabolites in the 
cell free extracts of the rnfC mutant strain compared to the wildtype strain. Here, the order of the me-
tabolites in the graph shows the development of the highly accumulated (FC > 2) to the reduced amounts 
of derivatives (FC < 0.2) at T1. The graph shows by far the highest accumulation of proline with FC of 60 
at T1. Followed by ribose (FC of 7.8) and phenylpyruvate (FC of 7.4). Compounds such as alanine (FC of 
0.05) or 3-(4-hydroxyphenyl)-lactate (FC of 0.1) at T1 were found highly reduced in the mutant strain. The 
highest accumulation of phenylpyruvate (FC of 7.9) and a reduced amount of tyrosine (FC of 0.2) in the 
mutant cell free extract compared to the wildtype was observed at T2. Acetoacetate was only present in 
the mutant strain at T2. 3-(4-hydroxyphenyl)-lactate, indole-3-acetaldehyde at T2 and hexanoate at T1 
were only present in the wildtype strain. The metabolites that were not found in both strains at T1 or T2 



































The figure 29 shows the heatmap of the 56 metabolites that were accumulated or de-
creased at T1 or T2 in the rnfC mutant strain compared to the wildtype. The values at T1 
begin with the most abundant metabolite, proline with an FC value of 60 and end with 
the most reduced metabolite of alanine (FC of 0.05). It is observed that metabolites like 
ribose (FC of 7.8), phenylpyruvate (FC of 7.4), adenine (FC of 6.1) and 3-phenyllactate 
(FC of 5.3) were significantly accumulated in the mutant strain in the exponential growth 
phase T1.  
Metabolites like phenylpyruvate (FCT1 of 7.4; FCT2 of 7.85), 3-phenyllactate (FCT1 of 5.3; 
FCT2 of 6.1) and fructose (FCT1 of 4.1; FCT2 of 2.6) were found highly accumulated in the 
rnfC mutant cell at T1 and T2, while tyrosine (FC of 0.2) and succinate (FC of 0.2) were 
found reduced at T2. Acetoacetate was also only detected in the rnfC mutant at T2. 
Nicotinic acid (FCT1 of 0.6; FCT2 of 0.4) and glycerol-3-phosphate (FCT1 of 0.6; FCT2 of 0.5) 
were found rarely present in the rnfC mutant at T1 and T2. In contrast hexanoate, 3-(4-
hydroxyphenyl)-lactate and indole-3-acetaldehyde were only present in the wildtype at 
T1 or T2. Derivates that were not found in both strains at the same time (T1 or T2) were 




The CoA-esters found in the wildtype and the rnfC mutant strain 
A total amount of 52 CoA-esters were found in the cell free extracts of the wildtype and 
the rnfC mutant strain at the time points T1 and T2. Subsequently, the identically tresh-
hold range as mentioned before were used and the corresponding fold change values 










Figure 30: Heatmap of the determined fold changes (FC) for CoA-esters extracted from the rnfC mutant 
strain CD630∆erm_rnfC636/637s::ermB in comparison to the wildtype CD630∆erm at the time points T1 
and T2. Shown are the fold change (FC) values (rnfC mutant versus wildtype) of the 41 LC-MS measured 
CoA-esters of the rnfC mutant in comparison to the wildtype in the exponential growth phase T1 (upper 
row) and in the stationary growth phase T2 (lower row). FC 0.67 to 1.5 (grey) (indicating no significant 
change between the rnfC mutant strain and wildtype). CoA-ester accumulation was determined by a  
FC > 1.5 and 2 shown in red color, while values of FC < 0.67 and 0.2 shown a reduced ester amount (blue 
color). Here, the accumulation of e.g. crotonyl-CoA (FC of 9.4), 3-hydroxyhexanoyl-CoA (FC of 7.5) and 
butanoyl-CoA (FC of 7.2) at T1 were visible. Derivatives such as pentanoyl-CoA (FC of 0.2) or 4-methylthio-
butyryl-CoA (FC of 0.3) at T1 were highly reduced in the rnfC mutant strain. Interestingly, hexanoyl-CoA 
was only present in the rnfC mutant strain at T1. CoA-esters that were not found in both strains at the 























The heatmap in figure 30 shows the fold changes of CoAs at T1 or T2 in the rnfC mutant 
strain compared to the wildtype. Here, 2-methyl-3-oxobutanoyl-CoA (FC of 6.0), 2-
isocaprenoyl-CoA (FC of 5.4) and acetoacetyl-CoA (FC of 3.3) were found highly accumu-
lated in the mutant strain at T1. In contrast, pentanoyl-CoA (FC of 0.2), 4-methylthio-
butyryl-CoA (FC of 0.3) and 2-pentenoyl-CoA (FC of 0.3) were only present in highly  
reduced quantities. At T2 lactoyl-CoA (FC of 4.1), 3-hydroxypentanoyl-CoA (FC of 4.0), 
hexenoyl-CoA (FC of 2.7), phenylacetyl-CoA (FC of 2.3) and propanoyl-CoA (FC of 2.1) 
were accumulated and NADH (FC of 0.3), hexanoyl-CoA (FC of 0.4) and ATP (FC of 0.4) 




Figure 31: The heatmap of the determined fold changes (FC) of volatile acids extracted from the rnfC 
mutant strain CD630∆erm_rnfC636/637s::ermB in comparison to the wildtype CD630∆erm at T1 and 
T2. Shown are the FC values of the 15 GC-MS measured volatile acids of the rnfC mutant strain in 
comparison to the wildtype at T1 (upper row) and at T2 (lower row). By using the threshold values  
FC 0.67 to 1.5 (grey) volatiles out of that range were focused in more detail. Here, 3-methyl-1-butanol 
(FC of 1.6) at T1 and 4-methyl-pent-2-enoate (FC of 2.7) at T2 were highly accumulated in the rnfC 
mutant strain. Whereby, 2-methylpropanoate (FC of 0.4) at T1 and 2-methyl-1-propanol (FC of 0.1),  
1-propanol (FC of 0.1), 1-pentanol (FC of 0.1), ethanol (FC of 0.2) and 5-methyl-1-hexanol  
(FC of 0.2) at T2 were detected in a highly reduced amount in the rnfC mutant strain. Only  
1-butanol was found in the wildtype at T1 and with a highly reduced value at T2 in the mutant strain.  
 
NADH (FCT1 of 0.3; FCT2 of 0.3), ATP (FCT1 of 0.6; FCT2 of 0.4), NAD+ (FCT1 of 0.6; FCT2 of 
0.5), ADP (FCT1 of 0.6; FCT2 of 0.5), malonyl-CoA (FCT1 of 0.5; FCT2 of 0.6), (S)-2-methyl-
butanoyl-CoA (FCT1 of 0.5; FCT2 of 0.6) and acetyl-CoA (FCT1 of 0.4; FCT2 of 0.6) revealed 
reduced amounts in the rnfC mutant strain at T1 and T2 in comparison to the wildtype.   
In contrast, 3-hydroxybutanoyl-CoA (FCT1 of 5.6; FCT2 of 4.9), crotonoyl-CoA (FCT1 of 9.4; 
FCT2 of 4.1), phenyllactyl-CoA (FCT1 of 2; FCT2 of 3.2), 3-hydroxyhexanoyl-CoA (FCT1 of 7.5; 
FCT2 of 2.9), 3-phenylpropanoyl-CoA (FCT1 of 2.3; FCT2 of 2.7), butanoyl-CoA (FCT1 of 7.2; 
FCT2 of 2.5) and 4-hydroxyphenylacetyl-CoA (FCT1 of 2.3; FCT2 of 2.3) were found highly 
enriched in the mutant strain. Only hexanoyl-CoA was present in the rnfC mutant strain 
at T1.  
 
 
The volatiles of the rnfC mutant strain in comparison to the wildtype 
Furthermore, 20 volatile acids were found in the cell free extracts of the wildtype and 
the rnfC mutant strain and at the time points T1 and T2 during the different growth 
phases. Fold change values in consideration of the mentioned-above threshold were de-


















The figure 31 describes the determined fold change values for the detected volatile acids 
in the rnfC mutant strain compared to the wildtype at T1 and T2. It is evident that  
3-methyl-1-butanol (FC of 1.6) was highly accumulated at T1, while 2-methylpropanoate 
(FC of 0.4), propanoate (FC of 0.5), 2-methylbutanoate (FC of 0.5), 4-methylpentanoate 
(FC of 0.5) and 3-methylbutanoate (FC of 0.6) were present in reduced quantities at the 
same time. In the stationary phase (T2) 4-methyl-pent-2-enoate (FC of 2.7),  
4-methylpentanoate (FC of 2.4) and propanoate (FC of 1.6) were accumulated in the 
mutant strain. In contrast, 1-butanol (FC of 0.03), 2-methyl-1-propanol (FC of 0.1),  
1-propanol (FC of 0.1), 1-pentanol (FC of 0.1), ethanol (FC of 0.2) and 5-methyl-1-hexanol 
(FC of 0.2) were detected in reduced quantities in the rnfC mutant at the same time. 




The exometabolites and amino acids of the rnfC mutant strain compared to the wildtype 
Overall, 30 exometabolites were found in the growth medium of the rnfC mutant strain 
and the wildtype strain at T1 and T2. After applying the above-mentioned settings and 
thresholds (FC 0.67 to 1.5) 20 exometabolites were found significantly changed in the 
concentrations. Additionally, 12 amino acids and 5-aminovalerate were found in differ-
ent concentrations in the growth medium (FC values see appendix). Figure 32 shows the 















Figure 32: The heatmap of the determined fold changes (FC) of the exomatabolites and amino acids 
extracted from the growth medium of the rnfC mutant strain CD630∆erm_rnfC636/637s::ermB in com-
parison to the wildtype CD630∆erm at T1 and T2.  The figure shows the FC values of the 20 measured 
exometabolites, 12 amino acids and 5- amino valerate analyzed from the growth medium of the rnfC 
mutant in comparison to the wildtype at T1 (upper row) and at T2 (lower row). The threshold range were 
from FC 0.67 to 1.5 (grey) (indicating no significant change between mutant strain and wildtype). Com-
pounds with FC values > 1.5 (red) and < 0.67 (blue) at T1 or T2 were in the focus. Here, 2-oxo-isocaproic-
acid (FC of 5.1) and proline (FC of 7.6) at T1 were the highest accumulated compounds. Phenylacetate 
(FC of 0.4) and threonine (FC of 0.6) were observed in a reduced amount from the rnfC mutant strain 
growth medium at T1. In contrast, phenylpyruvate (FC of 7.9) and isoleucine (FC of 5.2) are highly accu-
mulated at T2 in the mutant strain. 4-hydroxybutanoate and 3-(4-hydroxyphenyl)-lactate at T1 and  
2-oxo-isocaproic-acid, (4-hydroxyphenyl) pyruvate, cysteine, 4-methylthio-2-oxobutanoate and threo-
nine at the time point T2 were found in the growth medium of the rnfC mutant strain but not in the 



























It is shown that acidic metabolites and amino acids like 2-oxo-isocaproic-acid (FC of 5.1), 
3-phenyllactate (FC of 4.7), (4-hydroxyphenyl) pyruvate (FC of 3.3), 2-hydroxybutanoate 
(FC of 2.3) and proline (FC of 7.6) were highly accumulated at T1 in the growth medium 
of the rnfC mutant strain. Phenylacetate (FC of 0.4), (4-hydroxyphenyl) acetate (FC of 
0.5), glutarate (FC of 0.5), histidine (FC of 0.5), threonine (FC of 0.6) and 5-aminovalerate 
(FC of 0.35) on the other hand were found in reduced quantities at T1. At T2, when the 




2-oxoglutarate (FC of 3.0) and hydrocinnamic acid (FC of 1.8) and the amino acids iso-
leucine (FC of 5.2), valine (FC of 2.5) and serine (FC of 2.4) were found accumulated in 
the growth medium of the rnfC mutant strain. It became also visible that 2-oxoglutarate 
(FCT1 of 2.3; FCT2 of 3.0) was highly enriched at T1 and T2. 
Interestingly, 4-hydroxybutanoate and 3-(4-hydroxyphenyl)-lactate at T1 and 2-oxo-
isocaproic-acid, (4-hydroxyphenyl) pyruvate, cysteine, 4-methylthio-2-oxobutanoate 
and threonine were only present in the growth medium of the rnfC mutant strain at T2. 





Transcriptomics and proteomics of the wildtype and the rnfC mutant strain 
 
For the comparative analyses of gene expression in the rnfC mutant strain 
CD630∆erm_rnfC636/637s::ermB versus the wildtype CD630∆erm transcriptomics and 
proteomics experiments were performed for both strains at the time points T1 and T2 
(see chapter 3.6.2). For transcriptomics, the RNA of the strains (at T1 and T2) were iso-
lated and followed by rRNA depletion and cDNA libraries construction according to the 
protocol described in chapter 3.6.6. Finally, the cDNA sequencing was performed using 
the Illumina NextSeq system with the NextSeq 500/550 High Output Kit v2.5 (75 cycles) 
(Illumina Inc, San Diego, USA). The software Rockhopper version 2.03 (McClure et al. 
2013; Tjaden 2015) was used to map the cDNA reads to C. difficile 630 genome. After-
wards, the mean value of five biological replicates were calculated and the log2 fold 
change of each transcript of the rnfC mutant strain against the wildtype at T1 and T2 
were determined (see digital appendix). After RNA isolation the further RNA sample 
treatment and cDNA libraries preparation/ measurements, RNA mapping, Rockhopper 
analyses and log2 fold change calculation were performed by Dr. Petra Henke and Dr. 
Sabine Will (group of Dr. Meina Neumann-Schaal; Bacterial Metabolomics) at the DSMZ 
in Braunschweig. Afterwards, the data were provided in MS Excel® (Microsoft® Corpo-
ration, Washington, USA) for further analyses.  
The total amount of transcripts found in the rnfC mutant strain and in the wildtype was 
1653. Transcripts with a low expression value (<2) for all strains at both time points and 




transporter, cell division/surface proteins, cold shock proteins, DNA ligase/gyrase, poly-
merases, hypothetical proteins, lipoproteins or multidrug resistance proteins were dis-
cared from the study. Ultimately, 1201 transcripts were analyzed closely.  
 
The proteomics was performed using samples from three biological replicates from both 
strains at T1 and T2 as described in chapter 3.6.6 by Dr. Josef Wissing and Hedwig 
Schrader at the HZI in Braunschweig (group of Prof. Dr. Lothar Jänsch; Cellular Proteome 
Research). In total, 1298 proteins were identified in the samples of the strains 
CD630∆erm_rnfC636/637s::ermB and CD630∆erm at T1 and 1567 proteins at T2. After-
wards, proteins with a unique peptide value > 1 and occurring in at least two biological 
replicates for one strain were analyzed more in detail. Therefore, 1004 proteins from T1 
and 1323 proteins from T2 were identified. The mean values and the log2 fold change 
factors of proteins from the rnfC mutant strain compared to the wildtype at T1 and T2 
were calculated (see digital appendix). 
 
Found proteins and their respective transcripts were further categorized into metabolic 
pathways or cell functions regarding to their relation to energy production in C. difficile 
and according to previously identified metabolic compounds and the results of the toxin 
ELISAs. Here, the enzymes responsible for the generation of certain compounds released 
in a specific metabolic step were determined via KEGG. Obtained log2 fold changes (log2 
FC) for the transcripts and abundant proteins for the rnfC mutant strain in comparison 
to the wildtype were included in the table 25 subdivided for the time points T1 and T2. 
Transcripts and proteins with a log2 FC value of 0 indicate an identical amount of both 
in the rnfC mutant and wildtype. Values > 0 indicate the upregulation of the respective 
gene or a higher protein abundance in the rnfC mutant strain. Consequently, log2 FC 
values for transcripts and proteins of < 0 indicate a gene down regulation or a low pro-









Table 25: Determination of the log2 fold changes (log2 FC) of transcripts and proteins for the rnfC 
mutant strain CD630∆erm_rnfC636/637s::ermB versus the wildtype CD630∆erm at the time points 










  T1 T2 T1 T2 
































































































D-proline → 5-amino pen-











D-proline → 5-amino pen-











Glycine reduction  glycine/sarco-
sine/betaine reduc-
tase complex pro-

















Glycine reduction glycine reductase 
complex compo-














Glycine reduction glycine reductase 
complex compo-





















Glycine reduction glycine reductase 
complex compo-


















Glycolysis/pyruvate metabolism and pentose phosphate pathway 
Acetyl-CoA →  
Acetoacetyl-CoA 
Acetoacetyl-CoA 























































Pyruvate ↔ Malate 
NAD-dependent 
malic enzyme  0.89 0.28 -0.18 
 
-0.60 
Acetyl-CoA ↔ Pyruvate 
Pyruvate-ferredo-
xin oxidoreductase 





Pyruvate ↔ L-Lactate 
L-lactate dehydro-
genase (ldh) -1.66 -1 - 
 
-1.57 
Glycerate-1,3-P2 ↔  
3-phosphoglycerate 
Phosphoglycerate 
kinase (pgk) -0.53 -0.75 0.17 
 
-0.88 























































Glucose-1-P ↔  
Glucose-6-P 
Phosphoglu-
comutase (pgm) 1.14 0.05 -0.35 
 
-1.04 







































































































































































































































































noyl-CoA (Butyryl CoA) 
Electron transfer 
flavoproteins subu-
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Metabolism of amino acids 
4-Hydroxyphenyl) 





















































































































































































































Table 25 shows the log2 FC values for proteins and their respective transcripts in the 
rnfC mutant strain at T1 and T2 in comparison to the wildtype. The analyses showed that 
during Stickland fermentation the proteins and corresponding transcripts of the Rnf 
complex (RnfB, RnfC, RnfD, RnfE and RnfG) were present in negligible quantities in the 
rnfC mutant strain at T1 and T2. Interestingly, the log2 FC protein values of the D-proline 
reductase subunits PrdA and PrdB at T1 indicated a reduced amount in the mutant strain 
while corresponding transcript values were higher than in the wildtype. At T2 the pro-
tein log2 FC values of PrdA and PrdB changed to 0 and indicated the identical protein 
quantities in both strains. The transcripts for both proteins increased at the same time 











































Glycerollipid, glyoxylate/ dicarboxylate, propanoate and pyrimidine metabolism 


















































Toxin production  Toxin A (tcdA) 1.38 2.55 2.33 0.93 


















In addition, the glycine reductase (GrdA, GrdB, GrdE and GrdC) subunits were found en-
riched in the rnfC mutant strain at T1 and mainly at T2. Most of the corresponding tran-
scripts showed only marginally changed log2 FC values in the mutant strain at T1, but 
very high amounts at T2. Further proteins and corresponding transcripts with significant 
changed log2 FC values from energy generation pathways (e.g. glycolysis, butanoate me-
tabolism) were also identified in the rnfC mutant strain in comparison to the wildtype.   
 
 
4.5 In vivo behavior of the rnfC mutant strain in a mouse model 
As described above, the rnfC mutant strain CD630∆erm_rnfC636/637s::ermB was tested 
in comparison to the wildtype in vitro using multi-omic experiments in order to deter-
mine the physiological role of RnfC in C. difficile 630∆erm. Next, the rnfC mutant strain 
was further tested in a mouse model and compared to the wildtype in terms of infection 
efficiency. For this purpose, a prepared spore suspension of the strains 
CD630∆erm_rnfC636/637s::ermB_pMTL82151rnfC-strep II (complemented strain), 
CD630∆erm_rnfC636/637s::ermB_pMTL82151 (rnfC mutant) and 
CD630∆erm_pMTL82151 (wildtype) was used to infect under sterile conditions (SPF) the 
mouse wildtype (WTBL/6-SPF1) line of the HZI in Braunschweig as described in chapter 
3.7. The experiments were performed by Dr. Nathiana Smit at the HZI in Braunschweig 
(group of Prof. Dr. Till Strowig; Microbial Immune Regulation).  
 
4.5.1 Single infection experiments of the rnfC-mutant strain, the rnfC-complemeted 
mutant strain and the wildtype in a mouse model 
Single infection experiments with the wildtype, rnfC mutant strain and rnfC-comple-
mented mutant strain were performed. For this purpose, the log CFU per gram stool in 
cecum, colon and feces of day 1 (D1) and day 3 (D3) after infection were determined. 
The approach differentiated heated (spores) or non-heated (vegetative cells) samples 





















































































































































































































































































Figure 33: Determined log CFU/gram stool content of cecum (D3), colon (D3) and feces (D1 and D3), 
separated into heated (spores) and non-heated (vegetative cells) samples after single mice infection 
experiments with the rnfC mutant strain (mutant), wildtype (630) and the rnfC-complemented mutant 
strain (complement). The single mouse infection experiments were performed with the wildtype strain 
(630), rnfC mutant strain (mutant) and the rnfC-complemented mutant strain (complement). The feces 
were collected on day 1 and 3 (D1; D3). The contents of the colon and cecum was isolated on day 3 post 
infection. The samples were prepared according to outlined protocols (see chapter 3.7). The samples 
were also divided into unheated and heated samples and were treated accordingly. The log CFU/gram 
sample was determined and graphically displayed with a detection limit (~3 CFU/gram). The values of all 
samples were above the detection limit except for the spore sample of the rnfC mutant in the feces on 
day 1 (D1) after the mouse infection. The infection experiments were performed and the illustration was 
generated by Dr. Nathiana Smit at the HZI in Braunschweig (group of Prof. Dr. Till Strowig; Microbial 






The figure 33 shows the log CFU/gram of the heated (spores) and non-heated (vegeta-
tive cells) stool content of the cecum, colon and feces of the rnfC mutant strain (mutant), 
wildtype (630) and rnfC-complemented mutant strain (complement) obtained after sin-
gle infection in the mouse model. The graphs are divided into data from cecum (D3), 
colon (D3) and feces content (D1/D3). The samples of the colon and cecum show that 
the log CFU/gram stool for the vegetative cells and the spores were above the detection 
limit (3 log CFU/gram stool). At an average between 5 and 6 log CFU/gram were de-
tected. In the feces of D3 all samples were above the detection limit, whereas the spores 
of the individual samples were at an average between 5 and 6 log CFU/gram. In contrast, 
the log CFU/gram of the vegetative cells of the individual strains wildtype (630), rnfC 
mutant strain (mutant) and the complemented strain (complement) showed deviating 
mean values in the range between 4 and 6.5 log CFU/gram. The rnfC mutant (mutant) 
with a value of ~4 log CFU/gram showed the lowest value, while the wildtype (630) re-
vealed the highest one (~6.5 log CFU/gram). In the feces depicted in D1 of the graph the 
vegetative cells of the individual strains revealed similarly high mean values in the range 
between 7 and 8 log CFU/gram. Interestingly, the spore samples of the various strains 
led to clearly different values. No spores were detected for the rnfC mutant strain post 
infection and the corresponding log CFU/gram value was below the detection limit. On 
average, the log CFU/gram values of the rnfC-complemented mutant strain and the 
wildtype were between 7 and 8 log CFU/gram. 
As clear differences of the various investigated strains were only observed at day 1 for 
the feces and the experiments were repeated. The identical experiments were per-
formed with only the complemented strain and the rnfC mutant strain and data ob-



























































































































































































































Figure 34: Determined log CFU/gram stool content of cecum (D1), colon (D1) and feces (D1), sepa-
rated into heated (spores) and non-heated (vegetative cells) samples after single mice infection ex-
periments with the rnfC mutant strain (mutant) and the rnfC-complemented mutant strain (comple-
ment). As described before single mouse infection experiments were performed with the strains rnfC 
mutant strain (mutant) and the rnfC-complemented mutant strain (complement). In contrast, the stool 
contents of the feces, colon and cecum were collected and analyzed at day 1 (D1) after infection. The 
samples were also seperated into unheated and heated samples and were treated accordingly. The log 
CFU/gram stool content was determined and illustrated with a detection limit around 3 CFU/gram. 
Interestingly, only the log CFU/gram values of the rnfC mutant spores in cecum, colon and feces were 
closely at the detection limit. The illustration and the infection experiments were performed by Dr. 
Nathiana Smit at the HZI in Braunschweig (group of Prof. Dr. Till Strowig; Microbial Immune Regulation) 




For the experiment outlined in figure 34 it is worth to be noted that all spore samples 
from cecum, colon and feces of the rnfC mutant strain (mutant) post infection (D1) 
showed log CFU/gram values close to the detection limit. In contrast, the rnfC-comple-
mented mutant strain (complement) showed log CFU/gram values above the detection 
limit in a range between 4 and 5 in colon, cecum and feces. The unheated samples, con-
taining the vegetative cells showed values of 6 until 7 log CFU/gram in colon, cecum and 
feces. 
 
4.5.2 Competition infection experiments of the rnfC-mutant strain in comparison to the 
rnfC-complemeted mutant strain in a mouse model 
In addition, competition experiments applying both strains, rnfC mutant and rnfC-com-
plemented mutant strain, were conducted in order to examine the germination and in-
fection behavior when the mouse was infected with both strains simultaneously. For 
this purpose, five mice were infected. Post infection samples were collected from feces 
(D1/D3), colon (D3) and cecum (D3) and further processed as described in chapter 3.7. 
The samples were heated (spore samples) or not (vegetative cells) and spread onto CLO 
plates (bioMérieux GmbH, Nürtingen, Germany). A total of 100 individual colonies per 
sample were observed. The identity of the colony as the rnfC mutant or complemented 
strain was tested by PCR (confirmation of plasmid DNA, see chapter 3.3.9). This ap-
proach was used to determine the presence of the plasmid pMTL82151 or 
pMTL82151_rnfC-strep II (see appendix) to check for the existence of corresponding 
specific strain in colon, cecum and feces with or without heating treatment in five repli-



































Figure 35: The absolute number of colonies found post infection in mice experiments performed with 
the rnfC mutant strain (mutant) and the rnfC-complemented mutant strain (complement). Shown is the 
distribution and the absolute number of the rnfC mutant strain (light grey bar) and its complemented 
strain (dark grey bar) detected by a PCR analyses of 100 single colonies (from 5 replicates) post co-infection 
in a mouse. The samples were taken from feces day 1 and day 3 from the mouse after co-infection with 
both bacteria strains (D1/D3). Colon and cecum samples of the co-infected mouse after day 3 (D3) were 
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RnfC mutant and complementary strain colonies of post co-infection  
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RnfC mutant and complementary strain colonies of post co-infection  




Figure 35 shows the absolute number of identified rnfC mutants (light grey bar) and rnfC-
complemented mutant strains (dark grey bar) in a total 100 tested individual colonies  
(5 replicates) from post co-infection experiments. Colonies from obtained feces at day 
1 and day 3 (D1/D3) from the colon (D3) and cecum (D3) were tested after heating (H; 
spores) and non-heating conditions (vegetative cells). It became evident that only on 
day 1 there were more vegetative cells and spores of the rnfC mutant (vegetative cells: 
89; spores: 86) in the feces compared to the rnfC-complemented mutant strain (vegeta-
tive cells: 11; spores: 14). On the third day in feces, colon and cecum there were more 
spores and vegetative cells of the rnfC-complemented mutant strain in the tested sam-
ples. Here, 88 spores and 73 vegetative cells of the rnfC-complemented mutant strain 
were found in feces D3 and 12 spores, whereas only 27 vegetative cells of the rnfC mu-
tant strain were found. In cecum 52 spores and 70 vegetative cells of the rnfC- 
complemented mutant strain were identified, while 48 spore colonies and 30 vegetative 
cells of the rnfC mutant were detected. The content of the colon showed 93 spore colo-
nies and 81 vegetative cells of the rnfC-complemented mutant strain and 7 spore colo-















5 Discussion  
The hospital-associated human pathogen C. difficile is an anaerobic organism that in-
habits the intestine and has the ability to cause diseases ranging from diarrhea over 
pseudomembranous colitis to toxic megacolon. Annually, several thousand people die 
as a result of Clostridioides difficile infections worldwide (Kachrimanidou and Tsintarakis 
2020; Czepiel et al. 2019; Rao and Safdar 2016). Therefore, research on this pathogen is 
essential for its containment. 
As strict anaerobic organism C. difficile is capable of generating energy in the absence of 
oxygen as electron acceptor. During this process it employs organic compounds which 
are broken down during a fermentation process producing ATP in turn (Bouillaut et al. 
2013). This is usually done via substrate-level phosphorylations, as observed for the 
Wood-Ljungdahl pathway (WLP) or butanoate fermentation pathway. Nevertheless, this 
organism is able to actively produce a chemiosmotic ion-gradient at the membrane. The 
ions Na+/H+ are generally transported by the Rnf-complex, which enables the ATP syn-
thase to phosphorylate ADP utilizing the produced gradient (Müller and Wiechmann 
2017; Aboulnaga et al. 2013).  
C. difficile conducts specialized amino acid fermentation, called Stickland fermentation 
which consists of an oxidative and a reductive branch. This study laid its major focus on 
the energy-relevant reductive branch in which C. difficile employs a variety of amino 
acids to produce ATP and NAD+. The enzyme D-proline reductase (Prd) uses D-proline as 
well as NADH to convert the substrate into 5-aminovalerate and NAD+ (Bouillaut et al. 
2013). The NAD+-dependent Rnf complex (Rhodobacter nitrogen fixation) generates 
NADH by the reduction of NAD+ and the oxidation of ferredoxin during electron transfer 
(Müller and Wiechmann 2017; Biegel and Müller 2010; Biegel et al. 2009). The sugges-
tion that the reductive Stickland pathway, specifically the D-proline reductase (Prd), and 
the Rnf complex might be associated with each other has already been briefly proposed 





In this thesis the protein-protein interaction between Prd and Rnf was determined for 
the first time by affinity chromatography coupled with LC-MS/MS and immunogold la-
beling based of electron microscopy. The production of a mutant strain, which no longer 
carries RnfC also enabled the elucidation of the adaptational metabolic rewiring when 
the complex is absent and the assessment of infection impairments in mouse models.  
 
5.1 The high-ordered ion translocating Rnf-proline reductase complex in the 
Stickland fermentation of C. difficile 630∆erm 
A manifold of protein-protein interactions studies have largely relied on the well-de-
scribed method of affinity chromatography coupled with LC-MS/MS. Interactome map-
ping is a valuable tool to provide information on the complexity and functionality of the 
cell (Gingras et al. 2007). Protein interactions within the reductive Stickland fermenta-
tion specifically between D-proline reductase and the membrane-bound Rnf complex 
were analyzed in detail using that approach. The bait proteins PrdA 
(CD630DERM_32440), PrdB (CD630DERM_32410), RnfB (CD630DERM_11420) and RnfC 
(CD630DERM_11370) were analyzed in a gel-based method with and without formalde-
hyde cross-linking treatment and in a quantitative gel-free approach. For the verification 
of a direct interaction, the subunits PrdA, RnfB and RnfC were investigated for co-local-
ization in the immunogold labeling experiment by transmission electron microscopy. 
 
5.1.1 Protein-protein interactions between the Prd and the Rnf complex in the gel-
based affinity chromatography coupled with LC-MS/MS 
In the first place, the successful purification of the baits PrdA, PrdB, RnfB and RnfC (gel-
based affinity chromatographed LC-MS/MS approach without a formaldehyde cross-link 
treatment) proved the reliability of the chosen experimental design: employment of na-
tive promoters and fusion of a C-terminal Strep-tag® II for anaerobic production. For the 
subunits of D-proline reductase, the relative protein detection via Western blot using  
C-terminal Strep-tag® II displayed a distinctive band at Mr of ~70.000 for PrdA  
(68.000) and of ~25.000 for PrdB (26.000) (see chapter 4.1.2, figure 17). The proof of 




elution fraction and vice versa. The LC-MS/MS was also used to confirm the presence of 
PrdA and PrdB at their respective elution fraction. It is worth to note that a smaller sub-
unit herein described as PrdA*, which might result from proteolytic processing of the 
major PrdA subunit was also visualized on the SDS-PAGE and identified by LC-MS/MS as 
well as by Western blot analysis. It has been reported that the Mr of 68.000 PrdA from 
clostridial species has a proteolytically susceptible cleavage site, which means that the 
complete PrdA is divided into two differentially sized proteolytic products (Mr of 23.000 
and 45.000) (Kabisch et al. 1999; Jackson et al. 2006). Conversely, the detection of the 
membrane-bound Rnf subunits revealed several bands of mostly lower molecular 
weight. Most likely the sensitive membrane proteins were subjected to degradation by 
the harsh purification steps and therefore several bands were determined at different 
relative molecular masses. Nevertheless, the results of the LC-MS/MS analyses also 
showed that the target proteins RnfB (Mr 35.000) and RnfC (Mr 48.000) were properly 
produced and purified (see chapter 4.1.3, figure 18). For a better protein purification 
efficiency, the corresponding protocol and especially the solubilization of the membrane 
proteins might be adapted e.g using different solubilization detergents instead of  
Triton X-100.  
Remarkably, the cytosolic subunit PrdA was co-purified from the soluble fraction along 
with the membrane complex subunit RnfC without the need of cross-linker treatment. 
This indicates strong assotiation of the RnfC and PrdA components. The elutions of the 
baits RnfB and RnfC also contained the PrdA subunit after protein purification and LC-
MS/MS analyses. In contrast, the bait PrdB under same conditions, did show any of the 
Rnf subunit. The possible direct interplay between the energy generation fermentation 
procecess and the Rnf complex has already been briefly mentioned by Neumann-Schaal 
et al. 2019. However, these results are determining for the first time a tight interaction 
of both subunits, which is conceivable if the subunit PrdA is responsible for the transfer 
of the electron acceptor NAD+ to the RnfC subunit during the D-proline conversion to 
generate NADH (NAD+-channeling). Bouillaut et al. 2019 postulates the Prd activity 
seems the major NAD+ regeneration pathway in C. difficile. In the light of this assump-
tion, the strong interaction of PrdA and RnfC could ensure a rapid NAD+/NADH regener-
ation as well as energy production and might prevent the loss of electron transfer during 




In contrast, protein-protein interactions specific to the membrane can be observed 
more easily after a cross-linker treatment. All four bait proteins were purified from the 
insoluble fraction of the cell free extract using the Strep-tag® II and analyzed by Western 
blot analyses and LC-MS/MS measurements. The results of the bait eluates (figure 19 
and 20) show that generally more Rnf subunits were found by using the affinity chroma-
tography LC-MS/MS approach and a previously in vivo cross-linker treatment with ex-
ception of the purified PrdB. Here, only very few identified proteins were detected in 
LC-MS/MS, but unfortunately no PrdB. However, these results show that the method 
might not be applicable to PrdB and alternatively indicate that PrdB does not interact 
with proteins at the membrane level, which was already previously visible without cross-
linking due to the missing Rnf association. Alternatively, the interactions may be weak 
or occurring transiently and were not stable enough, even not with a cross-linker treat-
ment.  
Both methods not only analyzed the direct interactions between the Rnf complex and 
Prd. Furthermore, abundant proteins that play an important role in the different energy 
generation pathways were identified bound to Prd and Rnf. The tables 18-21 in chapter 
4.1.6 show that bait protein containing eluates include a wide spectrum of co-purified 
proteins that participate in the reductive branch of Stickland fermentation e.g. glycine 
reductase (Grd), ATP synthase, bifurcating enzymes (e.g. Bcd2/Etf) and proteins from 
various energy generating pathways and fermentation processes e.g. butanoate metab-
olism (e.g. Cat2, Crt2). Thus, to achieve a more profound interactomic analysis in order 
to map to a larger extent protein-protein interaction taking place in a weak or transient 
manner, quantitative analyses were performed. This is discussed in the next chapter. 
However, from a global point of view it is visible that a formaldehyde treatment can be 






5.1.2 Quantitative interactomic analyses of Prd and Rnf using a gel-free affinity chro-
matography coupled with LC-MS/MS and their validation by electron microscopy 
co-localization studies 
The gel-free quantitative formaldehyde cross-link affinity chromatography coupled with 
LC-MS/MS approach of the bait-prey interaction of the target proteins PrdA, PrdB, RnfB 
and RnfC were determined as described in chapter 3.5.6. Prey proteins which were 
closely identified with a high abundance after the above-mentioned approach from a 
total of 810 identified proteins are described in chapter 4.2.1. Figure 21 shows that most 
of these preys were found in all four baits eluates. Due to the different settings applied 
(unique peptides ≥ 2, protein coverage ≥ 5 %, excluding generic proteins) and the con-
centration normalization (0.24 mg/mL), the prey proteins were categorized according to 
Stickland fermentation, butanoate metabolism, fatty acid metabolism, glycolysis, pen-
tose phosphate pathway, pyruvate metabolism and TCA cycle and their functionality 
(e.g. ATP synthase subunits, electron transfer proteins, PTS system, cellular processes). 
By highlighting the enrichment factor in table 22-23 in chapter 4.2.1, strong (dark blue), 
moderate (bright blue) and weak transient interaction (grey) can be quickly spotted.  
In conclusion, the table shows strong to moderate transient interactions between the 
components of D-proline reductase and the Rnf complex. Especially, the chromato-
graphed bait samples RnfB and RnfC showed subunits of the D-proline reductase bound 
with a high abundance which is evidenced by the very high enrichment factor and indi-
cating a strong interaction. Since the prey proteins were purified natively and the for-
maldehyde treatment takes place in vivo, it might also be the case that preys adopted 
different oligomeric states (dimer/trimer) when binding to the bait protein to different 
extents. The analysis of the PrdA, on the other hand, showed a moderate to weak inter-
action with the Rnf complex depending on the subunits studied, but also with the subu-
nit PrdB.  
Obtained results were supported by the immunogold labeling electron microscopy ex-
periments. As seen in chapter 4.3, the TEM images showed a co-localization between 
Prd and Rnf which based on a semi-quantitative analyses, occured mainly at the mem-
brane. Microscopic analyses clearly demonstrated that there is a strong and direct in-
teraction between Prd and Rnf which leads to the assumption that these proteins were 




C. difficile to generate a chemiosmotic ion-gradient. Whether this complex was perma-
nently present in the cell as it is the case for the ATP synthase (De Las Rivas and Fon-
tanillo 2010) should be further studied in future experiments. Potentially, taking sam-
ples at different time points of the cell growth could also help to clarify this aspect. The 
protein composition of an observed multimeric species could also be investigated by 
using size-exclusion chromatography (SEC) coupled with multi-angle laser light (MALLS) 
(Mahler et al. 2009). 
Regarding the other identified prey proteins, the enzyme glycine reductase (Grd), which 
is also of high importance during reductive Stickland fermentation (Bouillaut et al. 2013), 
revealed a strong to moderate interaction to the Rnf complex components and medium 
to weak interaction to the Prd subunits. Furthermore, transient interactions were found 
of the Rnf complex with both types of the ATP synthase (F-type and V-type) and with 
electron transferring flavoproteins (Etf) of the bifurcating protein complex (Etf/Bcd) and 
also iron-dependent/transporting proteins. As previously explained, the Rnf complex is 
able to form a chemiosmotic ion-gradient at the membrane, which in turn can be used 
by the ATP synthase for ADP phosphorylation (Müller and Wiechmann 2017). Here, the 
Rnf complex in C. difficile interacted particularly strong with most of the subunits of both 
ATP synthase types. A direct interaction is conceivable, because the Rnf-ATPase super-
complex in Thermotoga maritima has already been published very recently (Kuhns et al. 
2020). Whereby the complex between Rnf and ATP synthase was discovered in liposome 
experiments (Kuhns et al. 2020), which could also be used to verify the interaction be-
tween both complexes in C. difficile. 
Furthermore, it is also known that in a variety of anaerobic bacteria including clostridial 
species, electron bifurcating protein complexes such as flavoprotein/butyryl-CoA dehy-
drogenase (EtfAB/Bcd) (Demmer et al. 2017) contribute to energy conservation. Elec-
trons are sinked into the butanoate metabolism resulting in reduced ferredoxins which 
are oxidized at the Rnf complex (specifically RnfB) coupled to electron transfer. The elec-
tron acceptor NAD+ is reduced and NADH regenerated via the subunit RnfC (Aboulnaga 
et al. 2013; Bertsch et al. 2013; Neumann-Schaal et al. 2019; Köpke et al. 2010; Chow-
dhury et al. 2016; Buckel and Thauer 2018). This functional arrangement explains these 




this components fosters the electron flow. The potential electron transfer and a rapid 
NADH/NAD+ generation would also allow for the production of an ion-gradient at the 
membrane without time limitations and energy depletion, and thus the ATP synthase 
could provide ATP to the cell more promptly.  
In general, the ion translocating function of the Rnf complex is sustained by electron 
transport driven by iron sulfur clusters as cofactors (Kuhns et al. 2020; Chowdhury et al. 
2016). An interaction of iron transporting proteins with the Rnf-Prd complex seems to 
be essential for the further maturation of involved cluster-coordinating enzymes. For 
instance, this thesis revealed the assoziation of the membrane bound protein subunit 
FeoB, which transports ferrous iron (Hastie et al. 2018; Lau et al. 2016) into the cell, and 
was identified as a potential interactor of the Rnf-Prd complex. 
Preys, which are part of alternative fermentation pathways (e.g. butanoate metabolism) 
and energy supplying processes were already observed in the gel-based experiment. The 
gel-free quantitative experiment identified enzymes such as Crt2, Cat2, Acc, Adh, LdhA, 
Fba, GapN, Buk2, PycA, PflE, Pyk, Tkt` or SucD to strongly interact with the core Rnf-Prd 
complex. Moreover, mostly moderate to weak interactions of these enzymes with the 
D-proline reductase were encountered. The interaction observed to other sorts of fer-
mentation-related proteins involved in alternative NAD+ regeneration systems (e.g bu-
tanoate metabolism (Bouillaut et al. 2019)), might ensure a seamless and rapid electron 
and NAD+ cofactor transport from found enzymes to the Rnf-Prd complex. That could be 
a benefit under conditions of NAD+ limitation if the Prd activity is reduced (e.g by a nu-
trient lack), which was postulated as the priority regeneration system of NAD+ in C. dif-
ficile (Bouillaut et al. 2019).  
In conclusion the analyses of the interaction partners of the membrane-bound Rnf-Prd 
complex, specifically of the Rnf part, provided the strong evidence for the existence of a 























Since this supercomplex, in combination with the ATP synthase and other energy-
providing systems, delivers energy to the cell, the significance and importance of the 




Figure 36: High-ordered ion translocating Rnf-Prd supercomplex in C. difficile. Shown are the most likely 
strong, direct interactions between D-proline reductase (green compounds) and the membrane-bound 
Rnf complex (grey compounds) identified by affinity chromatography coupled with LC-MS/MS and elec-
tron microscopy. Additional, interactions have been identified to proteins which belong to the two ATP 
synthase types (red compounds) or which are involved in reductive Stickland fermentation, other fer-
mentation pathways (e.g. butanoate metabolism), and in several energy producing processes 
(brown/blue compounds). Interactions concerning iron transport/containing proteins were also identi-
fied (orange compounds). Also, some of these transient interactions are represented by the dotted line 




5.2 Metabolic rearrangements caused by a non-functional Rnf-Prd complex 
in C. difficile   
For the better understanding of the impact of the RnfC subunit on the Rnf-Prd complex 
assembly and functionality, and its influence on the overall metabolism, a rnfC mutant 
strain was generated and regarding to this characterized. 
 
5.2.1 The restricted cell growth of the rnfC-lacking C. difficile strain 
The mutation of the rnfC causes the disruption of the Rnf-Prd complex and abolishes its 
functionality. Firstly, the mutant strain presented an arrested growth behavior com-
pared to the wildtype (figure 25). This is shown by a rather longer restricted exponential 
growth phase of the mutant strain. Finally, it reaches a lower maximum optical cell den-
sity. Depriving C. difficile of its RnfC subunit apparently results in an inefficient energy 
supply which is reflected by its diminished growth. The rnfC mutant strain also shows 
morphological differences (figure 26), like an abnormal formation of the flagellar appa-
ratus or the stacking of secreted proteins on the cell surface. Further experiments such 
as a swimming motility assay would provide critical information about the functionality 
of the flagella. However, a deeper look into the cell and into the metabolic behavior via 
the multi-omic assays (metabolomic, transcriptomic, proteomic) and the determination 
of the D-proline reductase activity, NAD+/NADH ratio in the cell and the concentration 
of secreted toxins, helped to shed light on the rnfC mutant physiology at different levels.  
 
5.2.2 Influence of a non-functional ion translocating Rnf-Prd complex on the reductive 
Stickland fermentation 
Proteomic and transcriptomic analyses of the rnfC mutant versus the wildtype revealed 
a drastically decreased amount of all rnf operon transcripts and a corresponding lower 
protein abundance (table 25). Only the partial rnfC transcripts were found enriched in 
the transcriptomic assessment. A higher amount of rnfC transcripts compared to a sig-
nificantly reduced protein amount could be explained by the partial transcription of this 
gene, which is disrupted in the middle by the introduced intron eluding thereby transla-




prevented the transcription of the downstream genes which means that the subsequent 
rnf genes were not transcribed and therefore not translated efficiently.  
However, the absence of the entire Rnf complex seemed to be detrimental to the  
D-proline reductase maturation as significantly reduced amounts of the subunits PrdA, 
PrdB or PrdF (table 25) were found by proteomics especially in the exponential growth 
phase. This is a hint to the dependence of the components of the Rnf-Prd complex in 
their formation. Interestingly, the prd genes were found upregulated and the amount of 
transcripts were higher than in the wildtype (at T1/T2) which might an indicative of a 
transcriptional compensatory effect elicited by the cell, although it was mirrored ineffi-
ciently at the protein level. The reduced D-proline reductase protein amount in the ex-
ponential growth phase led to an associated reduced 5-aminovalerate formation com-
pared to the wildtype which became obviously visible in the Prd activity test (figure 27) 
and in the exometabolome/amino acid and 5-aminovalerate measurements (figure 32). 
In addition, the reduced enzyme amount is responsible for the very high intracellular 
and extracellular D-proline accumulation compared to the wildtype (figure 29 and 32). 
In the stationary growth phase, the genes of Prd were upregulated and the amount of 
Prd proteins increased almost to the wildtype enzyme amount (table 25). This phenom-
enon was not accompanied by enhanced D-proline reductase activities in the stationary 
growth phase as shown in figure 27 at T2, presumably due to a malformation of the Prd 
complex which led to its impared functioning. Bioinformatic analyses using the KEGG 
database indicated that D-proline can be converted back to proline and then to 4-hy-
droxyproline or 1-pyrroline-5-carboxylate and may be metabolized in other metabolic 
processes. Furthermore, via lysine degradation the 5-aminovalerate can be formed and 
that might explain to a certain extent the extracellular product amount in the rnfC mu-
tant strain in the stationary growth phase (figure 32). 
It is also evident that glycine reductase (Grd) was influenced by the loss of function of 
the Rnf-Prd complex as the genes for grdA, grdB, grdE and grdC were found upregulated 
(table 25). The corresponding proteins were partly more abundant in both growth 
phases than in the wildtype. The slightly increase of intracellular glycine in the mutant 
strain in the exponential growth phase which was then reduced in the stationary growth 




Rnf-Prd complex loss. The ADP phosphorylation during acetate formation in the Grd 
pathway of the Stickland fermentation (Bouillaut et al. 2013), whose amount does not 
differ intracellularly from the wildtype neither in the exponential nor in the stationary 
growth phase (see digital appendix), also proved that the Grd pathway is not restricted 
by the rnfC mutation. Since, the acetate in the mutant strain was not significantly higher 
as in the wildtype, the Grd pathway does not appear to be compensating for the lack of 
the Rnf-Prd complex. 
In summary, these results show that the rnfC mutation led to a loss of the membrane-
bound Rnf complex. However, it is still unclear how the rnfC mutant compensated for 
this metabolic malfunctioning and preserved, although to lower extend energy conser-
vation. Therefore, the Omic studies were performed in order to identify the alternative 
ways of supplying energy. 
 
 
5.2.3 The alternative routes of energy production with an inactive Rnf-Prd complex con-
taining in the rnfC mutant strain 
Prd in the reductive Stickland fermentation generates NAD+ as electron acceptor for the 
Rnf complex through its enzymatic D-proline conversion. This pathway is the main one 
for NAD+ production in C. difficile (Bouillaut et al. 2019). Therefore, by limiting Prd func-
tion a reduced amount of the NAD+ in the cell was presumed. In turn, the lack of RnfC 
should lead to diminished NADH formation. Therefore, abnormal NAD+/NADH ratios 
were expected in the mutant. Surprisingly, the data of the NAD+/NADH ratio measure-
ment (table 24) show that in the exponential growth phase the mutant strain contained 
almost identical amounts of NAD+ as the wildtype which suggests that alternative NAD+ 
generating systems (such as the butanoate metabolism (Bouillaut et al. 2019)), must be 
activated in order to compensate for the D-proline reductase. Looking at the NADH value 
the rnfC mutant strain also produced almost twice as much NADH compared to the 
wildtype at the same growth phase. Here, existing NADH can be generated e.g. via the 




The ratios were reversed in the stationary growth phase. The rnfC mutant strain re-
vealed a 164-fold increased NAD+/NADH ratio in comparison to the wildtype. This un-
derscores the importance of NADH regeneration by the RnfC complex. Furthermore, the 
NAD+/NADH ratio indicated that previously formed NAD+ can be alternatively reduced 
to NADH, e.g. in the oxidative Stickland metabolism (figure 5), which is obviously not the 
primary pathway for NADH regeneration. These results may imply that the Rnf-Prd com-
plex is the primary pathway for NAD+/NADH homeostasis in C. difficile.  
Regarding the alternative NAD+ regeneration systems, the butaonate pathway, which is 
mainly activated in case of redox stress and nutrient starvation is worth to be mentioned 
(Bouillaut et al. 2019). During the employed nutrient-rich conditions the rnfC mutant 
strain presented a significant activation of this pathway and therefore the formation of 
NAD+ can be observed already in the exponential growth phase. Thus, most of the buta-
noate metabolism intermediates were intracellularly accumulated. Moreover, most of 
the proteins involved in butanoate metabolism were found highly abundant in the cell 
in the exponential and less of them in the stationary growth phase. The link between 
that activated pathway, especially the formed product butyrate, and the toxin regula-
tion was mentioned by Karlsson et al. 2000 and Bouillaut et al. 2019. In this case, the 
results revealed the activation of the butanoate pathway and therefore the accumula-
tion of compounds, which may influence the toxin formation. This became clear in the 
toxin ELISA experiment. Directly or indirectly, the upregulation of the butanoate path-
way appeared to have a strongly activating influence on TcdA formation, especially in 
the exponential growth phase, but not on TcdB production (figure 28). It is likely that 
the enzymes involved in butanoate metabolism or its related by-products had a gene 
regulatory influence on TcdA synthesis. This might exclude the final product butyrate, 
whose concentration did not differ highly from that of the wildtype (see digital appen-
dix).  
Also noticeable was the high accumulation of various amino acids in the exponential 
growth phase (figure 29), which was mostly reversed in the stationary growth phase. 
These include amino acids such as tyrosine, isoleucine, leucine, lysine, serine and valine. 
Also, many proteins which are involved in amino acid metabolism were found abundant 




providing sources as their conversion leads to different metabolic intermediates like py-
ruvate, oxaloacetate or 2-oxoglutarate and the synthesis of ATP via the corresponding 
pathways (Halsey et al. 2017). Especially the relevant electron donors isoleucine, alanine 
and leucine are used in oxidative Stickland fermentation for ATP generation (Bouillaut 
et al. 2013). In this context, the results show that the rnfC mutant strain was able to 
generate ATP via substrate-level phosphorylation e.g. in an upregulated oxidative Stick-
land fermentation. Whether the substrate-level phosphorylation derived ATP is ade-
quate for cell physiological maintenance remains still unclear.  
In a variety of pathogenic bacteria like Vibrio cholerae there are other known closely 
related ion-transporting complexes such as NADH:quinone oxidoreductase (Na+-NQR) 
(Juárez and Barquera 2012; Häse et al. 2001). In C. difficile the corresponding enzyme is 
annotated as Hym like protein (CD630DERM_34050; CD630DERM_34060; 
CD630DERM_34070), which was also identified in the proteome data set (see digital ap-
pendix), but not as abundant as in the wildtype. Nevertheless, this complex could be 
used to transfer ions across the membrane to generate a chemiosmotic ion-gradient by 
NADH conversion. Obviously, C. difficile did not maintain an effective chemiosmotic ion-
gradient using this alternative pumping system in the rnfC mutant strain (figure 25).  
Finally, the Omics experiments using the rnfC mutant strain revealed a significant effect 
of the rnfC mutation on energy production and the corresponding electron conversion 
pathways in the cell. The next figure illustrates metabolic changes in relevant fermenta-
tion and energy-producing pathways, which were discussed before, in the rnfC mutant 











Figure 37: Measured metabolic changes specific to the Stickland fermentation, glycolysis, TCA cycle and 
butanoate metabolism between the exponential (T1) [A] and stationary (T2) [B] growth phase of the 
rnfC mutant strain in relation to the wildtype. Shown is the most important metabolic changes in the 
energy production pathways in the rnfC mutant strain in relation to the wildtype at T1 [A] and T2 [B]. 
Accumulated (red) or reduced (blue) intermediates or with no changes (treshhold range [FC: 0.67-1.5]; 
black) are shown in the respective color code. Enzymes (partly at the arrows) and associated transcripts 
(dots) which were found highly abundant (log2 FC > 0; red), reduced (log2 FC < 0; grey) or without modi-
fication (log2 FC = 0; black) are illustrated. Intermediates which were not formed in the mutant strain in 
relation to the wildtype are shown in bright blue. Unidentified compounds were shown for completeness 
(orange). Metabolic changes induced by the lacking Rnf complex are visible e.g. in the reductive Stickland 
fermentation, an upregulation of the butanoate metabolism, TCA cycle and the phenylalanine degrada-































All results taken together provide strong evidence that the disruption of a functional 
Rnf-Prd supercomplex has a remarkable metabolic effect on the cell. Finally, it is note-
able that an anaerobic lifestyle without a functional Rnf-Prd complex is viable on the 
expenses of energy losses and extensive phyisiological re-adjustments. 
 
5.3 The negative influence on infection process by a non-functional Rnf-Prd 
complex tested in a mouse model 
 
Finally, individual infection experiments in the mouse model with the rnfC mutant strain 
and the rnfC-complemented mutant strain showed a drastic difference specifically at 
day 1 after infection. While the complemented strain resembled the expected wildtype 
behavior (figure 33) produced spores in the cecum, colon and feces at the first day after 
infection, the mutant was unable to sporulate in the different samples (figure 34). Nev-
ertheless, CFU counting resulted in similar numbers of vegetative cells for both strains 
in all samples (figure 34). This might imply that the rnfC mutant is highly restricted in the 
sporulation process as a result of a reduced mode of energy generation. Alternatively, 
important metabolic signal molecules involved in sporulation were missing. It is also 
likely that germination is diminished for this mutant. Specific experiments on the germi-
nation process with the use of bile acids (Sorg and Sonenshein 2008) in comparison with 
the rnfC-complemented mutant strain could provide further insights into this aspect. 
In order to determine the competitive fitness of both strains, they were subjected to a 
co-infection experiment in a mouse model. The experiment demonstrated obviously 
that at day 1 after co-infection mainly rnfC mutant spores but also vegetative cells were 
excreted. This ratio was reversed at day 3 which was also mirrored by the gut samples 
(figure 35). Obviously, the co-infection negatively impacted the fitness of the rnfC mu-
tant strain. Since many spores were found excreted here, a germination defect was con-
cluded for the rnfC mutant strain. 
Interestingly, vegetative cells of the rnfC mutant were also excreted after co-infection 
at day 1, which did not have any germination defects (figure 35). In comparison to the 




excreted, which indicated that the mutant cells were suppressed by the fitter rnfC-com-
plemented mutant strain and did not colonize effectively the gut. Obviously, the vege-
tative rnfC mutant cells were no longer able to adhere sufficiently to the epithelial cells, 
which may be caused by the abnormal flagellar morphology already visible by SEM  
(figure 26).  
However, only few rnfC mutant cells succeed and were identified in the samples at day 
3. The weakness of colonization of the C. difficile rnfC mutants in the gut has also been 
observed before with a prdB mutant strain (Battaglioli et al. 2018), which supports the 
claim that there is a correlation between effective colonization and an intact Rnf-Prd 
complex. Hence, in order to investigate observed defects, further adherence surface ex-
periments and moltility assessment studies with the rnfC mutant strain might enlighten 









Metabolic processes are central to toxin formation and corresponding infection success 
of the Gram-positive, anaerobic gut pathogen C. difficile. The bacterium utilizes a unique 
amino acid-based fermentation (Stickland reaction) in conjunction with a membrane-
spanning ion-pumping Rnf complex for ATP generation. Here, it was demonstrated by 
interactomics that one of the major enzymes of the reductive Stickland fermentation  
D-proline reductase forms a stable supercomplex with the Rnf complex. Other enzymes 
of Stickland fermentation (subunits of the glycine reductase), of ATP generation (F-type 
and V-type ATPase), of electron bifurcation (Bcd2/Etf), butanoate metabolism  
(e.g. Buk2, Cat2, Crt2 and SucD), glycolysis (e.g. Fba, Gap and Pyk) and the TCA cycle  
(e.g. PycA) are also members of the supercomplex.  
Correspondingly, a still viable rnfC mutant strain contained an almost inactive D-proline 
reductase, showed changes in cell morphology, flagella formation and toxin production. 
Detailed holistic Omics-based analyses of compensatory changes in gene regulation, the 
protein inventory and metabolite composition revealed a significant reprogramming of 
the overall cell physiology. The NAD+/NADH ratio was imbalanced, a compensatory up-
regulation of the butanoate metabolism and TCA cycle as well as changes in the amino 
acid pathways were observed. Finally, the rnfC mutant strain showed clear cut defects 
in the colonization of the host as tested in a mouse model. In summary, obtained results 
underscores the importance of the Rnf-proline reductase supercomplex for the infection 
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Figure 38: Illustration of the vector pMTL82151. Shown is the commercially available vector 
pMTL82151 ((Heap et al. 2009)/CHAIN Biotechnplogy Ltd; Nottingham, UK) with a size of 5354 
bp, which was used as the basis for cloning steps of the constructs: pMTL82151prdA-strep II, 
pMTL82151prdB-strep II, pMTL82151rnfB-strep II and pMTL82151rnfC-strep II (vector card: digital  
appendix). The vector has the following features: Binding sites for the general primers M13, traJ and 
oriT ((ColE1) Gram-negative replicon), ori (pBP1, Gram-positiv replicon), catP (Cm resistance) and lacZ. 































Figure 39: SDS-PAGEs of the baits PrdA [A] and PrdB [B] from C. difficile 630∆erm_pMTL82151prdA-
strep II and C. difficile 630∆erm_pMTL82151prdB-strep II after affinity chromatography of the corre-
sponding soluble fraction of the cell free extract. The different samples of the Strep-tagged affinity 
chromatographed bait proteins were loaded on a 15 % SDS-PAGE and separated according to their 
relative molecular masses at 45 mA for 45 min. The gel was stained with InstantBlue® Protein Stain 
(Expedeon Ltd, Cambridge, UK) solution. M: 5 µL PageRuler™ (Plus) Prestained Protein Ladder (Thermo 
Fisher Scientific, Schwerte, Germany); lane 1: 7 µL of the cell-free extract after ultracentrifugation 
(soluble fraction); lane 2: 7 µL flowthrough of the Strep-Tactin® column (Strep-Tactin® Superflow® high 
capacity, IBA Lifesciences, Göttingen, Germany); lane 3-7: 10 µL wash fractions 1 to 5; lane 8: 10 µL of 
the elution fraction of the bait protein PrdA [A] or PrdB [B]; lane 9: 10 µL of the 60-fold concentrated 
elution fraction of the bait protein; lane /: empty lanes. The PrdA encoding plasmid was constructed 
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8.2 SDS-PAGEs of the baits PrdA, PrdB, RnfB, RnfC and the wildtype in ab-































Figure 40: SDS-PAGEs of the baits RnfB [A] and RnfC [B] from C. difficile 630∆erm_ pMTL82151rnfB-
strep II and C. difficile 630∆erm_ pMTL82151rnfC-strep II after affinity chromatography of the solu-
ble fraction [RnfC] and insoluble fraction [RnfB] of the cell free extract. The samples of the protein 
purification were loaded on a 15 % SDS-PAGE and separated according to their relative molecular 
masses for 45 min at 45 mA. The gel was stained with InstantBlue® Protein Stain (Expedeon Ltd, Cam-
bridge, UK) solution. M: 5 µL PageRuler™ (Plus) Prestained Protein Ladder (Thermo Fisher Scientific, 
Schwerte, Germany); lane 1: 7 µL of the solubilized insoluble fraction in [A] or 7 µL of the cell-free 
extract after ultracentrifugation (soluble fraction) in [B]; lane 2: 7 µL flowthrough of the Strep-Tactin® 
column (Strep-Tactin® Superflow® high capacity, IBA Lifesciences, Göttingen, Germany); lane 3-7: 10 
µL wash fractions 1 to 5; lane 8: 10 µL of the elution fraction of the bait protein RnfB [A] or RnfC [B]; 



























































Figure 41: SDS-PAGEs of the affinity chromatographed wildtype proteins from C. difficile 
630Δerm_pMTL82151 of the soluble fraction [A] and insoluble fraction [B]. The affinity chromato-
graphed protein samples were loaded on a 15 % SDS-PAGE and separated according to their relative 
molecular masses for 45 min by 45 mA. The gel was stained with InstantBlue® Protein Stain (Expedeon 
Ltd, Cambridge, UK) solution. [A]: M: 5 µL PageRuler™ (Plus) Prestained Protein Ladder (Thermo Fisher 
Scientific, Schwerte, Germany); lane 1: 7 µL of the cell-free extract after ultracentrifugation (soluble 
fraction); lane 2: 7 µL flowthrough of the Strep-Tactin® column (Strep-Tactin® Superflow® high capac-
ity, IBA Lifesciences,Göttingen, Germany); lane 3-7: 10 µL wash fractions 1 to 5; lane 8: 10 µL of the 
elution fraction; lane 9: 10 µL of the 60-fold concentrated elution fraction; [B]: M: 5 µL PageRuler™ 
Prestained Protein Ladder (Thermo Fisher Scientific, Schwerte, Germany); lane 1: 10 µL of the 30-fold 
concentrated elution fraction after affinity chromatography of the insoluble fraction of the cell free 
extract from the wildtype C. difficile 630Δerm_pMTL82151; lane /: empty lanes. The SDS-PAGE of the 
insoluble fraction [B] were performed by Ilka Pusch during her master thesis (2018). 
 
 

























































Figure 42: SDS-PAGEs of the affinity chromatographed bait proteins PrdA [A] and PrdB [B] from  
C. difficile 630∆erm_pMTL82151prdA-strep II and C. difficile 630∆erm_pMTL82151prdB-strep II in 
presence of the cross-linker formaldehyde. The in-vivo cross-linked (formaldehyde; OD600 nm 1 = 0.156 
% crosslinker) and Strep-tagged affinity chromatographed bait proteins PrdA and PrdB from the insolu-
ble fractions were loaded on a 15 % SDS-PAGE, respectively. The proteins were separated according to 
their relative molecular masses at 45 mA for 45 min. Afterwards, the gel was stained with InstantBlue® 
Protein Stain (Expedeon Ltd, Cambridge, UK) solution. M: 5 µL PageRuler™ Plus Prestained Protein Lad-
der (Thermo Fisher Scientific, Schwerte, Germany); lane 1: 7 µL of the solubilized insoluble fraction; lane 
2: 7 µL flowthrough of the Strep-Tactin® column (Strep-Tactin® Superflow® high capacity, IBA Lifesci-
ences, Göttingen, Germany); lane 3-7: 10 µL wash fractions; lane 8: 10 µL of the elution fraction of the 
in-vivo cross-linked bait PrdA [A] or PrdB [B]; lane 9: 10 µL of the 30-fold concentrated elution fraction 
of the different bait. The PrdA plasmid was constructed and the purification steps were performed by 
Ilka Pusch during her master thesis (2018). 
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8.3 SDS-PAGEs of the baits PrdA, PrdB, RnfB and RnfC in presence of the 
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Figure 43: SDS-PAGEs of the fromaldehyde cross-linked bait proteins RnfB [A] and RnfC [B] after 
affinity chromatography of the insoluble fraction from C. difficile 630∆erm_ pMTL82151rnfB-strep II 
and C. difficile 630∆erm_ pMTL82151rnfC-strep II. The cross-linked (formaldehyde; OD600 nm 1 = 0.156 
% crosslinker) baits RnfB and RnfC after the Strep-tagged affinity chromatography of the insoluble 
fraction were loaded on a 15 % SDS-PAGE. The seperation of the proteins according to their relative 
molecular masses were performed at 45 mA for 45 min. The gel was stained with InstantBlue® Protein 
Stain (Expedeon Ltd, Cambridge, UK) solution. M: 5 µL PageRuler™  Prestained Protein Ladder (Thermo 
Fisher Scientific, Schwerte, Germany); lane 1: 7 µL of the solubilized insoluble fraction; lane 2: 7 µL 
flowthrough of the Strep-Tactin® column (Strep-Tactin® Superflow® high capacity, IBA Lifesciences, 
Göttingen, Germany); lane 3-7: 10 µL wash fractions; lane 8: 10 µL of the elution fraction of the in-vivo 
cross-linked bait protein RnfB [A] or RnfC [B]; lane 9: 10 µL of the 30-fold concentrated elution fraction 































































8.4 Gel-based LC-MS/MS identified interaction partners of the C. difficile 




C. difficile 630Δerm_pMTL82151 wildtype affinity chromatographed as a quality Strep-
Tactin® column control  
 
 
Table 26: List of the LC-MS/MS identified proteins in the cut-out gel-slices C1-C3 after affinity chroma-
tography of the soluble fraction of the cell free extract from C. difficile 630Δerm_pMTL82151 
 
 








4hbD CD630DERM_23380 42 10 6.28E+07 
Acetate kinase AckA CD630DERM_11750 44 21 2.53E+08 
Acetoacetyl-CoA 
thiolase 
ThlA1 CD630DERM_10590 41 24 1.30E+09 
Acryloyl-CoA reduc-
tase electron trans-
fer subunit beta 




AcdB CD630DERM_03990 41 19 2.45E+08 
Aldehyde-alcohol 
dehydrogenase 
AdhE1 CD630DERM_29660 96 5 3.26E+06 
Butyrate kinase Buk CD630DERM_01130 38 8 2.08E+07 
Butyryl-CoA dehyd-
rogenase 
Bcd2 CD630DERM_10540 41 14 1.95E+08 
Carnitine dehydra-
tase 
HadA CD630DERM_03950 44 28 7.16E+08 
Cysteine desul-
furase 
IscS1 CD630DERM_07530 44 10 3.49E+07 




EtfA1 CD630DERM_04010 36 4 3.03E+06 
Glutamate dehyd-
rogenase 











Protein-protein interactions of the bait proteins PrdA and PrdB of C. difficile 
630∆erm_pMTL82151prdA/prdB strep II in absence of the cross-linker formaldehyde  
 
Table 27: List of gel-based LC-MS/MS identified PrdA and PrdB interactions in the different gel slices 




Pgk CD630DERM_31730 43 17 1.78E+08 
Proline racemase PrdF CD630DERM_32370 36 9 6.04E+07 
Precursor of the S-
layer proteins 
SlpA CD630DERM_27930 76 27 1.42E+08 
Pyruvate car-
boxylase 
PycA CD630DERM_00210 128 6 6.70E+06 
Rubrerythrin family 
protein 
Rbr CD630DERM_08250 21 18 5.01E+09 
R-phenyllactate de-
hydratase 
FldB D5PZU3 47 9 7.89E+07 






 UP A UP A 
ATP synthase  











32 - - 3 1.90
E+06 
F-type H+-transporting 
ATPase subunit alpha 
AtpA1 CD630DERM_
34700 






subunit alpha  
EtfA1 CD630DERM_
04010 
36 - - 15 1.19
E+08 
Electron transfer fla-





















47 - - 30 3.12
E+08 
Proline racemase PrdF CD630DERM_
32370 
36 - - 26 2.81
E+08 
Butanoate-, fatty acid metabolism, glycolysis/glyconeogenesis, pentose phosphate  

















































Butyrate kinase Buk CD630DERM_
01130 




























genase subunit A 
GapA CD630DERM_
31740 




























128 - - 82 1.16
E+08 
Pyruvate kinase  Pyk CD630DERM_
33940 





Green highlight: proteins which are included in the list of identified proteins in the strep-tagged chro-
matographed wildtype (table 26), but in comparison to that the proteins here are highly enriched in the 




Protein-protein interactions of the bait proteins RnfB and RnfC of C. difficile 
630∆erm_pMTL82151rnfB/rnfC strep II in absence of the cross-linker formaldehyde  
 
 
Table 28: List of gel-based LC-MS/MS identified RnfB and RnfC interactions in the different gel-slices 






hyde dehydrogenase  
SucD CD630DERM_
23420 
51 - - 34 4.50
E+08 
Oxidoreductase  
Ferritin  FtnA CD630DERM_
21950 












GrdD A0A170WEG3  40 - - 9 4.88
E+06 
Indolepyruvate ferre-
doxin oxidoreductase  
IorA CD630DERM_
23810 
66 - - 3 4.28
E+06 






 UP A UP A 
ATP synthase 













































































































Butanoate-, fatty acid metabolism, glycolysis/glyconeogenesis, pentose phosphate 





















55 - - 12 1.76
E+07 
4-hydroxybutyrate 

























Green highlight: proteins which are included in the list of identified proteins in the strep-tagged chro-
matographed wildtype (table 26), but in comparison to that the proteins here are highly enriched in the 



























































33 - - 9 6.98
E+06 
Pyruvate carboxylase PycA CD630DERM_
00210 

















hyde dehydrogenase  
SucD CD630DERM_
23420 















66 - - 14 7.42
E+06 
Indolepyruvate ferre-















Protein-protein interactions of the bait proteins PrdA and PrdB of C. difficile 
630∆erm_pMTL82151prdA/prdB strep II in presence of the cross-linker formaldehyde  
 
Table 29: List of gel-based LC-MS/MS identified formaldehyde cross-linked PrdA and PrdB interactions 
in the gel-slices (UP: unique peptide; A: abundance) 






 UP A UP A 
ATP synthase  
































































Butanoate-, fatty acid metabolism, glycolysis/glyconeogenesis, pentose phosphate pathway, 










































tase electron transfer 
subunit beta 















































































































Green highlight: proteins which are included in the list of identified proteins in the strep-tagged chro-
matographed wildtype (table 26), but in comparison to that the proteins here are highly enriched in the 
elution fraction of the bait samples.  
 
 
Protein-protein interactions of the bait proteins RnfB and RnfC of C. difficile 




Table 30:  List of gel-based LC-MS/MS identified formaldehyde cross-linked RnfB and RnfC interactions 






























 UP A UP A 
ATP synthase 




65 - - 3 3.28
E+05 



































ATPase subunit delta AtpF1 CD630DERM_
34710 

























































36 - - 16 2.82
E+08 
Butanoate-, fatty acid metabolism, glycolysis/glyconeogenesis, pentose phosphate 





















































34 - - 15 4.35
E+07 
Butyrate kinase Buk CD630DERM_
01130 





















Green highlight: proteins which are included in the list of identified proteins in the strep-tagged chro-
matographed wildtype (table 26), but in comparison to that the proteins here are highly enriched in the 































































Ferritin  FtnA CD630DERM_
21950 
















66 - - 6 1.15
E+06 
Toxin 
Toxin A TcdA CD630DERM_
06630 
307 - - 18 4.20
E+06 










8.5 In vitro biochemically characterization of the rnfC mutant strain  
 
8.5.1 Data of growth curves of the rnfC mutant strain CD630∆erm_rnfC636/637s::ermB 
compared to the wildtype CD630∆erm in BHI(S) 
 




























0 0.05 0.06 0.06 0.05 0.05 0.05 0.00 
1 0.13 0.14 0.15 0.11 0.13 0.13 0.01 
2 0.28 0.27 0.29 0.27 0.27 0.28 0.01 
3 0.63 0.59 0.57 0.61 0.62 0.60 0.02 
4 1.18 1.05 1.06 1.1 1.07 1.09 0.05 
5 1.29 1.23 1.27 1.29 1.24 1.26 0.02 
6 1.46 1.4 1.45 1.44 1.43 1.44 0.02 
7 1.51 1.51 1.48 1.5 1.52 1.50 0.01 
8 1.57 1.56 1.57 1.59 1.57 1.57 0.01 
9 1.6 1.6 1.6 1.59 1.57 1.59 0.01 
10 1.53 1.53 1.52 1.56 1.55 1.54 0.01 
11 1.53 1.5 1.49 1.47 1.55 1.51 0.03 
12 1.45 1.48 1.48 1.49 1.47 1.47 0.01 
13 1.47 1.48 1.46 1.48 1.47 1.47 0.01 
14 1.43 1.44 1.43 1.41 1.41 1.42 0.01 
15 1.34 1.36 1.42 1.38 1.32 1.36 0.03 








8.5.2 Data of the fluorometric assay of the D-proline reductase activity  
 
Table 33:  Data of the fluorometric activity assay of the wildtype CD630∆erm for T1 and T2 at 450nm 

















0 0.05 0.06 0.05 0.06 0.05 0.05 0.00 
1 0.08 0.07 0.07 0.06 0.08 0.07 0.01 
2 0.08 0.08 0.1 0.1 0.08 0.09 0.01 
3 0.12 0.09 0.12 0.08 0.13 0.11 0.02 
4 0.18 0.12 0.17 0.14 0.16 0.15 0.02 
5 0.22 0.16 0.2 0.21 0.2 0.20 0.02 
6 0.36 0.29 0.37 0.37 0.34 0.35 0.03 
7 0.52 0.43 0.51 0.49 0.5 0.49 0.03 
8 0.71 0.64 0.71 0.7 0.69 0.69 0.03 
9 0.73 0.73 0.75 0.71 0.71 0.73 0.01 
10 0.76 0.75 0.75 0.74 0.74 0.75 0.01 
11 0.75 0.75 0.79 0.75 0.75 0.76 0.02 
12 0.74 0.74 0.76 0.72 0.72 0.74 0.01 
13 0.74 0.77 0.77 0.73 0.76 0.75 0.02 
14 0.72 0.71 0.72 0.69 0.71 0.71 0.01 
15 0.73 0.73 0.75 0.72 0.71 0.73 0.01 


















Relative fluorescence intensity  
(R1) + D-proline 
Relative fluorescence intensity 




0 586.92 347.14 505.74 484.43 87.44 310.93 
30 485.55 220.11 721.31 399.75 146.84 621.04 




0 586.93 1343.13 1528.35 585.22 1023.18 745.63 
30 580.27 1032.23 833.27 584.07 831.89 629.71 
60 761.36 1373.02 1079.30 757.32 1197.91 847.63 
5-aminovalerate 
determination 
Normalized fluorescence  
Intensity (R1-R2) 
Concentration of 5-aminovalerate 




0 102.49 259.70 194.82 0.95 2.40 1.80 
30 85.80 73.27 100.27 0.79 0.68 0.93 
60 179.33 298.19 227.41 1.66 2.75 2.10 
 
T2 
0 1.71 319.95 782.72 0.02 3.39 8.30 








Table 34:  Data of the fluorometric activity assay of the strain CD630∆erm_rnfC636/637s::ermB for T1 
and T2 at 450nm (5-aminovalerate standard of T1 data set: y = 105,62x and T2: y = 154,81x) 
 
 60 4.05 175.11 231.67 0.04 1.86 2.46 
5-aminovalerate 
determination 






0 1.70 0.59 
30 0.80 0.10 




0 3.90 3.40 
30 2.14 0.02 


















Relative fluorescence intensity  
(R1) + D-proline 
Relative fluorescence intensity 




0 470.06 476.15 380.49 383.16 425.87 330.73 
30 412.81 509.67 377.08 345.39 417.73 363.29 




0 647.27 544.46 546.76 384.64 483.96 446.24 
30 495.64 450.76 385.84 313.46 348.25 340.00 
60 558.66 522.53 604.42 480.27 455.96 448.29 
5-aminovalerate 
determination 
Normalized fluorescence  
Intensity (R1-R2) 
Concentration of 5-aminovalerate 




0 86.90 50.28 49.76 0.82 0.48 0.47 
30 67.42 91.94 13.79 0.64 0.87 0.13 




0 262.63 60.50 100.53 1.70 0.40 0.65 
30 182.19 102.51 45.84 1.18 0.66 0.30 
60 78.40 66.57 156.13 0.51 0.43 1.01 
5-aminovalerate 
determination 






0 0.59 0.16 
30 0.55 0.31 




0 0.92 0.56 
30 0.71 0.36 




The original fluorescence data and the analysis of the corresponding standards are 
shown in the digital appendix. The mean value and the sandard deviation of the concen-
tration of 5-aminovalerate after a reaction time of 60 min of the wildtype and rnfC mu-
tant strain at the time points T1 and T2 were included for the analysis in this thesis and 
highlighted in a grey box. 
 
 
8.5.3 Data of the NAD+/NADH ratio in the rnfC mutant and wildtype strain 
 
Table 35:  Data of the NAD+/NADH ratio measurement of the wildtype CD630∆erm for T1 and T2  






















































712.94 621.30 891.50 924.05 395.97 197.99 
NADH 
[nM] 






































































Table 36:  Data of the NAD+/NADH ratio measurement of the strain CD630∆erm_rnfC636/637s::ermB 
for T1 and T2 (values provided by Dr. Petra Henke, DSMZ in Braunschweig) 
 
 
8.5.4 Data of the TcdA and TcdB concentration in the rnfC mutant and willdtype strain 
supernatant performed via the toxin ELISA test  
Table 37:  Data of the TcdA and TcdB concentration measurement of the strains CD630∆erm (WT) and 
CD630∆erm_rnfC636/637s::ermB (rnfC mutant)  for T1 and T2 (TcdA standard: y = 0.1389x + 0.019; 

















































977.28 190.77 95.39 
NADH 
[nM] 
29.47 33.48 30.58 38.16 31.07 
 

















































































T1 0.019 0.021 0.022 0.022 0.022 
T2 0.046 0.042 0.046 0.043 0.029 
rnfC 
mutant 
T1 0.085 0.082 0.066 0.137 0.054 





T1 0.024 0.022 0.036 0.028 0.015 






The original fluorescence data of 450 nm and 620 nm as well as the analyses of the 
standard curve TcdA and TcdB are shown in the digital appendix. The mean value and 
the sandard deviation of the concentration of TcdA and TcdB of the wildtype and rnfC 
mutant strain at the time points T1 and T2 were included for the analyses in this thesis 










T1 0.028 0.033 0.020 0.024 0.018 
T2 0.020 0.019 0.022 0.027 0.025 
 
Concentration [ng/mL]  
(via standard) 






T1 0.000 0.014 0.022 0.022 0.022 
T2 0.194 0.166 0.194 0.173 0.072 
rnfC 
mutant 
T1 0.475 0.454 0.338 0.850 0.252 






T1 0.094 0.078 0.188 0.125 0.024 
T2 0.071 0.094 0.094 0.110 0.102 
rnfC 
mutant 
T1 0.125 0.165 0.063 0.094 0.047 
T2 0.063 0.055 0.078 0.118 0.102 






T1 0.016 0.009 
T2 0.160 0.045 
rnfC 
mutant 
T1 0.474 0.205 






T1 0.102 0.054 
T2 0.094 0.013 
rnfC 
mutant 
T1 0.099 0.043 




8.5.5 Fold change data of the metabolomics experiments  
 
Table 38:  Fold change (FC) data of the metabolite and CoA derivates MS measurement of the 
CD630∆erm_rnfC636/637s::ermB (rnfC mutant) versus  CD630∆erm (WT) at T1 and T2 (FC: mean 















Proline 60.02 0.86 Crotonoyl-CoA 9.35 4.12 





7.36 7.85 Butanoyl-CoA 7.15 2.52 








Fructose 4.10 2.85 2-Isocaprenoyl-CoA  5.36 1.38 
Succinate 2.82 0.23 Acetoacetyl-CoA 3.29 0.99 
Tyrosine 2.77 0.19 3-phenylpropanoyl-
CoA 
2.27 2.69 






2.21 WT Phenyllactyl-CoA 2.00 3.20 
lysine 2.21 0.94 3-Hydroxyisovaleryl-
CoA 
1.59 1.94 








Xylose 2.13 1.01 Lactoyl-CoA 1.44 4.11 
Valine 2.11 1.18 NADPH 1.15 0.47 
Ribose-5-
phosphate 
2.09 0.69 2-Heptenoyl-CoA 1.10 0.53 
N-acetyl- 
glucosamine 
1.97 1.34 Hexenoyl-CoA 0.91 2.68 
Threonine 1.96 1.44 Propanoyl-CoA 0.91 2..11 










1.85 1.23 Heptanoyl-CoA 0.63 0.75 
Ornithine 1.84 0.53 ADP 0.62 0.54 
2-phospho 
glycolate 





1.79 0.39 CoA-disulfide 0.60 1.36 
Glutamate 1.74 0.85 NAD 0.59 0.52 
Aspartate 1.74 0.66 ATP 0.55 0.44 
Leucine 1.74 1.10 Isocaproyl-CoA  0.49 0.97 
Cytosine 1.70 0.51 Malonyl-CoA 0.46 0.55 
Gluconic- 
acid 
1.64 1.18 (S)-2-Methyl- 
butanoyl-CoA 
0.46 0.56 
Glycine 1.63 1.23 AMP 0.45 0.89 
Hydrocinna-
mic acid 
1.59 1.27 (4-Hydroxyphenyl) 
lactoyl-CoA 
0.44 0.88 
Malate 1.58 0.75 3-Oxopentanoyl-CoA 0.43 1.19 
Fumarate 1.57 0.54 Acetyl-CoA 0.43 0.57 




1.55 0.58 NADH 0.32 0.32 
Acetoacetate 1.33 Mut 3-Hydroxypentanoyl-
CoA 
0.30 3.96 





1.18 0.31 2-Pentenoyl-CoA 0.28 1.65 
Thymine 1.18 0.51 4-Methylthio-
butyryl-CoA 
0.27 0.74 
AMP 1.15 0.27 Pentanoyl-CoA 0.21 1.60 
Tryptophan 1.10 0.37 Hexanoyl-CoA Mut 0.42 
Methionine 1.05 0.65    
2-oxogluta-
rate 
0.93 0.46    
3-phospho 
glycerate 




0.87 0.33    
Sorbitol-6-
phosphate 
0.77 0.48    








Table 39:  Fold change (FC) data of the volatile acids (cell content), exometabolites (culture superna-
tant), amino acids (culture supernatant) and 5-aminovalerate (culture supernatant) measurement of 
the CD630∆erm_rnfC636/637s::ermB (rnfC mutant) against  CD630∆erm (WT) at T1 and T2 (FC: mean 
normalized peak arearnfC mutant / mean normalized peak areaWT) 
Glycerol-3-
phosphate 
0.64 0.45    
Nicotinic  
acid 
0.60 0.39    
Iminodi 
acetate 
0.34 2.21    
Fructose-6-
phosphate 
0.33 1.35    
Glucose-6-
phosphate 




0.12 WT    




0.00 2.33    














5.05 Mut 3-Methyl-1- 
butanol 
1.55 1.35 





3.31 Mut Pentanoate 0.83 0.43 
2-oxoglutarate 2.27 3.03 5-Methyl 
hexanoate 
0.81 0.58 
2-hydroxybutanoate 2.27 0.93 3-Methyl 
butanoate 
0.58 0.77 
Hydrocinnamic acid 1.65 1.80 4-Methyl 
pentanoate 
0.48 2.37 














Phenylpyruvate 1.39 7.94 Propanoate 0.45 1.56 
Glycerate 1.18 0.52 2-Methyl 
propanoate 
0.37 0.70 
Succinate 1.05 0.58 2-Methyl-1- 
propanol 
0.00 0.09 
Cysteine 0.91 Mut 1-Propanol 0.00 0.10 
Isocaproate 0.71 0.53 1-Pentanol 0.00 0.12 
4-methylthio-2-oxo 
butanoate 
0.65 Mut Ethanol 0.00 0.15 





0.49 0.34 1-Butanol WT 0.03 
 







0.00 0.20 Proline 7.63 0.00 
3-(4-hydroxyphenyl) 
-lactate 
Mut 0.59 Alanine 0.87 1.74 
4-hydroxybutanoate Mut 1.15 Isoleucine 0.74 5.20 
3-hydroxybutanoate Mut Mut Serine 0.74 2.37 
   Valine 0.68 2.52 
   Glutamate 0.67 0.84 
   Phenylalanine 0.67 0.06 
   Lysine 0.67 0.78 
   Leucine 0.66 0.97 
   Methionine 0.65 1.13 
   Threonine 0.61 Mut 
   Histidine 0.54 0.77 






Figure 44: DNA agarose gel of the amplified DNA fragments of PCR samples from the wildtype C. difficile 
630Δerm strain (without pMTL82151), rnfC mutant strain 
(CD630∆erm_rnfC636/637s::ermB_pMTL82151) and rnfC-complemented mutant strain 
(CD630∆erm_rnfC636/637s::ermB_pMTL82151rnfC-strep II) using the primer M13_fw/M13_rev. Shown 
is an agarose gel containing amplified DNA fragments by using the primers M13_fw/M13_rev  binding to 
the vector pMTL82151 or pMTL82151rnfC-strep. After DNA extraction from the respective C. difficile 
strain, PCR "Confirmation of the constructed C. difficile pMTL82151 strains by PCR" (see chapter 3.3.10) 
was performed. Based on the different amplified DNA fragment sizes, conclusions can be reached about 
the previous strain for mouse infection experiments (see chapter 3.7). The expected amplified DNA target 
fragment of pMTL82151 has a size of ~150 bp and pMTL82151rnfC-strep II of ~1690 bp. The PCR samples 
were load onto a 1 % agarose gel and the fragments were separated for ~ 50 min and 100 V. 1: 7µL DNA 
ladder Quick-Load® Purple 1 kb Plus DNA Ladder (New England Biolabs GmbH; Frankfurt am Main, Ger-
many); 2: 10 µL PCR sample of dH2O as PCR template, negative control; 3: 10 µL PCR sample from the 
wildtype; 4: 10 µL PCR sample of amplified pMTL82151rnfC-strep II from rnfC-complemented mutant 
strain; 5: 10 µL PCR sample of amplified pMTL82151 from rnfC mutant strain; 6 – 10: empty 
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Ein besonderer Dank geht an meine besten Freunde, die immer an meiner Seite waren, 
in schönen sowie in traurigen Momenten. Ihr habt mich immer aufgefangen, gestärkt 
und begleitet. Ich danke Dir Stephen Heß, Gina Hoga, Miriam Mege und Anna Hirsch. 
Ebenfalls möchte ich mich bei Ümran Karsli und Jasper Liedtke für die tolle Freundschaft 
und der mentalen Unterstützung, vorallem in der Schreibphase der Doktorarbeit, herz-
lich bedanken!  
 
 
Zum Abschluss möchte ich noch den Menschen danken, die mich lieben, unterstützen, 
formen und prägen: Mama, Papa, Tom und Oma.  
Danke, dass ihr immer für mich da seid, mir ein Zuhause gebt und immer an mich ge-
glaubt habt. Ohne euch wäre ich nicht da, wo ich jetzt bin. Ich bin stolz, dass wir uns 
immer gegenseitig Halt geben. Ich liebe euch! 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
